2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007;9:335–79.

pubmed: 17599941 doi: 10.1093/europace/eum120

Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-96.e21.

pubmed: 22386883 doi: 10.1016/j.hrthm.2011.12.016

Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33:369–409.

pubmed: 29021841 pmcid: 5634725 doi: 10.1016/j.joa.2017.08.001

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125-51.

pubmed: 30686041 doi: 10.1161/CIR.0000000000000665

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.

pubmed: 32860505 doi: 10.1093/eurheartj/ehaa612

Diederichsen SZ, Haugan KJ, Brandes A, Lanng MB, Graff C, Krieger D, et al. Natural history of subclinical atrial fibrillation detected by implanted loop recorders. J Am Coll Cardiol. 2019;74:2771–81.

pubmed: 31779791 doi: 10.1016/j.jacc.2019.09.050

Aguilar M, Macle L, Deyell MW, Yao R, Hawkins NM, Khairy P, et al. Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design. Circulation. 2022;145:21–30.

pubmed: 34816727 doi: 10.1161/CIRCULATIONAHA.121.056109

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104–32.

pubmed: 30703431 doi: 10.1016/j.jacc.2019.01.011

Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36:1847–948.

pubmed: 33191198 doi: 10.1016/j.cjca.2020.09.001

NHFA CSANZ Atrial Fibrillation Guideline Working Group, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ. 2018;27:1209–66.

doi: 10.1016/j.hlc.2018.06.1043

Cheung CC, Nattel S, Macle L, Andrade JG. Management of atrial fibrillation in 2021: an updated comparison of the current CCS/CHRS, ESC, and AHA/ACC/HRS guidelines. Can J Cardiol. 2021;37:1607–18.

pubmed: 34186113 doi: 10.1016/j.cjca.2021.06.011

Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–68.

pubmed: 7671380 doi: 10.1161/01.CIR.92.7.1954

Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation. 1998;98:2202–9.

pubmed: 9815876 doi: 10.1161/01.CIR.98.20.2202

Crijns HJ, van Wijk LM, van Gilst WH, Kingma JH, van Gelder IC, Lie KI. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J. 1988;9:634–8.

pubmed: 3137061 doi: 10.1093/oxfordjournals.eurheartj.a062553

Suttorp MJ, Kingma JH, Jessurun ER, Lie AHL, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol. 1990;16:1722–7.

pubmed: 2123909 doi: 10.1016/0735-1097(90)90326-K

Andrade JG, Deyell MW, Verma A, Macle L, Champagne J, Leong-Sit P, et al. Association of atrial fibrillation episode duration with arrhythmia recurrence following ablation: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3: e208748.

pubmed: 32614422 pmcid: 7333024 doi: 10.1001/jamanetworkopen.2020.8748

Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke. 2011;42:1768–70.

pubmed: 21493904 doi: 10.1161/STROKEAHA.110.609297

Van Gelder IC, Healey JS, Crijns H, Wang J, Hohnloser SH, Gold MR, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38:1339–44.

pubmed: 28329139 doi: 10.1093/eurheartj/ehx042

Chew DS, Li Z, Steinberg BA, O’Brien EC, Pritchard J, Bunch TJ, et al. Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices. Circ Arrhythm Electrophysiol. 2022;15: e010304.

pubmed: 35089799 doi: 10.1161/CIRCEP.121.010304

Charitos EI, Purerfellner H, Glotzer TV, Ziegler PD. Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol. 2014;63:2840–8.

pubmed: 24814497 doi: 10.1016/j.jacc.2014.04.019

Andrade JG, Yao RRJ, Deyell MW, Hawkins NM, Rizkallah J, Jolly U, et al. Clinical assessment of AF pattern is poorly correlated with AF burden and post ablation outcomes: a CIRCA-DOSE sub-study. J Electrocardiol. 2020;60:159–64.

pubmed: 32371199 doi: 10.1016/j.jelectrocard.2020.03.008

De With RR, Erkuner O, Rienstra M, Nguyen BO, Korver FWJ, Linz D, et al. Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V. Europace. 2020;22:1162–72.

pubmed: 32642768 pmcid: 7400474 doi: 10.1093/europace/euaa123

Blum S, Meyre P, Aeschbacher S, Berger S, Auberson C, Briel M, et al. Incidence and predictors of atrial fibrillation progression: a systematic review and metaanalysis. Heart Rhythm. 2019;16:502–10.

pubmed: 30366160 doi: 10.1016/j.hrthm.2018.10.022

Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987;317:669–74.

pubmed: 3627174 doi: 10.1056/NEJM198709103171104

Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm. 2008;5:1501–7.

pubmed: 18842464 doi: 10.1016/j.hrthm.2008.08.011

Simantirakis EN, Papakonstantinou PE, Kanoupakis E, Chlouverakis GI, Tzeis S, Vardas PE. Recurrence rate of atrial fibrillation after the first clinical episode: a prospective evaluation using continuous cardiac rhythm monitoring. Clin Cardiol. 2018;41:594–600.

pubmed: 29761516 pmcid: 6489953 doi: 10.1002/clc.22904

Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2022;388:105–16.

pubmed: 36342178 doi: 10.1056/NEJMoa2212540

Nguyen BO, Weberndorfer V, Crijns HJ, Geelhoed B, Ten Cate H, Spronk H, et al. Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation. Heart. 2022;109:186–94.

pubmed: 35858774 doi: 10.1136/heartjnl-2022-321027

Potpara TS, Stankovic GR, Beleslin BD, Polovina MM, Marinkovic JM, Ostojic MC, et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade atrial fibrillation study. Chest. 2012;141:339–47.

pubmed: 21622553 doi: 10.1378/chest.11-0340

Padfield GJ, Steinberg C, Swampillai J, Qian H, Connolly SJ, Dorian P, et al. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. Heart Rhythm. 2017;14:801–7.

pubmed: 28232263 doi: 10.1016/j.hrthm.2017.01.038

Piccini JP, Passman R, Turakhia M, Connolly AT, Nabutovsky Y, Varma N. Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices. Europace. 2019;21:404–13.

pubmed: 30462208 doi: 10.1093/europace/euy222

de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–31.

pubmed: 20170808 doi: 10.1016/j.jacc.2009.11.040

Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149:489–96.

pubmed: 15864238 doi: 10.1016/j.ahj.2004.09.053

Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, et al. The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2004;148:649–54.

pubmed: 15459596 doi: 10.1016/j.ahj.2004.04.029

Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29:2227–33.

pubmed: 18611964 pmcid: 2733739 doi: 10.1093/eurheartj/ehn324

Vitolo M, Proietti M, Imberti JF, Bonini N, Romiti GF, Mei DA, et al. Factors associated with progression of atrial fibrillation and impact on all-cause mortality in a cohort of European patients. J Clin Med. 2023;12:768.

pubmed: 36769416 pmcid: 9917523 doi: 10.3390/jcm12030768

De With RR, Marcos EG, Dudink E, Spronk HM, Crijns H, Rienstra M, et al. Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study. Europace. 2020;22:352–60.

pubmed: 31865391 doi: 10.1093/europace/euz339

Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet. 2005;118:179–84.

pubmed: 16133178 doi: 10.1007/s00439-005-0034-8

Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006;27:708–12.

pubmed: 16428254 doi: 10.1093/eurheartj/ehi727

Lubitz SA, Yin X, Fontes JD, Magnani JW, Rienstra M, Pai M, et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA. 2010;304:2263–9.

pubmed: 21076174 pmcid: 3073054 doi: 10.1001/jama.2010.1690

Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003;299:251–4.

pubmed: 12522251 doi: 10.1126/science.1077771

Olesen MS, Bentzen BH, Nielsen JB, Steffensen AB, David JP, Jabbari J, et al. Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet. 2012;13:24.

pubmed: 22471742 pmcid: 3359244 doi: 10.1186/1471-2350-13-24

Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet. 2004;75:899–905.

pubmed: 15368194 pmcid: 1182120 doi: 10.1086/425342

Mann SA, Otway R, Guo G, Soka M, Karlsdotter L, Trivedi G, et al. Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol. 2012;59:1017–25.

pubmed: 22402074 doi: 10.1016/j.jacc.2011.11.039

Sinner MF, Pfeufer A, Akyol M, Beckmann BM, Hinterseer M, Wacker A, et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J. 2008;29:907–14.

pubmed: 18222980 doi: 10.1093/eurheartj/ehm619

Olesen MS, Refsgaard L, Holst AG, Larsen AP, Grubb S, Haunso S, et al. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res. 2013;98:488–95.

pubmed: 23400760 doi: 10.1093/cvr/cvt028

Christophersen IE, Olesen MS, Liang B, Andersen MN, Larsen AP, Nielsen JB, et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J. 2013;34:1517–25.

pubmed: 23264583 doi: 10.1093/eurheartj/ehs442

Tsai CT, Hsieh CS, Chang SN, Chuang EY, Juang JM, Lin LY, et al. Next-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation. J Med Genet. 2015;52:28–36.

pubmed: 25391453 doi: 10.1136/jmedgenet-2014-102618

Olesen MS, Yuan L, Liang B, Holst AG, Nielsen N, Nielsen JB, et al. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet. 2012;5:450–9.

pubmed: 22685113 doi: 10.1161/CIRCGENETICS.111.962597

Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS, et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:268–75.

pubmed: 19808477 pmcid: 2727725 doi: 10.1161/CIRCEP.108.779181

Li RG, Wang Q, Xu YJ, Zhang M, Qu XK, Liu X, et al. Mutations of the SCN4B-encoded sodium channel beta4 subunit in familial atrial fibrillation. Int J Mol Med. 2013;32:144–50.

pubmed: 23604097 doi: 10.3892/ijmm.2013.1355

Feghaly J, Zakka P, London B, MacRae CA, Refaat MM. Genetics of atrial fibrillation. J Am Heart Assoc. 2018;7: e009884.

pubmed: 30371258 pmcid: 6474960 doi: 10.1161/JAHA.118.009884

Pessente GD, Sacilotto L, Calil ZO, Olivetti NQS, Wulkan F, de Oliveira TGM, et al. Effect of occurrence of Lamin A/C (LMNA) genetic variants in a cohort of 101 consecutive apparent “Lone AF” patients: results and insights. Front Cardiovasc Med. 2022;9: 823717.

pubmed: 35449878 pmcid: 9016147 doi: 10.3389/fcvm.2022.823717

Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448:353–7.

pubmed: 17603472 doi: 10.1038/nature06007

Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018;50:1225–33.

pubmed: 29892015 pmcid: 6136836 doi: 10.1038/s41588-018-0133-9

Roselli C, Rienstra M, Ellinor PT. Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond. Circ Res. 2020;127:21–33.

pubmed: 32716721 pmcid: 7388073 doi: 10.1161/CIRCRESAHA.120.316575

Lee JY, Kim TH, Yang PS, Lim HE, Choi EK, Shim J, et al. Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility loci. Eur Heart J. 2017;38:2586–94.

pubmed: 28460022 doi: 10.1093/eurheartj/ehx213

Low SK, Takahashi A, Ebana Y, Ozaki K, Christophersen IE, Ellinor PT, et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat Genet. 2017;49:953–8.

pubmed: 28416822 doi: 10.1038/ng.3842

Weng LC, Choi SH, Klarin D, Smith JG, Loh PR, Chaffin M, et al. Heritability of atrial fibrillation. Circ Cardiovasc Genet. 2017;10: e001838.

pubmed: 29237688 pmcid: 5966046 doi: 10.1161/CIRCGENETICS.117.001838

Shoemaker MB, Shah RL, Roden DM, Perez MV. How will genetics inform the clinical care of atrial fibrillation? Circ Res. 2020;127:111–27.

pubmed: 32716712 pmcid: 8436048 doi: 10.1161/CIRCRESAHA.120.316365

Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. Europace. 2022;24:1307–67.

pubmed: 35373836 pmcid: 9435643 doi: 10.1093/europace/euac030

Weiss JN, Garfinkel A, Karagueuzian HS, Chen PS, Qu Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm. 2010;7:1891–9.

pubmed: 20868774 pmcid: 3005298 doi: 10.1016/j.hrthm.2010.09.017

Nattel S, Heijman J, Zhou L, Dobrev D. Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective. Circ Res. 2020;127:51–72.

pubmed: 32717172 pmcid: 7398486 doi: 10.1161/CIRCRESAHA.120.316363

Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453–68.

pubmed: 24763464 doi: 10.1161/CIRCRESAHA.114.303211

Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66.

pubmed: 9725923 doi: 10.1056/NEJM199809033391003

Ehrlich JR, Cha TJ, Zhang L, Chartier D, Melnyk P, Hohnloser SH, et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol. 2003;551:801–13.

pubmed: 12847206 pmcid: 2343292 doi: 10.1113/jphysiol.2003.046417

Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence S, et al. Electroanatomic properties of the pulmonary veins: slowed conduction, low voltage and altered refractoriness in AF patients. J Cardiovasc Electrophysiol. 2011;22:1083–91.

pubmed: 21635610 doi: 10.1111/j.1540-8167.2011.02089.x

Elbatran AI, Anderson RH, Mori S, Saba MM. The rationale for isolation of the left atrial pulmonary venous component to control atrial fibrillation: a review article. Heart Rhythm. 2019;16:1392–8.

pubmed: 30885736 doi: 10.1016/j.hrthm.2019.03.012

Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14:1087–96.

pubmed: 28259694 doi: 10.1016/j.hrthm.2017.02.030

Mansour M, Mandapati R, Berenfeld O, Chen J, Samie FH, Jalife J. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation. 2001;103:2631–6.

pubmed: 11382735 doi: 10.1161/01.CIR.103.21.2631

Lazar S, Dixit S, Marchlinski FE, Callans DJ, Gerstenfeld EP. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation. 2004;110:3181–6.

pubmed: 15533867 doi: 10.1161/01.CIR.0000147279.91094.5E

Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation. 2000;101:194–9.

pubmed: 10637208 doi: 10.1161/01.CIR.101.2.194

Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature. 1992;355:349–51.

pubmed: 1731248 doi: 10.1038/355349a0

Hansen BJ, Zhao J, Csepe TA, Moore BT, Li N, Jayne LA, et al. Atrial fibrillation driven by micro-anatomic intramural reentry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J. 2015;36:2390–401.

pubmed: 26059724 pmcid: 4568403 doi: 10.1093/eurheartj/ehv233

Narayan SM, Wright M, Derval N, Jadidi A, Forclaz A, Nault I, et al. Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm. 2011;8:244–53.

pubmed: 20955820 doi: 10.1016/j.hrthm.2010.10.020

Zaman JAB, Sauer WH, Alhusseini MI, Baykaner T, Borne RT, Kowalewski CAB, et al. Identification and characterization of sites where persistent atrial fibrillation is terminated by localized ablation. Circ Arrhythm Electrophysiol. 2018;11: e005258.

pubmed: 29330332 pmcid: 5769709 doi: 10.1161/CIRCEP.117.005258

Baykaner T, Rogers AJ, Meckler GL, Zaman J, Navara R, Rodrigo M, et al. Clinical implications of ablation of drivers for atrial fibrillation: a systematic review and metaanalysis. Circ Arrhythm Electrophysiol. 2018;11: e006119.

pubmed: 29743170 pmcid: 6474343 doi: 10.1161/CIRCEP.117.006119

Garrey WE. Auricular fibrillation. Physiol Rev. 1924;4:215–50.

doi: 10.1152/physrev.1924.4.2.215

Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964;67:200–20.

pubmed: 14118488 doi: 10.1016/0002-8703(64)90371-0

Kirchhof C, Chorro F, Scheffer GJ, Brugada J, Konings K, Zetelaki Z, et al. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs. Circulation. 1993;88:736–49.

pubmed: 8339434 doi: 10.1161/01.CIR.88.2.736

Lee S, Sahadevan J, Khrestian CM, Cakulev I, Markowitz A, Waldo AL. Simultaneous biatrial high-density (510–512 electrodes) epicardial mapping of persistent and long-standing persistent atrial fibrillation in patients: new insights into the mechanism of its maintenance. Circulation. 2015;132:2108–17.

pubmed: 26499963 pmcid: 4666790 doi: 10.1161/CIRCULATIONAHA.115.017007

Kamali R, Kump J, Ghafoori E, Lange M, Hu N, Bunch TJ, et al. Area available for atrial fibrillation to propagate is an important determinant of recurrence after ablation. JACC Clin Electrophysiol. 2021;7:896–908.

pubmed: 33640348 pmcid: 9255558 doi: 10.1016/j.jacep.2020.11.008

Eckstein J, Maesen B, Linz D, Zeemering S, van Hunnik A, Verheule S, et al. Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. Cardiovasc Res. 2011;89:816–24.

pubmed: 20978006 doi: 10.1093/cvr/cvq336

Zhang L, van Schie MS, Knops P, Taverne Y, de Groot NMS. A novel diagnostic tool to identify atrial endo-epicardial asynchrony using signal fingerprinting. Hellenic J Cardiol. 2024;75:9–20.

pubmed: 37482189 doi: 10.1016/j.hjc.2023.07.006

Lee G, Kumar S, Teh A, Madry A, Spence S, Larobina M, et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J. 2014;35:86–97.

pubmed: 23935092 doi: 10.1093/eurheartj/eht267

Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol. 2010;3:606–15.

pubmed: 20719881 doi: 10.1161/CIRCEP.109.910125

Parameswaran R, Teuwen CP, Watts T, Nalliah CJ, Royse A, Goldblatt J, et al. Functional atrial endocardial-epicardial dissociation in patients with structural heart disease undergoing cardiac surgery. JACC Clin Electrophysiol. 2020;6:34–44.

pubmed: 31971904 doi: 10.1016/j.jacep.2019.08.016

Parameswaran R, Kalman JM, Royse A, Goldblatt J, Larobina M, Watts T, et al. Endocardial-epicardial phase mapping of prolonged persistent atrial fibrillation recordings: high prevalence of dissociated activation patterns. Circ Arrhythm Electrophysiol. 2020;13: e008512.

pubmed: 32634027 doi: 10.1161/CIRCEP.120.008512

Hong KL, Baley J, Baranchuk A, Bisleri G, Glover BM. Epicardial electrical activation during atrial fibrillation: looking at the other side of the coin. JACC Case Rep. 2019;1:401–2.

pubmed: 34316835 pmcid: 8288599 doi: 10.1016/j.jaccas.2019.07.027

Jiang R, Buch E, Gima J, Upadhyay GA, Nayak HM, Beaser AD, et al. Feasibility of percutaneous epicardial mapping and ablation for refractory atrial fibrillation: insights into substrate and lesion transmurality. Heart Rhythm. 2019;16:1151–9.

pubmed: 30776449 doi: 10.1016/j.hrthm.2019.02.018

Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014;63:493–505.

pubmed: 24291276 doi: 10.1016/j.jacc.2013.10.055

Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7:1475–81.

pubmed: 20601148 pmcid: 3106345 doi: 10.1016/j.hrthm.2010.06.030

Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58:2225–32.

pubmed: 22078429 doi: 10.1016/j.jacc.2011.05.061

Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol. 2012;23:797–9.

pubmed: 22554187 doi: 10.1111/j.1540-8167.2012.02341.x

Cochet H, Mouries A, Nivet H, Sacher F, Derval N, Denis A, et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015;26:484–92.

pubmed: 25727248 doi: 10.1111/jce.12651

Chrispin J, Ipek EG, Habibi M, Yang E, Spragg D, Marine JE, et al. Clinical predictors of cardiac magnetic resonance late gadolinium enhancement in patients with atrial fibrillation. Europace. 2017;19:371–7.

pubmed: 26965439

Ben Amar B, Bianca C. Towards a unified approach in the modeling of fibrosis: a review with research perspectives. Phys Life Rev. 2016;17:61–85.

pubmed: 27079617 doi: 10.1016/j.plrev.2016.03.005

Jalife J. Mechanisms of persistent atrial fibrillation. Curr Opin Cardiol. 2014;29:20–7.

pubmed: 24281345 doi: 10.1097/HCO.0000000000000027

Xintarakou A, Tzeis S, Psarras S, Asvestas D, Vardas P. Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps. Europace. 2020;22:342–51.

pubmed: 31998939 doi: 10.1093/europace/euaa009

Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230–46.

pubmed: 12062329 doi: 10.1016/S0008-6363(02)00258-4

Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011;89:744–53.

pubmed: 20962103 doi: 10.1093/cvr/cvq329

Fedorov VV, Hansen BJ. A secret marriage between fibrosis and atrial fibrillation drivers. JACC Clin Electrophysiol. 2018;4:30–2.

pubmed: 29600783 doi: 10.1016/j.jacep.2017.09.176

Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506.

pubmed: 24496537 doi: 10.1001/jama.2014.3

Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9:2003–9.

pubmed: 23000671 doi: 10.1016/j.hrthm.2012.08.039

Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119:1758–67.

pubmed: 19307477 pmcid: 2725019 doi: 10.1161/CIRCULATIONAHA.108.811877

Chen J, Arentz T, Cochet H, Müller-Edenborn B, Kim S, Moreno-Weidmann Z, et al. Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibrosis and arrhythmogenesis. Europace. 2019;21:1484–93.

pubmed: 31280323 doi: 10.1093/europace/euz159

Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38:53–61.

pubmed: 26612579 doi: 10.1093/eurheartj/ehv625

Nalliah CJ, Bell JR, Raaijmakers AJA, Waddell HM, Wells SP, Bernasochi GB, et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality. J Am Coll Cardiol. 2020;76:1197–211.

pubmed: 32883413 doi: 10.1016/j.jacc.2020.07.017

Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66:1–11.

pubmed: 26139051 doi: 10.1016/j.jacc.2015.04.058

Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J. 2017;38:1294–302.

pubmed: 26935271

Rocken C, Peters B, Juenemann G, Saeger W, Klein HU, Huth C, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 2002;106:2091–7.

pubmed: 12379579 doi: 10.1161/01.CIR.0000034511.06350.DF

Leone O, Boriani G, Chiappini B, Pacini D, Cenacchi G, Martin Suarez S, et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J. 2004;25:1237–41.

pubmed: 15246642 doi: 10.1016/j.ehj.2004.04.007

Steiner I, Hajkova P. Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy. Cardiovasc Pathol. 2006;15:287–90.

pubmed: 16979036 doi: 10.1016/j.carpath.2006.01.005

Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014;114:1483–99.

pubmed: 24763466 doi: 10.1161/CIRCRESAHA.114.302226

Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1:62–73.

pubmed: 19808395 doi: 10.1161/CIRCEP.107.754564

Caballero R, de la Fuente MG, Gomez R, Barana A, Amoros I, Dolz-Gaiton P, et al. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both. J Am Coll Cardiol. 2010;55:2346–54.

pubmed: 20488306 doi: 10.1016/j.jacc.2010.02.028

Voigt N, Trausch A, Knaut M, Matschke K, Varro A, Van Wagoner DR, et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:472–80.

pubmed: 20657029 pmcid: 5832445 doi: 10.1161/CIRCEP.110.954636

Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85:428–36.

pubmed: 10473672 doi: 10.1161/01.RES.85.5.428

Martins RP, Kaur K, Hwang E, Ramirez RJ, Willis BC, Filgueiras-Rama D, et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014;129:1472–82.

pubmed: 24463369 pmcid: 3981906 doi: 10.1161/CIRCULATIONAHA.113.004742

Deshmukh A, Barnard J, Sun H, Newton D, Castel L, Pettersson G, et al. Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence. Circ Arrhythm Electrophysiol. 2015;8:32–41.

pubmed: 25523945 doi: 10.1161/CIRCEP.114.001632

Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007;76:442–52.

pubmed: 17720149 doi: 10.1016/j.cardiores.2007.07.013

Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precedethe onset of postoperative atrial fibrillation. J Am Coll Cardiol. 2003;42:1262–8.

pubmed: 14522493 doi: 10.1016/S0735-1097(03)00955-0

Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–9.

pubmed: 12057990 doi: 10.1161/01.CIR.0000018443.44005.D8

Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol. 2003;14:559–64.

pubmed: 12875412 doi: 10.1046/j.1540-8167.2003.02462.x

Scherlag BJ, Yamanashi W, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol. 2005;45:1878–86.

pubmed: 15936622 doi: 10.1016/j.jacc.2005.01.057

Patterson E, Po SS, Scherlag BJ, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2:624–31.

pubmed: 15922271 doi: 10.1016/j.hrthm.2005.02.012

Zhou J, Scherlag BJ, Edwards J, Jackman WM, Lazzara R, Po SS. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol. 2007;18:83–90.

pubmed: 17229305 doi: 10.1111/j.1540-8167.2006.00679.x

Patterson E, Jackman WM, Beckman KJ, Lazzara R, Lockwood D, Scherlag BJ, et al. Spontaneous pulmonary vein firing in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol. 2007;18:1067–75.

pubmed: 17655663 doi: 10.1111/j.1540-8167.2007.00909.x

Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, Olgin JE. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation. 2000;101:1185–91.

pubmed: 10715267 doi: 10.1161/01.CIR.101.10.1185

Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1:184–92.

pubmed: 19808412 pmcid: 2766842 doi: 10.1161/CIRCEP.108.784272

Stavrakis S, Stoner JA, Humphrey MB, Morris L, Filiberti A, Reynolds JC, et al. TREAT AF (transcutaneous electrical vagus nerve stimulation to suppress atrial fibrillation): a randomized clinical trial. JACC Clin Electrophysiol. 2020;6:282–91.

pubmed: 32192678 pmcid: 7100921 doi: 10.1016/j.jacep.2019.11.008

Shen MJ, Hao-Che C, Park HW, George Akingba A, Chang PC, Zheng Z, et al. Low-level vagus nerve stimulation upregulates small conductance calcium-activated potassium channels in the stellate ganglion. Heart Rhythm. 2013;10:910–5.

pubmed: 23357541 pmcid: 3671581 doi: 10.1016/j.hrthm.2013.01.029

Bernstein SA, Wong B, Vasquez C, Rosenberg SP, Rooke R, Kuznekoff LM, et al. Spinal cord stimulation protects against atrial fibrillation induced by tachypacing. Heart Rhythm. 2012;9:1426-33.e3.

pubmed: 22554859 pmcid: 3634125 doi: 10.1016/j.hrthm.2012.04.038

Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6:1257–64.

pubmed: 19656736 doi: 10.1016/j.hrthm.2009.05.018

Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 2008;102:330–4.

pubmed: 18638596 doi: 10.1016/j.amjcard.2008.03.062

Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8:672–8.

pubmed: 21199686 doi: 10.1016/j.hrthm.2010.12.047

Nakagawa H, Scherlag BJ, Wu R, Po S, Lockwood D, Yokoyama K, et al. Addition of selective ablation of autonomic ganglia to pulmonary vein antrum isolation for treatment of paroxysmal and persistent atrial fibrillation. Circulation. 2004;110:543.

Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100:1879–86.

pubmed: 10545432 doi: 10.1161/01.CIR.100.18.1879

Jaïs P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation. 2002;106:2479–85.

pubmed: 12417546 doi: 10.1161/01.CIR.0000036744.39782.9F

Cherry EM, Ehrlich JR, Nattel S, Fenton FH. Pulmonary vein reentry–properties and size matter: insights from a computational analysis. Heart Rhythm. 2007;4:1553–62.

pubmed: 18068635 doi: 10.1016/j.hrthm.2007.08.017

Bonczar M, Piątek-Koziej K, Wolska J, Tomala O, Stitou EA, Pękala J, et al. Variations in human pulmonary vein ostia morphology: a systematic review with metaanalysis. Clin Anat. 2022;35:906–26.

pubmed: 35460116 doi: 10.1002/ca.23896

Anselmino M, Blandino A, Beninati S, Rovera C, Boffano C, Belletti M, et al. Morphologic analysis of left atrial anatomy by magnetic resonance angiography in patients with atrial fibrillation: a large single center experience. J Cardiovasc Electrophysiol. 2011;22:1–7.

pubmed: 20662985 doi: 10.1111/j.1540-8167.2010.01853.x

Cheruiyot I, Munguti J, Olabu B, Gichangi P. A metaanalysis of the relationship between anatomical variations of pulmonary veins and atrial fibrillation. Acta Cardiol. 2020;75:1–9.

pubmed: 30736723 doi: 10.1080/00015385.2018.1544204

Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation. 1966;34:412–22.

pubmed: 5922708 doi: 10.1161/01.CIR.34.3.412

Rivaud MR, Blok M, Jongbloed MRM, Boukens BJ. How Cardiac Embryology Translates into Clinical Arrhythmias. J Cardiovasc Dev Dis. 2021;8:70.

pubmed: 34199178 pmcid: 8231901

Teres C, Soto-Iglesias D, Penela D, Jáuregui B, Ordoñez A, Chauca A, et al. Left atrial wall thickness of the pulmonary vein reconnection sites during atrial fibrillation redo procedures. Pacing Clin Electrophysiol. 2021;44:824–34.

pubmed: 33742716 doi: 10.1111/pace.14222

Barrio-Lopez MT, Sanchez-Quintana D, Garcia-Martinez J, Betancur A, Castellanos E, Arceluz M, et al. Epicardial connections involving pulmonary veins: the prevalence, predictors, and implications for ablation outcome. Circ Arrhythm Electrophysiol. 2020;13: e007544.

pubmed: 31940223 doi: 10.1161/CIRCEP.119.007544

Perez-Castellano N, Villacastin J, Salinas J, Vega M, Moreno J, Doblado M, et al. Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2011;22:149–59.

pubmed: 20807282

Barrio-Lopez MT, Castellanos E, Ortiz M, Arceluz M, Lazaro C, Salas J, et al. Atrial mapping during pulmonary vein pacing to detect conduction gaps in a second pulmonary vein isolation procedure. J Interv Card Electrophysiol. 2018;53:195–205.

pubmed: 29802499 doi: 10.1007/s10840-018-0371-x

Yoshida K, Baba M, Shinoda Y, Harunari T, Tsumagari Y, Koda N, et al. Epicardial connection between the right-sided pulmonary venous carina and the right atrium in patients with atrial fibrillation: a possible mechanism for preclusion of pulmonary vein isolation without carina ablation. Heart Rhythm. 2019;16:671–8.

pubmed: 30465905 doi: 10.1016/j.hrthm.2018.11.017

Cabrera JA, Ho SY, Climent V, Fuertes B, Murillo M, Sanchez-Quintana D. Morphological evidence of muscular connections between contiguous pulmonary venous orifices: relevance of the interpulmonary isthmus for catheter ablation in atrial fibrillation. Heart Rhythm. 2009;6:1192–8.

pubmed: 19632632 doi: 10.1016/j.hrthm.2009.04.016

Cabrera JA, Ho SY, Climent V, Sanchez-Quintana D. The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J. 2008;29:356–62.

pubmed: 18245120 doi: 10.1093/eurheartj/ehm606

Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol. 2012;5:220–8.

pubmed: 22334429 doi: 10.1161/CIRCEP.111.962720

Ho SY, Anderson RH, Sanchez-Quintana D. Atrial structure and fibres: morphologic bases of atrial conduction. Cardiovasc Res. 2002;54:325–36.

pubmed: 12062338 doi: 10.1016/S0008-6363(02)00226-2

Ho SY, Sanchez-Quintana D. The importance of atrial structure and fibers. Clin Anat. 2009;22:52–63.

pubmed: 18470938 doi: 10.1002/ca.20634

Patel PJ, D’Souza B, Saha P, Chik WW, Riley MP, Garcia FC. Electroanatomic mapping of the intercaval bundle in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:1262–7.

pubmed: 25516583 doi: 10.1161/CIRCEP.114.001738

Anderson RH, Spicer DE, Brown NA, Mohun TJ. The development of septation in the four-chambered heart. Anat Rec. 2014;297:1414–29.

doi: 10.1002/ar.22949

Klimek-Piotrowska W, Hołda MK, Koziej M, Piątek K, Hołda J. Anatomy of the true interatrial septum for transseptal access to the left atrium. Ann Anat. 2016;205:60–4.

pubmed: 26879344 doi: 10.1016/j.aanat.2016.01.009

Tzeis S, Andrikopoulos G, Deisenhofer I, Ho SY, Theodorakis G. Transseptal catheterization: considerations and caveats. Pacing Clin Electrophysiol. 2010;33:231–42.

pubmed: 19889183 doi: 10.1111/j.1540-8159.2009.02598.x

Meier D, Antiochos P, Herrera-Siklody C, Eeckhout E, Delabays A, Tzimas G, et al. Interatrial septum dissection and atrial wall hematoma following transseptal puncture: a systematic review of the literature. Catheter Cardiovasc Interv. 2020;96:424–31.

pubmed: 31642609 doi: 10.1002/ccd.28554

Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613–23.

pubmed: 11527606 doi: 10.1016/S0735-1097(01)01427-9

Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.

pubmed: 6694427 doi: 10.1016/S0025-6196(12)60336-X

Benvenuti F, Meucci F, Vuolo L, Nistri R, Pracucci G, Picchioni A, et al. Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke. Neurol Sci. 2022;43:453–8.

pubmed: 34050831 doi: 10.1007/s10072-021-05330-y

Knecht S, Wright M, Lellouche N, Nault I, Matsuo S, O’Neill MD, et al. Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2008;19:1236–41.

pubmed: 18662179 doi: 10.1111/j.1540-8167.2008.01260.x

Miyazaki S, Shah AJ, Nault I, Wright M, Jadidi AS, Forclaz A, et al. Impact of patent foramen ovale on left atrial linear lesions in the context of atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2011;22:846–50.

pubmed: 21288279 doi: 10.1111/j.1540-8167.2010.02007.x

Barrio-Lopez MT, Castellanos E, Betancur A, Zorita B, Medina J, Losada N, et al. The presence of a large patent foramen ovale reduces acute and chronic success in atrial fibrillation ablation. J Interv Card Electrophysiol. 2022;64:705–13.

pubmed: 35142969 doi: 10.1007/s10840-022-01134-y

Almendarez M, Alvarez-Velasco R, Pascual I, Alperi A, Moris C, Avanzas P. Transseptal puncture: review of anatomy, techniques, complications and challenges, a critical view. Int J Cardiol. 2022;351:32–8.

pubmed: 35007652 doi: 10.1016/j.ijcard.2022.01.011

De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A, et al. Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol. 2006;47:1037–42.

pubmed: 16516090 doi: 10.1016/j.jacc.2005.10.046

Li X, Wissner E, Kamioka M, Makimoto H, Rausch P, Metzner A, et al. Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices. Heart Rhythm. 2014;11:330–5.

pubmed: 24239844 doi: 10.1016/j.hrthm.2013.11.011

Santangeli P, Di Biase L, Burkhardt JD, Horton R, Sanchez J, Bailey S, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8:1669–75.

pubmed: 21703215 doi: 10.1016/j.hrthm.2011.06.023

Wang K, Ho SY, Gibson DG, Anderson RH. Architecture of atrial musculature in humans. Br Heart J. 1995;73:559–65.

pubmed: 7626357 pmcid: 483920 doi: 10.1136/hrt.73.6.559

Jais P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, et al. Technique and results of linear ablation at the mitral isthmus. Circulation. 2004;110:2996–3002.

pubmed: 15520313 doi: 10.1161/01.CIR.0000146917.75041.58

Derval N, Takigawa M, Frontera A, Mahida S, Konstantinos V, Denis A, et al. Characterization of complex atrial tachycardia in patients with previous atrial interventions using high-resolution mapping. JACC Clin Electrophysiol. 2020;6:815–26.

pubmed: 32703564 doi: 10.1016/j.jacep.2020.03.004

Hocini M, Jais P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005;112:3688–96.

pubmed: 16344401 doi: 10.1161/CIRCULATIONAHA.105.541052

Ho SY. Normal and abnormal atrial anatomy relevant to atrial flutters: areas of physiological and acquired conduction blocks and delays predisposing to reentry. Card Electrophysiol Clin. 2022;14:375–84.

pubmed: 36153120 doi: 10.1016/j.ccep.2022.03.001

van Campenhout MJ, Yaksh A, Kik C, de Jaegere PP, Ho SY, Allessie MA, et al. Bachmann’s bundle: a key player in the development of atrial fibrillation? Circ Arrhythm Electrophysiol. 2013;6:1041–6.

pubmed: 24129206 doi: 10.1161/CIRCEP.113.000758

Papez J. Heart musculature of the atria. Am J Anat. 1920;27:255–85.

doi: 10.1002/aja.1000270302

Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:1525–33.

pubmed: 10571372 doi: 10.1111/j.1540-8167.1999.tb00211.x

Pambrun T, Duchateau J, Delgove A, Denis A, Constantin M, Ramirez FD, et al. Epicardial course of the septopulmonary bundle: anatomical considerations and clinical implications for roof line completion. Heart Rhythm. 2021;18:349–57.

pubmed: 33188900 doi: 10.1016/j.hrthm.2020.11.008

Chauvin M, Shah DC, Haissaguerre M, Marcellin L, Brechenmacher C. The anatomic basis of connections between the coronary sinus musculature and the left atrium in humans. Circulation. 2000;101:647–52.

pubmed: 10673257 doi: 10.1161/01.CIR.101.6.647

von Ludinghausen M, Ohmachi N, Besch S, Mettenleiter A. Atrial veins of the human heart. Clin Anat. 1995;8:169–89.

doi: 10.1002/ca.980080302

Kim DT, Lai AC, Hwang C, Fan LT, Karagueuzian HS, Chen PS, et al. The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol. 2000;36:1324–7.

pubmed: 11028490 doi: 10.1016/S0735-1097(00)00819-6

Makino M, Inoue S, Matsuyama TA, Ogawa G, Sakai T, Kobayashi Y, et al. Diverse myocardial extension and autonomic innervation on ligament of Marshall in humans. J Cardiovasc Electrophysiol. 2006;17:594–9.

pubmed: 16836704 doi: 10.1111/j.1540-8167.2006.00375.x

Von Lüdinghausen M, Ohmachi N, Boot C. Myocardial coverage of the coronary sinus and related veins. Clin Anat. 1992;5:1–15.

doi: 10.1002/ca.980050102

Marshall J. On the development of the great anterior veins in man and mammalia; including an account of certain remnants of foetal structure found in the adult, a comparative view of these great veins in the different mammalia, and an analysis of their occasional peculiarities in the human subject. Philos Trans Roy Soc Lond. 1850;140:133–70.

doi: 10.1098/rstl.1850.0007

DeSimone CV, Noheria A, Lachman N, Edwards WD, Gami AS, Maleszewski JJ, et al. Myocardium of the superior vena cava, coronary sinus, vein of Marshall, and the pulmonary vein ostia: gross anatomic studies in 620 hearts. J Cardiovasc Electrophysiol. 2012;23:1304–9.

pubmed: 22830489 doi: 10.1111/j.1540-8167.2012.02403.x

Baez-Escudero JL, Keida T, Dave AS, Okishige K, Valderrabano M. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation. J Am Coll Cardiol. 2014;63:1892–901.

pubmed: 24561151 pmcid: 4035125 doi: 10.1016/j.jacc.2014.01.032

Hwang C, Chen PS. Ligament of Marshall: why it is important for atrial fibrillation ablation. Heart Rhythm. 2009;6:S35-40.

pubmed: 19959141 doi: 10.1016/j.hrthm.2009.08.034

Hwang C, Wu TJ, Doshi RN, Peter CT, Chen PS. Vein of Marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation. Circulation. 2000;101:1503–5.

pubmed: 10747341 doi: 10.1161/01.CIR.101.13.1503

Ulphani JS, Arora R, Cain JH, Villuendas R, Shen S, Gordon D, et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol. 2007;293:H1629-35.

pubmed: 17545480 doi: 10.1152/ajpheart.00139.2007

Hwang C, Karagueuzian HS, Chen PS. Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall. J Cardiovasc Electrophysiol. 1999;10:636–48.

pubmed: 10355919 doi: 10.1111/j.1540-8167.1999.tb00240.x

Wittkampf FH, van Oosterhout MF, Loh P, Derksen R, Vonken EJ, Slootweg PJ, et al. Where to draw the mitral isthmus line in catheter ablation of atrial fibrillation: histological analysis. Eur Heart J. 2005;26:689–95.

pubmed: 15637084 doi: 10.1093/eurheartj/ehi095

Pambrun T, Denis A, Duchateau J, Sacher F, Hocini M, Jaïs P, et al. Marshall bundles elimination, pulmonary veins isolation and Lines completion for anatomical ablation of persistent atrial fibrillation: Marshall-PLAN case series. J Cardiovasc Electrophysiol. 2019;30:7–15.

pubmed: 30461121 doi: 10.1111/jce.13797

Becker AE. Left atrial isthmus: anatomic aspects relevant for linear catheter ablation procedures in humans. J Cardiovasc Electrophysiol. 2004;15:809–12.

pubmed: 15250867 doi: 10.1046/j.1540-8167.2004.03651.x

Baez-Escudero JL, Morales PF, Dave AS, Sasaridis CM, Kim YH, Okishige K, et al. Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation. Heart Rhythm. 2012;9:1207–15.

pubmed: 22406143 pmcid: 3419362 doi: 10.1016/j.hrthm.2012.03.008

Takigawa M, Vlachos K, Martin CA, Bourier F, Denis A, Kitamura T, et al. Acute and mid-term outcome of ethanol infusion of vein of Marshall for the treatment of perimitral flutter. Europace. 2020;22:1252–60.

pubmed: 32594180 doi: 10.1093/europace/euaa137

Pambrun T, Derval N, Duchateau J, Denis A, Chauvel R, Tixier R, et al. Epicardial course of the musculature related to the great cardiac vein: anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion. Heart Rhythm. 2021;18:1951–8.

pubmed: 34217842 doi: 10.1016/j.hrthm.2021.06.1202

Tsai CF, Tai CT, Hsieh MH, Lin WS, Yu WC, Ueng KC, et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation. 2000;102:67–74.

pubmed: 10880417 doi: 10.1161/01.CIR.102.1.67

Nyuta E, Takemoto M, Sakai T, Mito T, Masumoto A, Todoroki W, et al. Importance of the length of the myocardial sleeve in the superior vena cava in patients with atrial fibrillation. J Arrhythm. 2021;37:43–51.

pubmed: 33664885 pmcid: 7896468 doi: 10.1002/joa3.12494

Depes D, Mennander A, Paavonen T, Kholová I. Autonomic nerves in myocardial sleeves around caval veins: potential role in cardiovascular mortality? Cardiovasc Pathol. 2022;59: 107426.

pubmed: 35354082 doi: 10.1016/j.carpath.2022.107426

Miyazaki S, Taniguchi H, Kusa S, Ichihara N, Nakamura H, Hachiya H, et al. Factors predicting an arrhythmogenic superior vena cava in atrial fibrillation ablation: insight into the mechanism. Heart Rhythm. 2014;11:1560–6.

pubmed: 24933296 doi: 10.1016/j.hrthm.2014.06.016

Corradi D, Callegari S, Gelsomino S, Lorusso R, Macchi E. Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation: part II: pulmonary veins, caval veins, ganglionated plexi, and ligament of Marshall. Int J Cardiol. 2013;168:1769–78.

pubmed: 23907042 doi: 10.1016/j.ijcard.2013.06.141

Wickramasinghe SR, Patel VV. Local innervation and atrial fibrillation. Circulation. 2013;128:1566–75.

pubmed: 24081952 doi: 10.1161/CIRCULATIONAHA.113.001596

Kusayama T, Wan J, Yuan Y, Chen PS. Neural mechanisms and therapeutic opportunities for atrial fibrillation. Methodist Debakey Cardiovasc J. 2021;17:43–7.

pubmed: 34104319 pmcid: 8158446 doi: 10.14797/FVDN2224

Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol. 2005;209:425–38.

doi: 10.1007/s00429-005-0462-1

Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114:1004–21.

pubmed: 24625726 doi: 10.1161/CIRCRESAHA.113.302549

Hou Y, Zhou Q, Po SS. Neuromodulation for cardiac arrhythmia. Heart Rhythm. 2016;13:584–92.

pubmed: 26440550 doi: 10.1016/j.hrthm.2015.10.001

Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289–98.

pubmed: 9026008 doi: 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L

Kim MY, Sandler BC, Sikkel MB, Cantwell CD, Leong KM, Luther V, et al. Anatomical distribution of ectopy-triggering plexuses in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13: e008715.

pubmed: 32718187 doi: 10.1161/CIRCEP.120.008715

Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:1186–9.

pubmed: 19563367 doi: 10.1111/j.1540-8167.2009.01515.x

Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13:37–42.

pubmed: 16133854 doi: 10.1007/s10840-005-2492-2

Lemery R, Birnie D, Tang AS, Green M, Gollob M. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm. 2006;3:387–96.

pubmed: 16567283 doi: 10.1016/j.hrthm.2006.01.009

Stirrup J, Gregg S, Baavour R, Roth N, Breault C, Agostini D, et al. Hybrid solid-state SPECT/CT left atrial innervation imaging for identification of left atrial ganglionated plexi: technique and validation in patients with atrial fibrillation. J Nucl Cardiol. 2020;27:1939–50.

pubmed: 30694425 doi: 10.1007/s12350-018-01535-5

Lemoine MD, Mencke C, Nies M, Obergassel J, Scherschel K, Wieboldt H, et al. Pulmonary vein isolation by pulsed-field ablation induces less neurocardiac damage than cryoballoon ablation. Circ Arrhythm Electrophysiol. 2023;16: e011598.

pubmed: 36938715 doi: 10.1161/CIRCEP.122.011598

Musikantow DR, Neuzil P, Petru J, Koruth JS, Kralovec S, Miller MA, et al. Pulsed field ablation to treat atrial fibrillation: autonomic nervous system effects. JACC Clin Electrophysiol. 2023;9:481–93.

pubmed: 36752473 doi: 10.1016/j.jacep.2022.10.028

von Olshausen G, Saluveer O, Schwieler J, Drca N, Bastani H, Tapanainen J, et al. Sinus heart rate post pulmonary vein ablation and long-term risk of recurrences. Clin Res Cardiol. 2021;110:851–60.

doi: 10.1007/s00392-020-01765-z

Yu HT, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, et al. Prognosis of high sinus heart rate after catheter ablation for atrial fibrillation. Europace. 2017;19:1132–9.

pubmed: 27256421

Goff ZD, Laczay B, Yenokyan G, Sivasambu B, Sinha SK, Marine JE, et al. Heart rate increase after pulmonary vein isolation predicts freedom from atrial fibrillation at 1 year. J Cardiovasc Electrophysiol. 2019;30:2818–22.

pubmed: 31670430 doi: 10.1111/jce.14257

DeLurgio DB, Crossen KJ, Gill J, Blauth C, Oza SR, Magnano AR, et al. Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial. Circ Arrhythm Electrophysiol. 2020;13: e009288.

pubmed: 33185144 doi: 10.1161/CIRCEP.120.009288

Makati KJ, Sood N, Lee LS, Yang F, Shults CC, DeLurgio DB, et al. Combined epicardial and endocardial ablation for atrial fibrillation: best practices and guide to hybrid convergent procedures. Heart Rhythm. 2021;18:303–12.

pubmed: 33045430 doi: 10.1016/j.hrthm.2020.10.004

Kress DC, Erickson L, Choudhuri I, Zilinski J, Mengesha T, Krum D, et al. Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation. JACC Clin Electrophysiol. 2017;3:341–9.

pubmed: 29759446 doi: 10.1016/j.jacep.2016.10.010

Reddy VY, Neuzil P, D’Avila A, Ruskin JN. Isolating the posterior left atrium and pulmonary veins with a “box” lesion set: use of epicardial ablation to complete electrical isolation. J Cardiovasc Electrophysiol. 2008;19:326–9.

pubmed: 17887980 doi: 10.1111/j.1540-8167.2007.00944.x

Piorkowski C, Kronborg M, Hourdain J, Piorkowski J, Kirstein B, Neudeck S, et al. Endo-/epicardial catheter ablation of atrial fibrillation: feasibility, outcome, and insights into arrhythmia mechanisms. Circ Arrhythm Electrophysiol. 2018;11: e005748.

pubmed: 29439000 doi: 10.1161/CIRCEP.117.005748

Tung R. Percutaneous epicardial ablation of atrial fibrillation. Card Electrophysiol Clin. 2020;12:371–81.

pubmed: 32771190 doi: 10.1016/j.ccep.2020.06.005

D’Avila A, Scanavacca M, Sosa E, Ruskin JN, Reddy VY. Pericardial anatomy for the interventional electrophysiologist. J Cardiovasc Electrophysiol. 2003;14:422–30.

pubmed: 12741718 doi: 10.1046/j.1540-8167.2003.02487.x

Smith NM, Segars L, Kauffman T, Olinger AB. Using anatomical landmark to avoid phrenic nerve injury during balloon-based procedures in atrial fibrillation patients. Surg Radiol Anat. 2017;39:1369–75.

pubmed: 28698895 doi: 10.1007/s00276-017-1895-y

Okumura Y, Henz BD, Bunch TJ, Dalegrave C, Johnson SB, Packer DL. Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. J Cardiovasc Electrophysiol. 2009;20:1151–7.

pubmed: 19500230 doi: 10.1111/j.1540-8167.2009.01495.x

Ströker E, de Asmundis C, Saitoh Y, Velagić V, Mugnai G, Irfan G, et al. Anatomic predictors of phrenic nerve injury in the setting of pulmonary vein isolation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2016;13:342–51.

pubmed: 26573972 doi: 10.1016/j.hrthm.2015.10.017

Romero J, Natale A, Lakkireddy D, Cerna L, Diaz JC, Alviz I, et al. Mapping and localization of the left phrenic nerve during left atrial appendage electrical isolation to avoid inadvertent injury in patients undergoing catheter ablation of atrial fibrillation. Heart Rhythm. 2020;17:527–34.

pubmed: 31634618 doi: 10.1016/j.hrthm.2019.10.020

Gupta T, Cheema N, Randhawa A, Sahni D. Translational anatomy of the left atrium and esophagus as relevant to the pulmonary vein antral isolation for atrial fibrillation. Surg Radiol Anat. 2020;42:367–76.

pubmed: 31542799 doi: 10.1007/s00276-019-02327-3

Bunch TJ, May HT, Crandall BG, Weiss JP, Bair TL, Osborn JS, et al. Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:33–9.

pubmed: 23067340 doi: 10.1111/j.1540-8167.2012.02441.x

Jang SW, Kwon BJ, Choi MS, Kim DB, Shin WS, Cho EJ, et al. Computed tomographic analysis of the esophagus, left atrium, and pulmonary veins: implications for catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2011;32:1–6.

pubmed: 21695522 doi: 10.1007/s10840-011-9594-9

Sarairah SY, Woodbury B, Methachittiphan N, Tregoning DM, Sridhar AR, Akoum N. Esophageal thermal injury following cryoballoon ablation for atrial fibrillation. JACC Clin Electrophysiol. 2020;6:262–8.

pubmed: 32192675 doi: 10.1016/j.jacep.2019.10.014

Lemola K, Sneider M, Desjardins B, Case I, Han J, Good E, et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation. 2004;110:3655–60.

pubmed: 15569839 doi: 10.1161/01.CIR.0000149714.31471.FD

Good E, Oral H, Lemola K, Han J, Tamirisa K, Igic P, et al. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2005;46:2107–10.

pubmed: 16325049 doi: 10.1016/j.jacc.2005.08.042

Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303:333–40.

pubmed: 20103757 doi: 10.1001/jama.2009.2029

Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and metaanalyses. Circ Arrhythm Electrophysiol. 2009;2:349–61.

pubmed: 19808490 doi: 10.1161/CIRCEP.108.824789

Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118:2498–505.

pubmed: 19029470 doi: 10.1161/CIRCULATIONAHA.108.772582

Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61:1713–23.

pubmed: 23500312 doi: 10.1016/j.jacc.2012.11.064

Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, et al. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J Am Coll Cardiol. 2020;75:3105–18.

pubmed: 32586583 pmcid: 8064404 doi: 10.1016/j.jacc.2020.04.065

Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35:501–7.

pubmed: 24135832 doi: 10.1093/eurheartj/eht457

Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8:18–24.

pubmed: 25528745 doi: 10.1161/CIRCEP.114.001943

Wazni OM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021;384:316–24.

pubmed: 33197158 doi: 10.1056/NEJMoa2029554

Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384:305–15.

pubmed: 33197159 doi: 10.1056/NEJMoa2029980

Kuniss M, Pavlovic N, Velagic V, Hermida JS, Healey S, Arena G, et al. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021;23:1033–41.

pubmed: 33728429 pmcid: 8286851 doi: 10.1093/europace/euab029

Cosedis Nielsen C, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367:1587–95.

pubmed: 23094720 doi: 10.1056/NEJMoa1113566

Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311:692–700.

pubmed: 24549549 doi: 10.1001/jama.2014.467

Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634–40.

pubmed: 15928285 doi: 10.1001/jama.293.21.2634

Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJ. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and metaanalysis. Europace. 2015;17:370–8.

pubmed: 25643988 doi: 10.1093/europace/euu376

Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70:1949–61.

pubmed: 28855115 doi: 10.1016/j.jacc.2017.08.041

Sugumar H, Prabhu S, Costello B, Chieng D, Azzopardi S, Voskoboinik A, et al. Catheter ablation versus medication in atrial fibrillation and systolic dysfunction: late outcomes of CAMERA-MRI study. JACC Clin Electrophysiol. 2020;6:1721–31.

pubmed: 33334453 doi: 10.1016/j.jacep.2020.08.019

Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–8.

pubmed: 24382410 doi: 10.1161/CIRCEP.113.000806

Parkash R, Wells GA, Rouleau J, Talajic M, Essebag V, Skanes A, et al. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation. 2022;145:1693–704.

pubmed: 35313733 doi: 10.1161/CIRCULATIONAHA.121.057095

Romero J, Gabr M, Alviz I, Briceno D, Diaz JC, Rodriguez D, et al. Improved survival in patients with atrial fibrillation and heart failure undergoing catheter ablation compared to medical treatment: a systematic review and metaanalysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2022;33:2356–66.

pubmed: 35842804 doi: 10.1111/jce.15622

Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133:1637–44.

pubmed: 27029350 doi: 10.1161/CIRCULATIONAHA.115.019406

Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, et al. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF trial. Circ Arrhythm Electrophysiol. 2020;13: e008461.

pubmed: 32903044 doi: 10.1161/CIRCEP.120.008461

Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143:1377–90.

pubmed: 33554614 pmcid: 8030730 doi: 10.1161/CIRCULATIONAHA.120.050991

Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and metaanalysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12: e007414.

pubmed: 31431051 doi: 10.1161/CIRCEP.119.007414

Briceño DF, Markman TM, Lupercio F, Romero J, Liang JJ, Villablanca PA, et al. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and metaanalysis of randomized controlled trials. J Interv Card Electrophysiol. 2018;53:19–29.

pubmed: 30066291 doi: 10.1007/s10840-018-0425-0

Sohns C, Fox H, Marrouche NF, Crijns H, Costard-Jaeckle A, Bergau L, et al. Catheter ablation in end-stage heart failure with atrial fibrillation. N Engl J Med. 2023;389:1380–9.

pubmed: 37634135 doi: 10.1056/NEJMoa2306037

Sciarra L, Rebecchi M, De Ruvo E, De Luca L, Zuccaro LM, Fagagnini A, et al. How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation. Europace. 2010;12:1707–12.

pubmed: 20833693 doi: 10.1093/europace/euq327

Katritsis DG, Giazitzoglou E, Wood MA, Shepard RK, Parvez B, Ellenbogen KA. Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation. Europace. 2007;9:785–9.

pubmed: 17545655 doi: 10.1093/europace/eum105

Delise P, Gianfranchi L, Paparella N, Brignole M, Menozzi C, Themistoclakis S, et al. Clinical usefulness of slow pathway ablation in patients with both paroxysmal atrioventricular nodal reentrant tachycardia and atrial fibrillation. Am J Cardiol. 1997;79:1421–3.

pubmed: 9165175 doi: 10.1016/S0002-9149(97)00157-4

Torbey E, Karam B, Sleiman E, Tabet R, Kirk M, Donaldson D, et al. Incidence and risk factors for atrial fibrillation recurrence after ablation of nodal and atrioventricular reentrant tachycardia: a metaanalysis. Cureus. 2020;12: e7824.

pubmed: 32467799 pmcid: 7249774

Inada K, Yamane T, Tokutake K, Yokoyama K, Mishima T, Hioki M, et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2014;16:208–13.

pubmed: 23751930 doi: 10.1093/europace/eut159

Chen YW, Bai R, Lin T, Salim M, Sang CH, Long DY, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37:403–11.

pubmed: 24456243 doi: 10.1111/pace.12340

Scharf C, Veerareddy S, Ozaydin M, Chugh A, Hall B, Cheung P, et al. Clinical significance of inducible atrial flutter during pulmonary vein isolation in patients with atrial fibrillation. J Am Coll Cardiol. 2004;43:2057–62.

pubmed: 15172412 doi: 10.1016/j.jacc.2003.11.063

Wazni O, Marrouche NF, Martin DO, Gillinov AM, Saliba W, Saad E, et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation. 2003;108:2479–83.

pubmed: 14610012 doi: 10.1161/01.CIR.0000101684.88679.AB

Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a metaanalysis. Circ Arrhythm Electrophysiol. 2009;2:393–401.

pubmed: 19808495 doi: 10.1161/CIRCEP.109.871665

Prasitlumkum N, Tokavanich N, Trongtorsak A, Cheungpasitporn W, Kewcharoen J, Chokesuwattanaskul R, et al. Catheter ablation for atrial fibrillation in the elderly >75 years old: systematic review and metaanalysis. J Cardiovasc Electrophysiol. 2022;33:1435–49.

pubmed: 35589557 doi: 10.1111/jce.15549

Kawamura I, Aikawa T, Yokoyama Y, Takagi H, Kuno T. Catheter ablation for atrial fibrillation in elderly patients: systematic review and a metaanalysis. Pacing Clin Electrophysiol. 2022;45:59–71.

pubmed: 34816458 doi: 10.1111/pace.14413

Nielsen J, Kragholm KH, Christensen SB, Johannessen A, Torp-Pedersen C, Kristiansen SB, et al. Periprocedural complications and one-year outcomes after catheter ablation for treatment of atrial fibrillation in elderly patients: a nationwide Danish cohort study. J Geriatr Cardiol. 2021;18:897–907.

pubmed: 34908927 pmcid: 8648543

Providencia R, Elliott P, Patel K, McCready J, Babu G, Srinivasan N, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and metaanalysis. Heart. 2016;102:1533–43.

pubmed: 27234160 doi: 10.1136/heartjnl-2016-309406

Zhao DS, Shen Y, Zhang Q, Lin G, Lu YH, Chen BT, et al. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and metaanalysis. Europace. 2016;18:508–20.

pubmed: 26612881 doi: 10.1093/europace/euv339

Dinshaw L, Münkler P, Schäffer B, Klatt N, Jungen C, Dickow J, et al. Ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: treatment strategy, characteristics of consecutive atrial tachycardia and long-term outcome. J Am Heart Assoc. 2021;10: e017451.

pubmed: 33455428 pmcid: 7955439 doi: 10.1161/JAHA.120.017451

Creta A, Elliott P, Earley MJ, Dhinoja M, Finlay M, Sporton S, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study. Europace. 2021;23:1409–17.

pubmed: 33930121 doi: 10.1093/europace/euab022

Santangeli P, Di Biase L, Themistoclakis S, Raviele A, Schweikert RA, Lakkireddy D, et al. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence. Circ Arrhythm Electrophysiol. 2013;6:1089–94.

pubmed: 24114776 doi: 10.1161/CIRCEP.113.000339

Rozen G, Elbaz-Greener G, Marai I, Andria N, Hosseini SM, Biton Y, et al. Utilization and complications of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Am Heart Assoc. 2020;9: e015721.

pubmed: 32573325 pmcid: 7670519 doi: 10.1161/JAHA.119.015721

Ezzeddine FM, Agboola KM, Hassett LC, Killu AM, Del-Carpio Munoz F, DeSimone CV, et al. Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and metaanalysis. Europace. 2023;25.

Dorian P, Guerra PG, Kerr CR, O’Donnell SS, Crystal E, Gillis AM, et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol. 2009;2:218–24.

pubmed: 19808471 doi: 10.1161/CIRCEP.108.812347

Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace. 2007;9:1006–23.

pubmed: 17897925 doi: 10.1093/europace/eum191

Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012;125:2933–43.

pubmed: 22689930 pmcid: 3402179 doi: 10.1161/CIRCULATIONAHA.111.069450

Sugishita K, Shiono E, Sugiyama T, Ashida T. Diabetes influences the cardiac symptoms related to atrial fibrillation. Circ J. 2003;67:835–8.

pubmed: 14578615 doi: 10.1253/circj.67.835

Hermans ANL, Gawalko M, Slegers DPJ, Andelfinger N, Pluymaekers N, Verhaert DVM, et al. Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation. Int J Cardiol. 2022;367:29–37.

pubmed: 35963443 doi: 10.1016/j.ijcard.2022.08.021

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305–16.

pubmed: 32865375 doi: 10.1056/NEJMoa2019422

Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace. 2011;13:329–45.

pubmed: 21227948 doi: 10.1093/europace/euq450

Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2019;9:Cd005049.

pubmed: 31483500

Chew DS, Black-Maier E, Loring Z, Noseworthy PA, Packer DL, Exner DV, et al. Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and metaanalysis of observational studies. Circ Arrhythm Electrophysiol. 2020;13: e008128.

pubmed: 32191539 pmcid: 7359927 doi: 10.1161/CIRCEP.119.008128

Kawaji T, Shizuta S, Yamagami S, Aizawa T, Komasa A, Yoshizawa T, et al. Early choice for catheter ablation reduced readmission in management of atrial fibrillation: impact of diagnosis-to-ablation time. Int J Cardiol. 2019;291:69–76.

pubmed: 30948218 doi: 10.1016/j.ijcard.2019.03.036

Bisbal F, Alarcón F, Ferrero-De-Loma-Osorio A, González-Ferrer JJ, Alonso-Martín C, Pachón M, et al. Diagnosis-to-ablation time in atrial fibrillation: a modifiable factor relevant to clinical outcome. J Cardiovasc Electrophysiol. 2019;30:1483–90.

pubmed: 31115940 doi: 10.1111/jce.14000

Kalman JM, Al-Kaisey AM, Parameswaran R, Hawson J, Anderson RD, Lim M, et al. Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences. Eur Heart J. 2023;44:2447–54.

pubmed: 37062010 doi: 10.1093/eurheartj/ehad247

Andrade JG, Wazni OM, Kuniss M, Hawkins NM, Deyell MW, Chierchia GB, et al. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78:914–30.

pubmed: 34446164 doi: 10.1016/j.jacc.2021.06.038

Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140:1779–88.

pubmed: 31630538 doi: 10.1161/CIRCULATIONAHA.119.042622

Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.

pubmed: 27042964 doi: 10.1056/NEJMoa1602014

Walters TE, Wick K, Tan G, Mearns M, Joseph SA, Morton JB, et al. Psychological distress and suicidal ideation in patients with atrial fibrillation: prevalence and response to management strategy. J Am Heart Assoc. 2018;7: e005502.

pubmed: 30371197 pmcid: 6222970 doi: 10.1161/JAHA.117.005502

Al-Kaisey AM, Parameswaran R, Bryant C, Anderson RD, Hawson J, Chieng D, et al. Atrial fibrillation catheter ablation vs medical therapy and psychological distress: a randomized clinical trial. JAMA. 2023;330:925–33.

pubmed: 37698564 pmcid: 10498333 doi: 10.1001/jama.2023.14685

Providencia R, Defaye P, Lambiase PD, Pavin D, Cebron JP, Halimi F, et al. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? Europace. 2017;19:48–57.

pubmed: 27267554

Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128:2104–12.

pubmed: 24061087 doi: 10.1161/CIRCULATIONAHA.113.003862

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275-444.

pubmed: 28506916 pmcid: 6019327 doi: 10.1016/j.hrthm.2017.05.012

Monahan KH, Bunch TJ, Mark DB, Poole JE, Bahnson TD, Al-Khalidi HR, et al. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. Europace. 2022;24:1430–40.

pubmed: 35640922 doi: 10.1093/europace/euac055

Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359:1778–85.

pubmed: 18946063 doi: 10.1056/NEJMoa0708234

MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97:740–7.

pubmed: 21051458 doi: 10.1136/hrt.2010.207340

Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61:1894–903.

pubmed: 23500267 doi: 10.1016/j.jacc.2013.01.069

Kuck KH, Merkely B, Zahn R, Arentz T, Seidl K, Schlüter M, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12: e007731.

pubmed: 31760819 doi: 10.1161/CIRCEP.119.007731

Chen S, Pürerfellner H, Meyer C, Acou WJ, Schratter A, Ling Z, et al. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data. Eur Heart J. 2020;41:2863–73.

pubmed: 31298266 doi: 10.1093/eurheartj/ehz443

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27.

pubmed: 29385358 doi: 10.1056/NEJMoa1707855

Bergonti M, Spera F, Tijskens M, Bonomi A, Saenen J, Huybrechts W, et al. A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure: the ANTWOORD Study. Int J Cardiol. 2022;358:45–50.

pubmed: 35443194 doi: 10.1016/j.ijcard.2022.04.040

Bergonti M, Ascione C, Marcon L, Pambrun T, Della Rocca DG, Ferrero TG, et al. Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model. Eur Heart J. 2023;44:3327–5.

pubmed: 37387689 doi: 10.1093/eurheartj/ehad428

Kawaji T, Shizuta S, Aizawa T, Yamagami S, Kato M, Yokomatsu T, et al. Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure. ESC Heart Fail. 2021;8:670–9.

pubmed: 33305495 doi: 10.1002/ehf2.13160

Okada M, Tanaka N, Oka T, Tanaka K, Ninomiya Y, Hirao Y, et al. Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction. J Cardiol. 2021;77:500–8.

pubmed: 33272779 doi: 10.1016/j.jjcc.2020.11.007

Kirstein B, Neudeck S, Gaspar T, Piorkowski J, Wechselberger S, Kronborg MB, et al. Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: the Fibrosis-HF study. Europace. 2020;22:1812–21.

pubmed: 32830233 doi: 10.1093/europace/euaa179

Tsuji A, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, et al. Impact of the temporal relationship between atrial fibrillation and heart failure on prognosis after ablation. Circ J. 2020;84:1467–74.

pubmed: 32684540 doi: 10.1253/circj.CJ-20-0191

Ishiguchi H, Yoshiga Y, Shimizu A, Ueyama T, Fukuda M, Kato T, et al. Long-term events following catheter-ablation for atrial fibrillation in heart failure with preserved ejection fraction. ESC Heart Fail. 2022;9:3505–18.

pubmed: 35894764 pmcid: 9715889 doi: 10.1002/ehf2.14079

Smit MD, Moes ML, Maass AH, Achekar ID, Van Geel PP, Hillege HL, et al. The importance of whether atrial fibrillation or heart failure develops first. Eur J Heart Fail. 2012;14:1030–40.

pubmed: 22733981 doi: 10.1093/eurjhf/hfs097

von Olshausen G, Benson L, Dahlström U, Lund LH, Savarese G, Braunschweig F. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. Eur J Heart Fail. 2022;24:1636–46.

doi: 10.1002/ejhf.2604

Shiraishi Y, Kohsaka S, Ikemura N, Kimura T, Katsumata Y, Tanimoto K, et al. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study. Europace. 2023;25:83–91.

pubmed: 35851807 doi: 10.1093/europace/euac108

Gu G, Wu J, Gao X, Liu M, Jin C, Xu Y. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: a metaanalysis. Clin Cardiol. 2022;45:786–93.

pubmed: 35544952 pmcid: 9286329 doi: 10.1002/clc.23841

Yamauchi R, Morishima I, Okumura K, Kanzaki Y, Morita Y, Takagi K, et al. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide. Europace. 2021;23:1252–61.

pubmed: 33693617 doi: 10.1093/europace/euaa420

Rordorf R, Scazzuso F, Chun KRJ, Khelae SK, Kueffer FJ, Braegelmann KM, et al. Cryoballoon ablation for the treatment of atrial fibrillation in patients with concomitant heart failure and either reduced or preserved left ventricular ejection fraction: results from the Cryo AF Global Registry. J Am Heart Assoc. 2021;10: e021323.

pubmed: 34889108 pmcid: 9075259 doi: 10.1161/JAHA.121.021323

Aldaas OM, Lupercio F, Darden D, Mylavarapu PS, Malladi CL, Han FT, et al. Metaanalysis of the usefulness of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. Am J Cardiol. 2021;142:66–73.

pubmed: 33290688 doi: 10.1016/j.amjcard.2020.11.039

Black-Maier E, Ren X, Steinberg BA, Green CL, Barnett AS, Rosa NS, et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm. 2018;15:651–7.

pubmed: 29222043 doi: 10.1016/j.hrthm.2017.12.001

Chieng D, Sugumar H, Segan L, Tan C, Vizi D, Nanayakkara S, et al. Atrial fibrillation ablation for heart failure with preserved ejection fraction. JACC Heart Fail. 2023;11:646–58.

pubmed: 36868916 doi: 10.1016/j.jchf.2023.01.008

Ganapathy AV, Monjazeb S, Ganapathy KS, Shanoon F, Razavi M. “Asymptomatic” persistent or permanent atrial fibrillation: a misnomer in selected patients. Int J Cardiol. 2015;185:112–3.

pubmed: 25791105 doi: 10.1016/j.ijcard.2015.03.122

Shin DI, Jaekel K, Schley P, Sause A, Müller M, Fueth R, et al. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol. 2005;94:795–800.

pubmed: 16382379 doi: 10.1007/s00392-005-0301-7

Stojadinović P, Deshraju A, Wichterle D, Fukunaga M, Peichl P, Kautzner J, et al. The hemodynamic effect of simulated atrial fibrillation on left ventricular function. J Cardiovasc Electrophysiol. 2022;33:2569–77.

pubmed: 36069129 doi: 10.1111/jce.15669

Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039–45.

pubmed: 9316536 doi: 10.1016/S0735-1097(97)00254-4

Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and metaanalysis. Eur Heart J. 2016;37:1591–602.

pubmed: 26888184 doi: 10.1093/eurheartj/ehw007

Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, et al. Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction 48). Circ Arrhythm Electrophysiol. 2017;10: e004267.

pubmed: 28077507 doi: 10.1161/CIRCEP.116.004267

Kuck KH, Lebedev DS, Mikhaylov EN, Romanov A, Gellér L, Kalējs O, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23:362–9.

pubmed: 33330909 doi: 10.1093/europace/euaa298

Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1275–85.

pubmed: 30874716 pmcid: 6450275 doi: 10.1001/jama.2019.0692

Bahnson TD, Giczewska A, Mark DB, Russo AM, Monahan KH, Al-Khalidi HR, et al. Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial. Circulation. 2022;145:796–804.

pubmed: 34933570 doi: 10.1161/CIRCULATIONAHA.121.055297

Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns H, et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur Heart J. 2022;43:1219–30.

pubmed: 34447995 doi: 10.1093/eurheartj/ehab593

Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S, et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification. Circulation. 2006;114:191–5.

pubmed: 16831982 doi: 10.1161/CIRCULATIONAHA.106.621896

Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett EL. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 1995;25:984–8.

pubmed: 7897142 doi: 10.1016/0735-1097(94)00512-O

Dagres N, Clague JR, Lottkamp H, Hindricks G, Breithardt G, Borggrefe M. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age. Eur Heart J. 2001;22:423–7.

pubmed: 11207084 doi: 10.1053/euhj.2000.2429

Hocini M, Sanders P, Deisenhofer I, Jaïs P, Hsu LF, Scavée C, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108:1172–5.

pubmed: 12952840 doi: 10.1161/01.CIR.0000090685.13169.07

Akoum N, McGann C, Vergara G, Badger T, Ranjan R, Mahnkopf C, et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol. 2012;23:44–50.

pubmed: 21806700 doi: 10.1111/j.1540-8167.2011.02140.x

Calkins H. Should catheter ablation be the preferred approach for treatment of atrial fibrillation related symptomatic sinus node dysfunction? Pacing Clin Electrophysiol. 2014;37:401–2.

pubmed: 24456425 doi: 10.1111/pace.12350

Merino JL. Slow conduction and flutter following atrial fibrillation ablation: proarrhythmia or unmasking effect of radiofrequency application? J Cardiovasc Electrophysiol. 2006;17:516–9.

pubmed: 16684025 doi: 10.1111/j.1540-8167.2006.00454.x

Hwang TH, Yu HT, Kim TH, Uhm JS, Kim JY, Joung B, et al. Permanent pacemaker implantations after catheter ablation in patients with atrial fibrillation associated with underlying sinus node dysfunction. Korean Circ J. 2020;50:346–57.

pubmed: 31960638 doi: 10.4070/kcj.2019.0268

Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol. 2008;51:779–86.

pubmed: 18294560 doi: 10.1016/j.jacc.2007.08.066

Gupta D, Ding WY, Calvert P, Williams E, Das M, Tovmassian L, et al. Cryoballoon pulmonary vein isolation as first-line treatment for typical atrial flutter. Heart. 2023;109:364–71.

pubmed: 36396438

Chugh A, Oral H, Lemola K, Hall B, Cheung P, Good E, et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm. 2005;2:464–71.

pubmed: 15840468 doi: 10.1016/j.hrthm.2005.01.027

Chen J, Hocini M, Larsen TB, Proclemer A, Sciaraffia E, Blomström-Lundqvist C. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey. Europace. 2015;17:314–7.

pubmed: 25634939 doi: 10.1093/europace/euv010

Ikenouchi T, Nitta J, Nitta G, Kato S, Iwasaki T, Murata K, et al. Propensity-matched comparison of cryoballoon and radiofrequency ablation for atrial fibrillation in elderly patients. Heart Rhythm. 2019;16:838–45.

pubmed: 30576880 doi: 10.1016/j.hrthm.2018.12.019

Guttmann OP, Rahman MS, O’Mahony C, Anastasakis A, Elliott PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014;100:465–72.

pubmed: 24014282 doi: 10.1136/heartjnl-2013-304276

Rowin EJ, Orfanos A, Estes NAM, Wang W, Link MS, Maron MS, et al. Occurrence and natural history of clinically silent episodes of atrial fibrillation in hypertrophic cardiomyopathy. Am J Cardiol. 2017;119:1862–5.

pubmed: 28395893 doi: 10.1016/j.amjcard.2017.02.040

Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, et al. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation. 2017;136:2420–36.

pubmed: 28916640 doi: 10.1161/CIRCULATIONAHA.117.029267

Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Obesity is associated with incident atrial fibrillation independent of gender: a metaanalysis. J Cardiovasc Electrophysiol. 2018;29:725–32.

pubmed: 29443438 doi: 10.1111/jce.13458

Sivasambu B, Balouch MA, Zghaib T, Bajwa RJ, Chrispin J, Berger RD, et al. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J Cardiovasc Electrophysiol. 2018;29:239–45.

pubmed: 29131442 doi: 10.1111/jce.13388

Glover BM, Hong KL, Dagres N, Arbelo E, Laroche C, Riahi S, et al. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation. Heart. 2019;105:244–50.

pubmed: 30279268 doi: 10.1136/heartjnl-2018-313490

Shoemaker MB, Muhammad R, Farrell M, Parvez B, White BW, Streur M, et al. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol. 2013;111:368–73.

pubmed: 23168290 doi: 10.1016/j.amjcard.2012.10.013

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222–31.

pubmed: 25456757 doi: 10.1016/j.jacc.2014.09.028

Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159–69.

pubmed: 25792361 doi: 10.1016/j.jacc.2015.03.002

Zhang D, Ma Y, Xu J, Yi F. Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): a dose-response metaanalysis. Medicine. 2022;101: e29443.

pubmed: 35905270 pmcid: 9333485 doi: 10.1097/MD.0000000000029443

Szymanski FM, Filipiak KJ, Platek AE, Hrynkiewicz-Szymanska A, Kotkowski M, Kozluk E, et al. Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations—a long-term prospective, cross-sectional cohort study. Sleep Breath. 2015;19:849–56.

pubmed: 25566942 pmcid: 4559085 doi: 10.1007/s11325-014-1102-x

Li L, Wang ZW, Li J, Ge X, Guo LZ, Wang Y, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a metaanalysis of observational studies. Europace. 2014;16:1309–14.

pubmed: 24696222 doi: 10.1093/europace/euu066

Kawakami H, Nagai T, Fujii A, Uetani T, Nishimura K, Inoue K, et al. Apnea-hypopnea index as a predictor of atrial fibrillation recurrence following initial pulmonary vein isolation: usefulness of type-3 portable monitor for sleep-disordered breathing. J Interv Card Electrophysiol. 2016;47:237–44.

pubmed: 27272651 doi: 10.1007/s10840-016-0148-z

Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Metaanalysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:47–51.

pubmed: 21529734 doi: 10.1016/j.amjcard.2011.02.343

Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10:331–7.

pubmed: 23178687 doi: 10.1016/j.hrthm.2012.11.015

Li X, Zhou X, Xu X, Dai J, Chen C, Ma L, et al. Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: a metaanalysis. Medicine. 2021;100: e25438.

pubmed: 33847645 pmcid: 8051983 doi: 10.1097/MD.0000000000025438

Nalliah CJ, Wong GR, Lee G, Voskoboinik A, Kee K, Goldin J, et al. Impact of CPAP on the atrial fibrillation substrate in obstructive sleep apnea: the SLEEP-AF study. JACC Clin Electrophysiol. 2022;8:869–77.

pubmed: 35863812 doi: 10.1016/j.jacep.2022.04.015

Hunt TE, Traaen GM, Aakerøy L, Bendz C, Øverland B, Akre H, et al. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial. Heart Rhythm. 2022;19:1433–41.

pubmed: 35716856 doi: 10.1016/j.hrthm.2022.06.016

Donnellan E, Aagaard P, Kanj M, Jaber W, Elshazly M, Hoosien M, et al. Association between preablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation. JACC Clin Electrophysiol. 2019;5:897–903.

pubmed: 31439289 doi: 10.1016/j.jacep.2019.05.018

Takahashi Y, Nitta J, Kobori A, Sakamoto Y, Nagata Y, Tanimoto K, et al. Alcohol consumption reduction and clinical outcomes of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2021;14: e009770.

pubmed: 33999699 doi: 10.1161/CIRCEP.121.009770

Cheng WH, Lo LW, Lin YJ, Chang SL, Hu YF, Hung Y, et al. Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation. J Cardiovasc Electrophysiol. 2018;29:699–706.

pubmed: 29424013 doi: 10.1111/jce.13451

Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F, et al. NOACs and atrial fibrillation: incidence and predictors of left atrial thrombus in the real world. Int J Cardiol. 2017;249:179–83.

pubmed: 29121724 doi: 10.1016/j.ijcard.2017.07.048

Lurie A, Wang J, Hinnegan KJ, McIntyre WF, Belley-Côté EP, Amit G, et al. Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2021;77:2875–86.

pubmed: 34112315 doi: 10.1016/j.jacc.2021.04.036

Lip GY, Frison L, Grind M. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. J Intern Med. 2008;264:50–61.

pubmed: 18266660 doi: 10.1111/j.1365-2796.2007.01909.x

Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013;34:2464–71.

pubmed: 23594592 doi: 10.1093/eurheartj/eht135

Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015;36:288–96.

pubmed: 25209598 doi: 10.1093/eurheartj/ehu359

Jung H, Sung JH, Yang PS, Jang E, Yu HT, Kim TH, et al. Stroke risk stratification for atrial fibrillation patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2018;72:2409–11.

pubmed: 30384898 doi: 10.1016/j.jacc.2018.07.098

Manjunath CN, Srinivasa KH, Panneerselvam A, Prabhavathi B, Ravindranath KS, Rangan K, et al. Incidence and predictors of left atrial thrombus in patients with rheumatic mitral stenosis and sinus rhythm: a transesophageal echocardiographic study. Echocardiography. 2011;28:457–60.

pubmed: 21426392 doi: 10.1111/j.1540-8175.2010.01361.x

Saidi SJ, Motamedi MH. Incidence and factors influencing left atrial clot in patients with mitral stenosis and normal sinus rhythm. Heart. 2004;90:1342–3.

pubmed: 15486142 pmcid: 1768547 doi: 10.1136/hrt.2003.024315

Ahmed K, Rehman Memon A, Liaquat H Sr, Mujtaba M, Parkash C, Sultan FAT, et al. The frequency of left atrial thrombus on transthoracic echocardiogram in patients with mitral stenosis. Cureus. 2020;12: e7453.

pubmed: 32351832 pmcid: 7188021

Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007;116:2420–6.

pubmed: 17984380 doi: 10.1161/CIRCULATIONAHA.107.697763

Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, et al. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009;119:2490–7.

pubmed: 19414641 doi: 10.1161/CIRCULATIONAHA.108.785014

El-Am EA, Dispenzieri A, Melduni RM, Ammash NM, White RD, Hodge DO, et al. Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis. J Am Coll Cardiol. 2019;73:589–97.

pubmed: 30732713 pmcid: 6378685 doi: 10.1016/j.jacc.2018.10.079

Touboul O, Algalarrondo V, Oghina S, Elbaz N, Rouffiac S, Hamon D, et al. Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants. ESC Heart Fail. 2022;9:3556–64.

pubmed: 35903879 pmcid: 9715864 doi: 10.1002/ehf2.14082

Burczak DR, Julakanti RR, Kara Balla A, Scott CG, Geske JB, Ommen SR, et al. Risk of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Am Coll Cardiol. 2023;82:278–9.

pubmed: 37438012 doi: 10.1016/j.jacc.2023.05.021

Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550–6.

pubmed: 20516376 doi: 10.1161/CIRCULATIONAHA.109.921320

Santangeli P, Di Biase L, Horton R, Burkhardt JD, Sanchez J, Al-Ahmad A, et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a metaanalysis. Circ Arrhythm Electrophysiol. 2012;5:302–11.

pubmed: 22271713 doi: 10.1161/CIRCEP.111.964916

Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116:2531–4.

pubmed: 17998456 doi: 10.1161/CIRCULATIONAHA.107.727784

Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation. 2014;129:2638–44.

pubmed: 24744272 doi: 10.1161/CIRCULATIONAHA.113.006426

Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36:1805–11.

pubmed: 25975659 pmcid: 4508487 doi: 10.1093/eurheartj/ehv177

Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376:1627–36.

pubmed: 28317415 doi: 10.1056/NEJMoa1701005

Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, et al. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J. 2018;39:2942–55.

pubmed: 29579168 pmcid: 6110196 doi: 10.1093/eurheartj/ehy176

Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbüchel H, Mont L, et al. Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial. Eur Heart J. 2019;40:3013–21.

pubmed: 30976787 pmcid: 6754569 doi: 10.1093/eurheartj/ehz190

Cardoso R, Knijnik L, Bhonsale A, Miller J, Nasi G, Rivera M, et al. An updated metaanalysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation. Heart Rhythm. 2018;15:107–15.

pubmed: 28917562 doi: 10.1016/j.hrthm.2017.09.011

Romero J, Cerrud-Rodriguez RC, Alviz I, Diaz JC, Rodriguez D, Arshad S, et al. Significant benefit of uninterrupted DOACs versus VKA during catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2019;5:1396–405.

pubmed: 31857038 doi: 10.1016/j.jacep.2019.08.010

Di Biase L, Callans D, Haeusler KG, Hindricks G, Al-Khalidi H, Mont L, et al. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. Europace. 2017;19:132–8.

pubmed: 28130378 doi: 10.1093/europace/euw368

Romero J, Cerrud-Rodriguez RC, Diaz JC, Michaud GF, Taveras J, Alviz I, et al. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and metaanalysis of randomized controlled trials. Europace. 2018;20:1612–20.

pubmed: 29982383 doi: 10.1093/europace/euy133

Di Biase L, Lakkireddy D, Trivedi C, Deneke T, Martinek M, Mohanty S, et al. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Heart Rhythm. 2015;12:1162–8.

pubmed: 25728754 doi: 10.1016/j.hrthm.2015.02.028

Yu HT, Shim J, Park J, Kim TH, Uhm JS, Kim JY, et al. When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study. Eur Heart J. 2019;40:1531–7.

pubmed: 30590600 doi: 10.1093/eurheartj/ehy870

Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M, et al. A Prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial. JACC Clin Electrophysiol. 2018;4:580–8.

pubmed: 29798783 doi: 10.1016/j.jacep.2017.11.005

Nakamura K, Naito S, Sasaki T, Take Y, Minami K, Kitagawa Y, et al. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on postablation thromboembolic and haemorrhagic events. Europace. 2019;21:259–67.

pubmed: 29982562 doi: 10.1093/europace/euy148

Ando M, Inden Y, Yoshida Y, Sairaku A, Yanagisawa S, Suzuki H, et al. Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study. Heart Vessels. 2019;34:1533–41.

pubmed: 30840130 doi: 10.1007/s00380-019-01370-9

Nagao T, Suzuki H, Matsunaga S, Nishikawa Y, Harada K, Mamiya K, et al. Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy. Europace. 2019;21:590–7.

pubmed: 30376051 doi: 10.1093/europace/euy224

Patel K, Natale A, Yang R, Trivedi C, Romero J, Briceno D, et al. Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter registry. Heart Rhythm. 2020;17:2093–9.

pubmed: 32681991 doi: 10.1016/j.hrthm.2020.07.017

Wang Y, Zhao Y, Zhou K, Zei PC, Wang Y, Cheng H, et al. Intracardiac echocardiography is a safe and effective alternative to transesophageal echocardiography for left atrial appendage thrombus evaluation at the time of atrial fibrillation ablation: the ICE-TEE study. Pacing Clin Electrophysiol. 2023;46:3–10.

pubmed: 36301182 doi: 10.1111/pace.14601

Morton JB, Sanders P, Sparks PB, Morgan J, Kalman JM. Usefulness of phased-array intracardiac echocardiography for the assessment of left atrial mechanical “stunning” in atrial flutter and comparison with multiplane transesophageal echocardiography(*). Am J Cardiol. 2002;90:741–6.

pubmed: 12356388 doi: 10.1016/S0002-9149(02)02601-2

Baran J, Stec S, Pilichowska-Paszkiet E, Zaborska B, Sikora-Frąc M, Kryński T, et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I study. Circ Arrhythm Electrophysiol. 2013;6:1074–81.

pubmed: 24243787 doi: 10.1161/CIRCEP.113.000504

Tsyganov A, Shapieva A, Sandrikov V, Fedulova S, Mironovich S, Dzeranova A, et al. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban. BMC Cardiovasc Disord. 2017;17:171.

pubmed: 28662693 pmcid: 5492399 doi: 10.1186/s12872-017-0607-1

Saksena S, Sra J, Jordaens L, Kusumoto F, Knight B, Natale A, et al. A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study. Circ Arrhythm Electrophysiol. 2010;3:571–7.

pubmed: 20852299 doi: 10.1161/CIRCEP.110.936161

Sriram CS, Banchs JE, Moukabary T, Moradkhan R, Gonzalez MD. Detection of left atrial thrombus by intracardiac echocardiography in patients undergoing ablation of atrial fibrillation. J Interv Card Electrophysiol. 2015;43:227–36.

pubmed: 25935227 doi: 10.1007/s10840-015-0008-2

Yu S, Zhang H, Li H. Cardiac computed tomography versus transesophageal echocardiography for the detection of left atrial appendage thrombus: a systemic review and metaanalysis. J Am Heart Assoc. 2021;10: e022505.

pubmed: 34796743 pmcid: 9075398 doi: 10.1161/JAHA.121.022505

Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I. Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echocardiography for diagnosing left atrial appendage thrombi. Europace. 2019;21:e1-10.

pubmed: 29961869 doi: 10.1093/europace/euy142

Spagnolo P, Giglio M, Di Marco D, Cannaò PM, Agricola E, Della Bella PE, et al. Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT. Eur Radiol. 2021;31:1236–44.

pubmed: 32886202 doi: 10.1007/s00330-020-07172-2

Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M, et al. Preprocedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J. 2007;28:836–41.

pubmed: 17395676 doi: 10.1093/eurheartj/ehm027

Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol. 2010;21:1071–8.

pubmed: 20500237 doi: 10.1111/j.1540-8167.2010.01786.x

Arya A, Hindricks G, Sommer P, Huo Y, Bollmann A, Gaspar T, et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace. 2010;12:173–80.

pubmed: 19889688 doi: 10.1093/europace/eup331

Santoro F, Di Biase L, Trivedi C, Burkhardt JD, Paoletti Perini A, Sanchez J, et al. Impact of uncontrolled hypertension on atrial fibrillation ablation outcome. JACC Clin Electrophysiol. 2015;1:164–73.

pubmed: 29759360 doi: 10.1016/j.jacep.2015.04.002

Anselmino M, Matta M, D’Ascenzo F, Pappone C, Santinelli V, Bunch TJ, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and metaanalysis. Europace. 2015;17:1518–25.

pubmed: 26498716 doi: 10.1093/europace/euv214

Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH, et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: who benefits and who does not? Data from the German ablation registry. Int J Cardiol. 2016;214:25–30.

pubmed: 27057967 doi: 10.1016/j.ijcard.2016.03.069

Creta A, Providencia R, Adragao P, de Asmundis C, Chun J, Chierchia G, et al. Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European observational multicentre study). Am J Cardiol. 2020;125:901–6.

pubmed: 31973808 doi: 10.1016/j.amjcard.2019.12.037

Wang A, Truong T, Black-Maier E, Green C, Campbell KB, Barnett AS, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus. Heart Rhythm. 2020;O2(1):180–8.

doi: 10.1016/j.hroo.2020.04.006

Deshmukh A, Ghannam M, Liang J, Saeed M, Cunnane R, Ghanbari H, et al. Effect of metformin on outcomes of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32:1232–9.

pubmed: 33600005 doi: 10.1111/jce.14954

De Maat GE, Mulder BA, Berretty WL, Al-Jazairi MIH, Tan ES, Wiesfeld ACP, et al. Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation. Open Heart. 2018;5: e000771.

pubmed: 29862033 pmcid: 5976117 doi: 10.1136/openhrt-2017-000771

Winkle RA, Mead RH, Engel G, Kong MH, Fleming W, Salcedo J, et al. Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm. 2017;14:819–27.

pubmed: 28232261 doi: 10.1016/j.hrthm.2017.02.023

Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol. 2009;103:67–72.

pubmed: 19101232 doi: 10.1016/j.amjcard.2008.08.042

Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J. 2009;73:438–43.

pubmed: 19179774 doi: 10.1253/circj.CJ-08-0832

Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59:1295–301.

pubmed: 22464257 doi: 10.1016/j.jacc.2011.11.051

Donnellan E, Wazni OM, Harb S, Kanj M, Saliba WI, Jaber WA. Higher baseline cardiorespiratory fitness is associated with lower arrhythmia recurrence and death after atrial fibrillation ablation. Heart Rhythm. 2020;17:1687–93.

pubmed: 32762978 doi: 10.1016/j.hrthm.2020.05.013

Mandsager KT, Phelan DM, Diab M, Baranowski B, Saliba WI, Tarakji KG, et al. Outcomes of pulmonary vein isolation in athletes. JACC Clin Electrophysiol. 2020;6:1265–74.

pubmed: 33092753 doi: 10.1016/j.jacep.2020.05.009

Liu MB, Lee JZ, Klooster L, Petty SA, Scott LR. Influence of endurance sports on atrial fibrillation ablation outcomes. J Arrhythm. 2022;38:1–16.

doi: 10.1002/joa3.12746

Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386–93.

pubmed: 21646230 doi: 10.1093/europace/eur142

Kato M, Ogano M, Mori Y, Kochi K, Morimoto D, Kito K, et al. Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial. Eur J Prev Cardiol. 2019;26:1931–40.

pubmed: 31272205 doi: 10.1177/2047487319859974

Congrete S, Bintvihok M, Thongprayoon C, Bathini T, Boonpheng B, Sharma K, et al. Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: a metaanalysis. J Evid Based Med. 2018;11:145–51.

pubmed: 30091301 doi: 10.1111/jebm.12313

Matiello M, Nadal M, Tamborero D, Berruezo A, Montserrat J, Embid C, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010;12:1084–9.

pubmed: 20488856 doi: 10.1093/europace/euq128

Takigawa M, Takahashi A, Kuwahara T, Takahashi Y, Okubo K, Nakashima E, et al. Impact of alcohol consumption on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation. J Am Heart Assoc. 2016;5: e004149.

pubmed: 27895043 pmcid: 5210418 doi: 10.1161/JAHA.116.004149

Qiao Y, Shi R, Hou B, Wu L, Zheng L, Ding L, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4: e002349.

pubmed: 26553213 pmcid: 4845226 doi: 10.1161/JAHA.115.002349

Fukamizu S, Sakurada H, Takano M, Hojo R, Nakai M, Yuba T, et al. Effect of cigarette smoking on the risk of atrial fibrillation recurrence after pulmonary vein isolation. J Arrhythm. 2010;26:21–9.

doi: 10.1016/S1880-4276(10)80032-8

Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Author correction: epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20:429.

pubmed: 36650290 doi: 10.1038/s41569-023-00834-w

Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA. 1994;271:840–4.

pubmed: 8114238

Kim D, Yang PS, Kim TH, Jang E, Shin H, Kim HY, et al. Ideal blood pressure in patients with atrial fibrillation. J Am Coll Cardiol. 2018;72:1233–45.

pubmed: 30190001 doi: 10.1016/j.jacc.2018.05.076

Okin PM, Hille DA, Larstorp AC, Wachtell K, Kjeldsen SE, Dahlof B, et al. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients. Hypertension. 2015;66:368–73.

pubmed: 26056336 doi: 10.1161/HYPERTENSIONAHA.115.05728

Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res. 2018;122:352–68.

pubmed: 29348255 doi: 10.1161/CIRCRESAHA.117.311402

Zylla MM, Hochadel M, Andresen D, Brachmann J, Eckardt L, Hoffmann E, et al. Ablation of atrial fibrillation in patients with hypertension-an analysis from the German Ablation Registry. J Clin Med. 2020;9:2402.

pubmed: 32727136 pmcid: 7463680 doi: 10.3390/jcm9082402

Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, et al. Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control]). Circulation. 2017;135:1788–98.

pubmed: 28228428 doi: 10.1161/CIRCULATIONAHA.116.026230

Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163–70.

pubmed: 22958958 doi: 10.1016/j.jacc.2012.05.036

Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial. JAMA. 2020;323:248–55.

pubmed: 31961420 pmcid: 6990678 doi: 10.1001/jama.2019.21187

Hohl M, Selejan SR, Wintrich J, Lehnert U, Speer T, Schneider C, et al. Renal denervation prevents atrial arrhythmogenic substrate development in CKD. Circ Res. 2022;130:814–28.

pubmed: 35130718 doi: 10.1161/CIRCRESAHA.121.320104

Al-Kaisey AM, Kalman JM. Obesity and atrial fibrillation: epidemiology, pathogenesis and effect of weight loss. Arrhythm Electrophysiol Rev. 2021;10:159–64.

pubmed: 34777820 pmcid: 8576485 doi: 10.15420/aer.2021.36

Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, et al. Obesity and the risk of incident, postoperative, and postablation atrial fibrillation: a metaanalysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1:139–52.

pubmed: 29759357 doi: 10.1016/j.jacep.2015.04.004

Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90–100.

pubmed: 23063864 doi: 10.1016/j.hrthm.2012.08.043

Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug BA, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851–60.

pubmed: 22726633 doi: 10.1016/j.jacc.2012.03.042

Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745–51.

pubmed: 21511110 doi: 10.1016/j.jacc.2010.11.045

Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205–13.

pubmed: 24648445 doi: 10.1093/cvr/cvu045

Mohanty S, Mohanty P, Natale V, Trivedi C, Gianni C, Burkhardt JD, et al. Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:246–53.

pubmed: 29171116 doi: 10.1111/jce.13394

Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N, et al. Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial. Europace. 2021;23:1548–58.

pubmed: 33895833 pmcid: 8502497 doi: 10.1093/europace/euab122

Donnellan E, Wazni OM, Kanj M, Baranowski B, Cremer P, Harb S, et al. Association between preablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Europace. 2019;21:1476–83.

pubmed: 31304532 doi: 10.1093/europace/euz183

Youssef I, Kamran H, Yacoub M, Patel N, Goulbourne C, Kumar S, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a metaanalysis. J Sleep Disord Ther. 2018;7:282.

pubmed: 29657903 pmcid: 5898401 doi: 10.4172/2167-0277.1000282

Linz D, Schotten U, Neuberger HR, Bohm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436–43.

pubmed: 21457790 doi: 10.1016/j.hrthm.2011.03.053

Holtstrand Hjalm H, Fu M, Hansson PO, Zhong Y, Caidahl K, Mandalenakis Z, et al. Association between left atrial enlargement and obstructive sleep apnea in a general population of 71-year-old men. J Sleep Res. 2018;27:252–8.

pubmed: 28836321 doi: 10.1111/jsr.12585

Iwasaki YK, Kato T, Xiong F, Shi YF, Naud P, Maguy A, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64:2013–23.

pubmed: 25440097 doi: 10.1016/j.jacc.2014.05.077

Qureshi WT, Nasir UB, Alqalyoobi S, O’Neal WT, Mawri S, Sabbagh S, et al. Metaanalysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol. 2015;116:1767–73.

pubmed: 26482182 doi: 10.1016/j.amjcard.2015.08.046

Linz D, McEvoy RD, Cowie MR, Somers VK, Nattel S, Lévy P, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3:532–40.

pubmed: 29541763 doi: 10.1001/jamacardio.2018.0095

Gallagher C, Hendriks JML, Elliott AD, Wong CX, Rangnekar G, Middeldorp ME, et al. Alcohol and incident atrial fibrillation—a systematic review and metaanalysis. Int J Cardiol. 2017;246:46–52.

pubmed: 28867013 doi: 10.1016/j.ijcard.2017.05.133

Voskoboinik A, Wong G, Lee G, Nalliah C, Hawson J, Prabhu S, et al. Moderate alcohol consumption is associated with atrial electrical and structural changes: insights from high-density left atrial electroanatomic mapping. Heart Rhythm. 2019;16:251–9.

pubmed: 30639070 doi: 10.1016/j.hrthm.2018.10.041

Mandyam MC, Vedantham V, Scheinman MM, Tseng ZH, Badhwar N, Lee BK, et al. Alcohol and vagal tone as triggers for paroxysmal atrial fibrillation. Am J Cardiol. 2012;110:364–8.

pubmed: 22521307 pmcid: 3398200 doi: 10.1016/j.amjcard.2012.03.033

Khawaja O, Bartz TM, Ix JH, Heckbert SR, Kizer JR, Zieman SJ, et al. Plasma free fatty acids and risk of atrial fibrillation (from the cardiovascular health study). Am J Cardiol. 2012;110:212–6.

pubmed: 22503582 pmcid: 3383877 doi: 10.1016/j.amjcard.2012.03.010

McManus DD, Yin X, Gladstone R, Vittinghoff E, Vasan RS, Larson MG, et al. Alcohol consumption, left atrial diameter, and atrial fibrillation. J Am Heart Assoc. 2016;5: e004060.

pubmed: 27628571 pmcid: 5079048 doi: 10.1161/JAHA.116.004060

Sagawa Y, Nagata Y, Miwa N, Yamaguchi T, Watanabe K, Kaneko M, et al. Alcohol consumption is associated with postablation recurrence but not changes in atrial substrate in patients with atrial fibrillation: insight from a high-density mapping study. J Am Heart Assoc. 2022;11: e025697.

pubmed: 35766315 pmcid: 9333400 doi: 10.1161/JAHA.121.025697

Barmano N, Charitakis E, Kronstrand R, Walfridsson U, Karlsson JE, Walfridsson H, et al. The association between alcohol consumption, cardiac biomarkers, left atrial size and reablation in patients with atrial fibrillation referred for catheter ablation. PLoS One. 2019;14: e0215121.

pubmed: 30970005 pmcid: 6457637 doi: 10.1371/journal.pone.0215121

Mohanty S, Mohanty P, Tamaki M, Natale V, Gianni C, Trivedi C, et al. Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a metaanalysis. J Cardiovasc Electrophysiol. 2016;27:1021–9.

pubmed: 27245609 doi: 10.1111/jce.13023

Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118:800–7.

pubmed: 18678768 pmcid: 3133958 doi: 10.1161/CIRCULATIONAHA.108.785626

Jin MN, Yang PS, Song C, Yu HT, Kim TH, Uhm JS, et al. Physical activity and risk of atrial fibrillation: a nationwide cohort study in general population. Sci Rep. 2019;9:13270.

pubmed: 31519947 pmcid: 6744571 doi: 10.1038/s41598-019-49686-w

Morseth B, Graff-Iversen S, Jacobsen BK, Jørgensen L, Nyrnes A, Thelle DS, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø study. Eur Heart J. 2016;37:2307–13.

pubmed: 26966149 pmcid: 4986028 doi: 10.1093/eurheartj/ehw059

Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66:985–96.

pubmed: 26113406 doi: 10.1016/j.jacc.2015.06.488

Elliott AD, Verdicchio CV, Mahajan R, Middeldorp ME, Gallagher C, Mishima RS, et al. An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial. JACC Clin Electrophysiol. 2023;9:455–65.

pubmed: 36752479 doi: 10.1016/j.jacep.2022.12.002

Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12:30–6.

pubmed: 19923171 doi: 10.1093/europace/eup320

Decroocq M, Ninni S, Klein C, Machuron F, Verbrugge E, Klug D, et al. No impact of sports practice before or after atrial fibrillation ablation on procedure efficacy in athletes: a case-control study. Europace. 2019;21:1833–42.

pubmed: 31436840 doi: 10.1093/europace/euz231

Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and metaanalysis of cohort studies. J Diabetes Complicat. 2018;32:501–11.

doi: 10.1016/j.jdiacomp.2018.02.004

Liu C, Fu H, Li J, Yang W, Cheng L, Liu T, et al. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyol Derg. 2012;12:543–50.

pubmed: 22877897

Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, et al. Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study. Heart Rhythm. 2011;8:1160–6.

pubmed: 21419237 pmcid: 3139831 doi: 10.1016/j.hrthm.2011.03.038

Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25:95–102.

pubmed: 19936945 doi: 10.1007/s10654-009-9404-1

Zhu W, Yuan P, Shen Y, Wan R, Hong K. Association of smoking with the risk of incident atrial fibrillation: a metaanalysis of prospective studies. Int J Cardiol. 2016;218:259–66.

pubmed: 27236125 doi: 10.1016/j.ijcard.2016.05.013

Albertsen IE, Rasmussen LH, Lane DA, Overvad TF, Skjoth F, Overvad K, et al. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish diet, cancer, and health study. Chest. 2014;145:559–66.

pubmed: 24091709 doi: 10.1378/chest.13-1740

Kwon S, Kim TJ, Choi EK, Ahn HJ, Lee E, Lee SR, et al. Predictors of ischemic stroke for low-risk patients with atrial fibrillation: a matched case-control study. Heart Rhythm. 2021;18:702–8.

pubmed: 33482386 doi: 10.1016/j.hrthm.2021.01.016

Pathak RK, Middeldorp ME, Stolcman S, Willoughby S, Mahajan R, Lau D, et al. Aggressive risk factor REduction STudy: implications for the substrate for atrial fibrillation (ARREST-AF substrate study). Circ J. 2015;132:S115–6.

John B, Stiles MK, Kuklik P, Brooks AG, Chandy ST, Kalman JM, et al. Reverse remodeling of the atria after treatment of chronic stretch in humans: implications for the atrial fibrillation substrate. J Am Coll Cardiol. 2010;55:1217–26.

pubmed: 20298929 doi: 10.1016/j.jacc.2009.10.046

Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brügemann J, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39:2987–96.

pubmed: 29401239 doi: 10.1093/eurheartj/ehx739

Pandey AK, Okaj I, Kaur H, Belley-Cote EP, Wang J, Oraii A, et al. Sodium-glucose co-transporter inhibitors and atrial fibrillation: a systematic review and metaanalysis of randomized controlled trials. J Am Heart Assoc. 2021;10: e022222.

pubmed: 34459238 pmcid: 8649253 doi: 10.1161/JAHA.121.022222

Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47:1997–2004.

pubmed: 16697316 doi: 10.1016/j.jacc.2006.01.060

Cheng WH, Lo LW, Lin YJ, Chang SL, Hu YF, Hung Y, et al. Ten-year ablation outcomes of patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation. Heart Rhythm. 2019;16:1327–33.

pubmed: 30946970 doi: 10.1016/j.hrthm.2019.03.028

Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol. 2009;104:366–72.

pubmed: 19616669 pmcid: 2892619 doi: 10.1016/j.amjcard.2009.03.044

Uchiyama T, Miyazaki S, Taniguchi H, Komatsu Y, Kusa S, Nakamura H, et al. Six-year follow-up of catheter ablation in paroxysmal atrial fibrillation. Circ J. 2013;77:2722–7.

pubmed: 23924888 doi: 10.1253/circj.CJ-13-0468

Gokoglan Y, Mohanty S, Gunes MF, Trivedi C, Santangeli P, Gianni C, et al. Pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: more than a decade of follow-up. Circ Arrhythm Electrophysiol. 2016;9: e003660.

pubmed: 27162030 doi: 10.1161/CIRCEP.115.003660

Hung Y, Lo LW, Lin YJ, Chang SL, Hu YF, Chung FP, et al. Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers. Int J Cardiol. 2017;241:205–11.

pubmed: 28456483 doi: 10.1016/j.ijcard.2017.04.050

Wynn GJ, El-Kadri M, Haq I, Das M, Modi S, Snowdon R, et al. Long-term outcomes after ablation of persistent atrial fibrillation: an observational study over 6 years. Open Heart. 2016;3: e000394.

pubmed: 27547426 pmcid: 4975869 doi: 10.1136/openhrt-2015-000394

Chew DS, Jones KA, Loring Z, Black-Maier E, Noseworthy PA, Exner DV, et al. Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation. Heart Rhythm. 2022;O2(3):23–31.

doi: 10.1016/j.hroo.2021.11.012

De Greef Y, Schwagten B, Chierchia GB, de Asmundis C, Stockman D, Buysschaert I. Diagnosis-to-ablation time as a predictor of success: early choice for pulmonary vein isolation and long-term outcome in atrial fibrillation: results from the Middelheim-PVI Registry. Europace. 2018;20:589–95.

pubmed: 28340103 doi: 10.1093/europace/euw426

Baysal E, Okşul M, Burak C, Yalin K, Soysal AU, Yalman H, et al. Decreasing time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation positively affects long-term consequences. J Interv Card Electrophysiol. 2022;65:365–72.

pubmed: 35220509 doi: 10.1007/s10840-022-01167-3

Takamiya T, Nitta J, Inaba O, Sato A, Inamura Y, Murata K, et al. Impact of diagnosis-to-ablation time on non-pulmonary vein triggers and ablation outcomes in persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32:1251–8.

pubmed: 33713521 doi: 10.1111/jce.15002

D’Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a metaanalysis. Int J Cardiol. 2013;167:1984–9.

pubmed: 22626840 doi: 10.1016/j.ijcard.2012.05.008

Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a metaanalysis. Europace. 2018;20:33–42.

pubmed: 28444307 doi: 10.1093/europace/eux013

Costa FM, Ferreira AM, Oliveira S, Santos PG, Durazzo A, Carmo P, et al. Left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation. Int J Cardiol. 2015;184:56–61.

pubmed: 25697871 doi: 10.1016/j.ijcard.2015.01.060

Zhuang J, Wang Y, Tang K, Li X, Peng W, Liang C, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and metaanalysis of observational studies. Europace. 2012;14:638–45.

pubmed: 22117033 doi: 10.1093/europace/eur364

Blanche C, Tran N, Rigamonti F, Burri H, Zimmermann M. Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Europace. 2013;15:198–204.

pubmed: 22941968 doi: 10.1093/europace/eus251

Yugo D, Kuo MJ, Hu YF, Liu CM, Lin YJ, Chang SL, et al. Dynamic changes in signal-averaged P wave after catheter ablation of atrial fibrillation. J Chin Med Assoc. 2022;85:549–53.

pubmed: 35506949 doi: 10.1097/JCMA.0000000000000709

Salah A, Zhou S, Liu Q, Yan H. P wave indices to predict atrial fibrillation recurrences post pulmonary vein isolation. Arq Bras Cardiol. 2013;101:519–27.

pubmed: 24173135 pmcid: 4106810

Pranata R, Yonas E, Vania R. Prolonged P-wave duration in sinus rhythm preablation is associated with atrial fibrillation recurrence after pulmonary vein isolation-a systematic review and metaanalysis. Ann Noninvasive Electrocardiol. 2019;24: e12653.

pubmed: 30983090 pmcid: 6931719 doi: 10.1111/anec.12653

Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Kataoka N, Kinugawa K. P-wave vector magnitude predicts recurrence of atrial fibrillation after catheter ablation in patients with persistent atrial fibrillation. Ann Noninvasive Electrocardiol. 2019;24: e12646.

pubmed: 30896059 pmcid: 6931428 doi: 10.1111/anec.12646

Müller-Edenborn B, Chen J, Allgeier J, Didenko M, Moreno-Weidmann Z, Neumann FJ, et al. Amplified sinus-P-wave reveals localization and extent of left atrial low-voltage substrate: implications for arrhythmia freedom following pulmonary vein isolation. Europace. 2020;22:240–9.

pubmed: 31782781 doi: 10.1093/europace/euz297

Moreno-Weidmann Z, Müller-Edenborn B, Jadidi AS, Bazan-Gelizo V, Chen J, Park CI, et al. Easily available ECG and echocardiographic parameters for prediction of left atrial remodeling and atrial fibrillation recurrence after pulmonary vein isolation: a multicenter study. J Cardiovasc Electrophysiol. 2021;32:1584–93.

pubmed: 33772926 doi: 10.1111/jce.15013

Liu P, Lv T, Yang Y, Gao Q, Zhang P. Use of P wave indices to evaluate efficacy of catheter ablation and atrial fibrillation recurrence: a systematic review and metaanalysis. J Interv Card Electrophysiol. 2022;65:827–40.

pubmed: 35488962 doi: 10.1007/s10840-022-01147-7

Jadidi A, Müller-Edenborn B, Chen J, Keyl C, Weber R, Allgeier J, et al. The duration of the amplified sinus-P-wave identifies presence of left atrial low voltage substrate and predicts outcome after pulmonary vein isolation in patients with persistent atrial fibrillation. JACC Clin Electrophysiol. 2018;4:531–43.

pubmed: 30067494 doi: 10.1016/j.jacep.2017.12.001

Koutalas E, Kallergis E, Nedios S, Kochiadakis G, Kanoupakis E. P-wave duration as a marker of atrial remodeling in patients referred to ablation for atrial fibrillation: a new stratification tool emerging? Hellenic J Cardiol. 2023.

Okumura Y, Watanabe I, Ohkubo K, Ashino S, Kofune M, Hashimoto K, et al. Prediction of the efficacy of pulmonary vein isolation for the treatment of atrial fibrillation by the signal-averaged P-wave duration. Pacing Clin Electrophysiol. 2007;30:304–13.

pubmed: 17367349 doi: 10.1111/j.1540-8159.2007.00670.x

Kuppahally SS, Akoum N, Badger TJ, Burgon NS, Haslam T, Kholmovski E, et al. Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. Am Heart J. 2010;160:877–84.

pubmed: 21095275 pmcid: 2995281 doi: 10.1016/j.ahj.2010.07.003

Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K, et al. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace. 2013;15:1725–32.

pubmed: 23711578 doi: 10.1093/europace/eut147

McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol. 2014;7:23–30.

pubmed: 24363354 doi: 10.1161/CIRCEP.113.000689

Ambale-Venkatesh B, Lima JA. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2015;12:18–29.

pubmed: 25348690 doi: 10.1038/nrcardio.2014.159

Nairn D, Eichenlaub M, Müller-Edenborn B, Huang T, Lehrmann H, Nagel C, et al. Differences in atrial substrate localization using late gadolinium enhancement-magnetic resonance imaging, electrogram voltage, and conduction velocity: a cohort study using a consistent anatomical reference frame in patients with persistent atrial fibrillation. Europace. 2023;25:euad278.

pubmed: 37713626 pmcid: 10533207 doi: 10.1093/europace/euad278

Nakahara S, Hori Y, Kobayashi S, Sakai Y, Taguchi I, Takayanagi K, et al. Epicardial adipose tissue-based defragmentation approach to persistent atrial fibrillation: its impact on complex fractionated electrograms and ablation outcome. Heart Rhythm. 2014;11:1343–51.

pubmed: 24793457 doi: 10.1016/j.hrthm.2014.04.040

Chao TF, Hung CL, Tsao HM, Lin YJ, Yun CH, Lai YH, et al. Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation. PLoS One. 2013;8: e74926.

pubmed: 24066158 pmcid: 3774729 doi: 10.1371/journal.pone.0074926

Masuda M, Mizuno H, Enchi Y, Minamiguchi H, Konishi S, Ohtani T, et al. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation. J Interv Card Electrophysiol. 2015;44:31–7.

pubmed: 26123095 doi: 10.1007/s10840-015-0031-3

Sepehri Shamloo A, Dagres N, Dinov B, Sommer P, Husser-Bollmann D, Bollmann A, et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and metaanalysis. Int J Cardiol Heart Vasc. 2019;22:132–8.

pubmed: 30740509 pmcid: 6356021

Nagashima K, Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T, et al. Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation. Circ J. 2011;75:2559–65.

pubmed: 21869533 doi: 10.1253/circj.CJ-11-0554

Vroomen M, Olsthoorn JR, Maesen B, L’Espoir V, La Meir M, Das M, et al. Quantification of epicardial adipose tissue in patients undergoing hybrid ablation for atrial fibrillation. Eur J Cardiothorac Surg. 2019;56:79–86.

pubmed: 30753389 doi: 10.1093/ejcts/ezy472

El Mahdiui M, Simon J, Smit JM, Kuneman JH, van Rosendael AR, Steyerberg EW, et al. Posterior left atrial adipose tissue attenuation assessed by computed tomography and recurrence of atrial fibrillation after catheter ablation. Circ Arrhythm Electrophysiol. 2021;14: e009135.

pubmed: 33720759 doi: 10.1161/CIRCEP.120.009135

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.

pubmed: 32860505 doi: 10.1093/eurheartj/ehaa612

van Vugt SPG, Westra SW, Volleberg R, Hannink G, Nakamura R, de Asmundis C, et al. Metaanalysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation. Europace. 2021;23:1961–9.

pubmed: 34333631 pmcid: 8651164 doi: 10.1093/europace/euab175

Yadav R, Brilliant J, Akhtar T, Milstein J, Sampognaro JR, Marine J, et al. Relationship between amiodarone response prior to ablation and 1-year outcomes of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2023;34:860–8.

pubmed: 36738148 doi: 10.1111/jce.15845

Dukes JW, Chilukuri K, Scherr D, Marine JE, Berger RD, Nazarian S, et al. The effect of antiarrhythmic medication management on atrial fibrillation ablation outcomes. J Cardiovasc Electrophysiol. 2013;24:882–7.

pubmed: 23578073 doi: 10.1111/jce.12147

Miwa Y, Minamiguchi H, Bhandari AK, Cannom DS, Ho IC. Amiodarone reduces the amount of ablation during catheter ablation for persistent atrial fibrillation. Europace. 2014;16:1007–14.

pubmed: 24446509 doi: 10.1093/europace/eut399

Mohanty S, Di Biase L, Mohanty P, Trivedi C, Santangeli P, Bai R, et al. Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE). Heart Rhythm. 2015;12:477–83.

pubmed: 25460855 doi: 10.1016/j.hrthm.2014.11.016

Efremidis M, Bazoukis G, Vlachos K, Prappa E, Megarisiotou A, Dragasis S, et al. Safety of catheter ablation of atrial fibrillation without pre- or periprocedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation. J Arrhythm. 2021;37:28–32.

pubmed: 33664883 doi: 10.1002/joa3.12466

Diab M, Wazni OM, Saliba WI, Tarakji KG, Ballout JA, Hutt E, et al. Ablation of atrial fibrillation without left atrial appendage imaging in patients treated with direct oral anticoagulants. Circ Arrhythm Electrophysiol. 2020;13: e008301.

pubmed: 32706992 doi: 10.1161/CIRCEP.119.008301

Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WH, Gabriel RS, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol. 2009;54:2032–9.

pubmed: 19926009 doi: 10.1016/j.jacc.2009.07.037

Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med. 1995;123:817–22.

pubmed: 7486462 doi: 10.7326/0003-4819-123-11-199512010-00001

Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26:921–64.

pubmed: 23998692 doi: 10.1016/j.echo.2013.07.009

Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation. 1991;83:817–21.

pubmed: 1999032 doi: 10.1161/01.CIR.83.3.817

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2020;2:85–93.

pubmed: 33015613 pmcid: 7525144 doi: 10.1016/j.xkme.2020.01.001

Stocker TJ, Deseive S, Leipsic J, Hadamitzky M, Chen MY, Rubinshtein R, et al. Reduction in radiation exposure in cardiovascular computed tomography imaging: results from the PROspective multicenter registry on radiaTion dose Estimates of cardiac CT angIOgraphy iN daily practice in 2017 (PROTECTION VI). Eur Heart J. 2018;39:3715–23.

pubmed: 30165629 pmcid: 6455904 doi: 10.1093/eurheartj/ehy546

Kitkungvan D, Nabi F, Ghosn MG, Dave AS, Quinones M, Zoghbi WA, et al. Detection of LA and LAA thrombus by CMR in patients referred for pulmonary vein isolation. JACC Cardiovasc Imaging. 2016;9:809–18.

pubmed: 27236529 doi: 10.1016/j.jcmg.2015.11.029

Rathi VK, Reddy ST, Anreddy S, Belden W, Yamrozik JA, Williams RB, et al. Contrast-enhanced CMR is equally effective as TEE in the evaluation of left atrial appendage thrombus in patients with atrial fibrillation undergoing pulmonary vein isolation procedure. Heart Rhythm. 2013;10:1021–7.

pubmed: 23454807 doi: 10.1016/j.hrthm.2013.02.029

Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M, et al. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke. 2003;34:2436–9.

pubmed: 12970519 doi: 10.1161/01.STR.0000090350.73614.0F

Brooks AG, Wilson L, Chia NH, Lau DH, Alasady M, Leong DP, et al. Accuracy and clinical outcomes of CT image integration with Carto-Sound compared to electro-anatomical mapping for atrial fibrillation ablation: a randomized controlled study. Int J Cardiol. 2013;168:2774–82.

pubmed: 23623342 doi: 10.1016/j.ijcard.2013.03.130

Di Biase L, Zou F, Lin AN, Grupposo V, Marazzato J, Tarantino N, et al. Feasibility of three-dimensional artificial intelligence algorithm integration with intracardiac echocardiography for left atrial imaging during atrial fibrillation catheter ablation. Europace. 2023;25:euad211.

pubmed: 37477946 pmcid: 10403247 doi: 10.1093/europace/euad211

Vicera JJB, Lin YJ, Lee PT, Chang SL, Lo LW, Hu YF, et al. Identification of critical isthmus using coherent mapping in patients with scar-related atrial tachycardia. J Cardiovasc Electrophysiol. 2020;31:1436–7.

pubmed: 32227530 pmcid: 7383970 doi: 10.1111/jce.14457

Deno DC, Bhaskaran A, Morgan DJ, Goksu F, Batman K, Olson GK, et al. High-resolution, live, directional mapping. Heart Rhythm. 2020;17:1621–8.

pubmed: 32438020 doi: 10.1016/j.hrthm.2020.04.039

Unland R, Bergau L, El Hamriti M, Guckel D, Piran M, Fink T, et al. Find me if you can: first clinical experience using the novel CARTOFINDER algorithm in a routine workflow for atrial fibrillation ablation. J Clin Med. 2021;10:2979.

pubmed: 34279463 pmcid: 8269300 doi: 10.3390/jcm10132979

Honarbakhsh S, Schilling RJ, Dhillon G, Ullah W, Keating E, Providencia R, et al. A novel mapping system for panoramic mapping of the left atrium: application to detect and characterize localized sources maintaining atrial fibrillation. JACC Clin Electrophysiol. 2018;4:124–34.

pubmed: 29387810 pmcid: 5777816 doi: 10.1016/j.jacep.2017.09.177

Chang TY, Lin CY, Lin YJ, Wu CI, Chang SL, Lo LW, et al. Long-term outcome of patients with long-standing persistent atrial fibrillation undergoing ablation guided by a novel high-density panoramic mapping system: a propensity score matching study. Heart Rhythm. 2022;O2(3):269–78.

doi: 10.1016/j.hroo.2022.04.003

Sporton SC, Earley MJ, Nathan AW, Schilling RJ. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15:310–5.

pubmed: 15030422 doi: 10.1111/j.1540-8167.2004.03356.x

Estner HL, Deisenhofer I, Luik A, Ndrepepa G, von Bary C, Zrenner B, et al. Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX). Europace. 2006;8:583–7.

pubmed: 16831837 doi: 10.1093/europace/eul079

Scaglione M, Biasco L, Caponi D, Anselmino M, Negro A, Di Donna P, et al. Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. Europace. 2011;13:955–62.

pubmed: 21421574 doi: 10.1093/europace/eur062

Martinek M, Nesser HJ, Aichinger J, Boehm G, Purerfellner H. Impact of integration of multislice computed tomography imaging into three-dimensional electroanatomic mapping on clinical outcomes, safety, and efficacy using radiofrequency ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2007;30:1215–23.

pubmed: 17897124 doi: 10.1111/j.1540-8159.2007.00843.x

Caponi D, Corleto A, Scaglione M, Blandino A, Biasco L, Cristoforetti Y, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12:1098–104.

pubmed: 20400766 doi: 10.1093/europace/euq107

Bertaglia E, Bella PD, Tondo C, Proclemer A, Bottoni N, De Ponti R, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace. 2009;11:1004–10.

pubmed: 19541681 doi: 10.1093/europace/eup152

Della Bella P, Fassini G, Cireddu M, Riva S, Carbucicchio C, Giraldi F, et al. Image integration-guided catheter ablation of atrial fibrillation: a prospective randomized study. J Cardiovasc Electrophysiol. 2009;20:258–65.

pubmed: 19261038 doi: 10.1111/j.1540-8167.2008.01311.x

Kistler PM, Rajappan K, Harris S, Earley MJ, Richmond L, Sporton SC, et al. The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J. 2008;29:3029–36.

pubmed: 18931059 doi: 10.1093/eurheartj/ehn453

Duytschaever M, Vijgen J, De Potter T, Scherr D, Van Herendael H, Knecht S, et al. Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. Europace. 2020;22:1645–52.

pubmed: 32879974 doi: 10.1093/europace/euaa157

Duytschaever M, De Pooter J, Demolder A, El Haddad M, Phlips T, Strisciuglio T, et al. Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: the CLOSE to CURE study. Heart Rhythm. 2020;17:535–43.

pubmed: 31707159 doi: 10.1016/j.hrthm.2019.11.004

De Pooter J, Strisciuglio T, El Haddad M, Wolf M, Phlips T, Vandekerckhove Y, et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin Electrophysiol. 2019;5:295–305.

pubmed: 30898231 doi: 10.1016/j.jacep.2018.11.020

Hussein A, Das M, Riva S, Morgan M, Ronayne C, Sahni A, et al. Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients: the PRAISE study results. Circ Arrhythm Electrophysiol. 2018;11: e006576.

pubmed: 30354288 doi: 10.1161/CIRCEP.118.006576

Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y, et al. Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study. JACC Clin Electrophysiol. 2018;4:99–108.

pubmed: 29600792 doi: 10.1016/j.jacep.2017.06.023

Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace. 2018;20:f419-27.

pubmed: 29315411 doi: 10.1093/europace/eux376

Grace A, Willems S, Meyer C, Verma A, Heck P, Zhu M, et al. High-resolution noncontact charge-density mapping of endocardial activation. JCI Insight. 2019;4: e126422.

pubmed: 30895945 pmcid: 6483005 doi: 10.1172/jci.insight.126422

Willems S, Verma A, Betts TR, Murray S, Neuzil P, Ince H, et al. Targeting nonpulmonary vein sources in persistent atrial fibrillation identified by noncontact charge density mapping: UNCOVER AF trial. Circ Arrhythm Electrophysiol. 2019;12: e007233.

pubmed: 31242746 doi: 10.1161/CIRCEP.119.007233

Shi R, Parikh P, Chen Z, Angel N, Norman M, Hussain W, et al. Validation of dipole density mapping during atrial fibrillation and sinus rhythm in human left atrium. JACC Clin Electrophysiol. 2020;6:171–81.

pubmed: 32081219 doi: 10.1016/j.jacep.2019.09.012

Haines DE, Kong MH, Ruppersberg P, Haeusser P, Avitall B, Szili Torok T, et al. Electrographic flow mapping for atrial fibrillation: theoretical basis and preliminary observations. J Interv Card Electrophysiol. 2022;66:1015–28.

pubmed: 35969338 pmcid: 10172240 doi: 10.1007/s10840-022-01308-8

Reddy VY, Neuzil P, Langbein A, Petru J, Funasako M, Dinshaw L, et al. AB-453070-2 FLOW-AF: a randomized controlled trial of electrographic flow-guided ablation in redo patients with non-paroxysmal atrial fibrillation. Heart Rhythm. 2023;20:S1-2.

doi: 10.1016/j.hrthm.2023.03.211

Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2008;51:843–9.

pubmed: 18294570 doi: 10.1016/j.jacc.2007.10.044

Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812–22.

pubmed: 25946280 doi: 10.1056/NEJMoa1408288

Seitz J, Bars C, Theodore G, Beurtheret S, Lellouche N, Bremondy M, et al. AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient-tailored approach. J Am Coll Cardiol. 2017;69:303–21.

pubmed: 28104073 pmcid: 5568427 doi: 10.1016/j.jacc.2016.10.065

Lin R, Zeng C, Xu K, Wu S, Qin M, Liu X. Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation. Int J Cardiol. 2019;278:97–103.

pubmed: 30587415 doi: 10.1016/j.ijcard.2018.12.051

Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, et al. Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics. Circ Arrhythm Electrophysiol. 2016;9: e002962.

pubmed: 26966286 doi: 10.1161/CIRCEP.115.002962

Seitz J, Durdez TM, Albenque JP, Pisapia A, Gitenay E, Durand C, et al. Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2022;33:2250–60.

pubmed: 35989543 pmcid: 9826214 doi: 10.1111/jce.15657

Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. J Am Coll Cardiol. 2012;60:628–36.

pubmed: 22818076 pmcid: 3416917 doi: 10.1016/j.jacc.2012.05.022

Gray RA, Jalife J, Panfilov AV, Baxter WT, Cabo C, Davidenko JM, et al. Mechanisms of cardiac fibrillation. Science. 1995;270:1222–3; author reply 1224–5.

Salinet J, Molero R, Schlindwein FS, Karel J, Rodrigo M, Rojo-Alvarez JL, et al. Electrocardiographic imaging for atrial fibrillation: a perspective from computer models and animal experiments to clinical value. Front Physiol. 2021;12: 653013.

pubmed: 33995122 pmcid: 8120164 doi: 10.3389/fphys.2021.653013

Ramanathan C, Ghanem RN, Jia P, Ryu K, Rudy Y. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med. 2004;10:422–8.

pubmed: 15034569 pmcid: 1950745 doi: 10.1038/nm1011

Molero R, González-Ascaso A, Climent AM, Guillem MS. Robustness of imageless electrocardiographic imaging against uncertainty in atrial morphology and location. J Electrocardiol. 2023;77:58–61.

pubmed: 36634462 doi: 10.1016/j.jelectrocard.2022.12.007

Cuculich PS, Wang Y, Lindsay BD, Faddis MN, Schuessler RB, Damiano RJ Jr, et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation. 2010;122:1364–72.

pubmed: 20855661 pmcid: 2996091 doi: 10.1161/CIRCULATIONAHA.110.945709

Haissaguerre M, Hocini M, Denis A, Shah AJ, Komatsu Y, Yamashita S, et al. Driver domains in persistent atrial fibrillation. Circulation. 2014;130:530–8.

pubmed: 25028391 doi: 10.1161/CIRCULATIONAHA.113.005421

Lim HS, Hocini M, Dubois R, Denis A, Derval N, Zellerhoff S, et al. Complexity and distribution of drivers in relation to duration of persistent atrial fibrillation. J Am Coll Cardiol. 2017;69:1257–69.

pubmed: 28279292 doi: 10.1016/j.jacc.2017.01.014

Knecht S, Sohal M, Deisenhofer I, Albenque JP, Arentz T, Neumann T, et al. Multicentre evaluation of non-invasive biatrial mapping for persistent atrial fibrillation ablation: the AFACART study. Europace. 2017;19:1302–9.

pubmed: 28204452 doi: 10.1093/europace/euw168

Honarbakhsh S, Dhillon G, Abbass H, Waddingham PH, Dennis A, Ahluwalia N, et al. Noninvasive electrocardiographic imaging-guided targeting of drivers of persistent atrial fibrillation: the TARGET-AF1 trial. Heart Rhythm. 2022;19:875–84.

pubmed: 35134548 doi: 10.1016/j.hrthm.2022.01.042

Gao X, Lam AG, Bilchick KC, Darby A, Mehta N, Mason PK, et al. The use of non-invasive mapping in persistent AF to predict acute procedural outcome. J Electrocardiol. 2019;57S:S21-6.

pubmed: 31474375 doi: 10.1016/j.jelectrocard.2019.08.012

Rodrigo M, Climent AM, Hernandez-Romero I, Liberos A, Baykaner T, Rogers AJ, et al. Noninvasive assessment of complexity of atrial fibrillation: correlation with contact mapping and impact of ablation. Circ Arrhythm Electrophysiol. 2020;13: e007700.

pubmed: 32078374 pmcid: 7508259 doi: 10.1161/CIRCEP.119.007700

Badger TJ, Adjei-Poku YA, Marrouche NF. MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation. Future Cardiol. 2009;5:63–70.

pubmed: 19371204 doi: 10.2217/14796678.5.1.63

Bisbal F, Calvo M, Trucco E, Arbelo E, Berruezo A, Mont L. Left atrial tachycardia after atrial fibrillation ablation: can magnetic resonance imaging assist the ablation? Can J Cardiol. 2015;31(104):e1-3.

Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9:1789–95.

pubmed: 22820056 doi: 10.1016/j.hrthm.2012.07.016

Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6:327–33.

pubmed: 23515263 doi: 10.1161/CIRCEP.113.000374

Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015;17:1229–35.

pubmed: 26041872 pmcid: 4535556 doi: 10.1093/europace/euv057

Andrade JG, Monir G, Pollak SJ, Khairy P, Dubuc M, Roy D, et al. Pulmonary vein isolation using “contact force” ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation—a prospective study. Heart Rhythm. 2014;11:1919–24.

pubmed: 25068575 doi: 10.1016/j.hrthm.2014.07.033

Squara F, Latcu DG, Massaad Y, Mahjoub M, Bun SS, Saoudi N. Contact force and force-time integral in atrial radiofrequency ablation predict transmurality of lesions. Europace. 2014;16:660–7.

pubmed: 24798957 doi: 10.1093/europace/euu068

Whitaker J, Fish J, Harrison J, Chubb H, Williams SE, Fastl T, et al. Lesion index-guided ablation facilitates continuous, transmural, and durable lesions in a porcine recovery model. Circ Arrhythm Electrophysiol. 2018;11: e005892.

pubmed: 29654131 doi: 10.1161/CIRCEP.117.005892

Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19:775–83.

pubmed: 27247002

Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M, et al. High-power short-duration versus standard radiofrequency ablation: insights on lesion metrics. J Cardiovasc Electrophysiol. 2018;29:1570–5.

pubmed: 30168230 doi: 10.1111/jce.13724

Borne RT, Sauer WH, Zipse MM, Zheng L, Tzou W, Nguyen DT. Longer duration versus increasing power during radiofrequency ablation yields different ablation lesion characteristics. JACC Clin Electrophysiol. 2018;4:902–8.

pubmed: 30025690 doi: 10.1016/j.jacep.2018.03.020

Kyriakopoulou M, Wielandts JY, Strisciuglio T, El Haddad M, Pooter J, Almorad A, et al. Evaluation of higher power delivery during RF pulmonary vein isolation using optimized and contiguous lesions. J Cardiovasc Electrophysiol. 2020;31:1091–8.

pubmed: 32147899 doi: 10.1111/jce.14438

Berte B, Hilfiker G, Russi I, Moccetti F, Cuculi F, Toggweiler S, et al. Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter. J Cardiovasc Electrophysiol. 2019;30:2199–204.

pubmed: 31424123 doi: 10.1111/jce.14122

Chen S, Schmidt B, Bordignon S, Urbanek L, Tohoku S, Bologna F, et al. Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: procedural data, lesion analysis, and initial results from the FAFA AI high power study. J Cardiovasc Electrophysiol. 2019;30:2724–31.

pubmed: 31588620 doi: 10.1111/jce.14219

Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G, et al. Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations. Heart Rhythm. 2019;16:165–9.

pubmed: 30712645 doi: 10.1016/j.hrthm.2018.11.031

Winkle RA, Moskovitz R, Hardwin Mead R, Engel G, Kong MH, Fleming W, et al. Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters. J Interv Card Electrophysiol. 2018;52:1–8.

pubmed: 29460232 pmcid: 5924666 doi: 10.1007/s10840-018-0322-6

Wielandts JY, Kyriakopoulou M, Almorad A, Hilfiker G, Strisciuglio T, Phlips T, et al. Prospective randomized evaluation of high power during CLOSE-guided pulmonary vein isolation: the POWER-AF study. Circ Arrhythm Electrophysiol. 2021;14: e009112.

pubmed: 33300809 doi: 10.1161/CIRCEP.120.009112

Lee AC, Voskoboinik A, Cheung CC, Yogi S, Tseng ZH, Moss JD, et al. A randomized trial of high vs standard power radiofrequency ablation for pulmonary vein isolation: SHORT-AF. JACC Clin Electrophysiol. 2023;9:1038–47.

pubmed: 37495318 doi: 10.1016/j.jacep.2022.12.020

Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, et al. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace. 2020;22:388–93.

pubmed: 31872249 doi: 10.1093/europace/euz342

Castrejón-Castrejón S, Martínez Cossiani M, Jáuregui-Abularach M, Basterra Sola N, Ibáñez Criado JL, Osca Asensi J, et al. POWER FAST III trial investigators. Multicenter prospective comparison of conventional and high-power short duration radiofrequency application for pulmonary vein isolation: the high-power shortduration radiofrequency application for faster and safer pulmonary vein ablation (POWER FAST III) trial. J Interv Card Electrophysiol. 2023;66:1889–99.

Leung LWM, Akhtar Z, Sheppard MN, Louis-Auguste J, Hayat J, Gallagher MM. Preventing esophageal complications from atrial fibrillation ablation: a review. Heart Rhythm. 2021;O2(2):651–64.

doi: 10.1016/j.hroo.2021.09.004

Kautzner J, Albenque JP, Natale A, Maddox W, Cuoco F, Neuzil P, et al. A novel temperature-controlled radiofrequency catheter ablation system used to treat patients with paroxysmal atrial fibrillation. JACC Clin Electrophysiol. 2021;7:352–63.

pubmed: 33516712 doi: 10.1016/j.jacep.2020.11.009

Almorad A, Wielandts JY, El Haddad M, Knecht S, Tavernier R, Kobza R, et al. Performance and safety of temperature- and flow-controlled radiofrequency ablation in ablation index-guided pulmonary vein isolation. JACC Clin Electrophysiol. 2021;7:408–9.

pubmed: 33736759 doi: 10.1016/j.jacep.2020.10.005

Bortone A, Albenque JP, Ramirez FD, Haïssaguerre M, Combes S, Constantin M, et al. 90 vs 50-watt radiofrequency applications for pulmonary vein isolation: experimental and clinical findings. Circ Arrhythm Electrophysiol. 2022;15: e010663.

pubmed: 35363039 doi: 10.1161/CIRCEP.121.010663

Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A, et al. High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol. 2018;4:467–79.

pubmed: 30067486 doi: 10.1016/j.jacep.2017.11.018

Takigawa M, Kitamura T, Martin CA, Fuimaono K, Datta K, Joshi H, et al. Temperature- and flow-controlled ablation/very-high-power short-duration ablation vs conventional power-controlled ablation: comparison of focal and linear lesion characteristics. Heart Rhythm. 2021;18:553–61.

pubmed: 33127542 doi: 10.1016/j.hrthm.2020.10.021

Nakagawa H, Ikeda A, Sharma T, Govari A, Ashton J, Maffre J, et al. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with high power-short duration and moderate power-moderate duration: effects of thermal latency and contact force on lesion formation. Circ Arrhythm Electrophysiol. 2021;14: e009899.

pubmed: 34138641 doi: 10.1161/CIRCEP.121.009899

Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, et al. Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol. 2019;5:778–86.

pubmed: 31320006 doi: 10.1016/j.jacep.2019.04.009

Halbfass P, Wielandts JY, Knecht S, Le Polain de Waroux JB, Tavernier R, De Wilde V, et al. Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury. Europace. 2022;24:400–5.

Richard Tilz R, Sano M, Vogler J, Fink T, Saraei R, Sciacca V, et al. Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: the fast and furious – AF study. Int J Cardiol Heart Vasc. 2021;35: 100847.

pubmed: 34381869 pmcid: 8333145

O’Neill L, El Haddad M, Berte B, Kobza R, Hilfiker G, Scherr D, et al. Very high-power ablation for contiguous pulmonary vein isolation: results from the randomized POWER PLUS trial. JACC Clin Electrophysiol. 2022;9:511–22.

doi: 10.1016/j.jacep.2022.10.039

Reddy VY, Schilling R, Grimaldi M, Horton R, Natale A, Riva S, et al. Pulmonary vein isolation with a novel multielectrode radiofrequency balloon catheter that allows directionally tailored energy delivery: short-term outcomes from a multicenter first-in-human study (RADIANCE). Circ Arrhythm Electrophysiol. 2019;12: e007541.

pubmed: 31826648 doi: 10.1161/CIRCEP.119.007541

Dhillon GS, Honarbakhsh S, Di Monaco A, Coling AE, Lenka K, Pizzamiglio F, et al. Use of a multielectrode radiofrequency balloon catheter to achieve pulmonary vein isolation in patients with paroxysmal atrial fibrillation: 12-month outcomes of the RADIANCE study. J Cardiovasc Electrophysiol. 2020;31:1259–69.

pubmed: 32250514 doi: 10.1111/jce.14476

Almorad A, Del Monte A, Della Rocca DG, Pannone L, Ramak R, Overeinder I, et al. Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study. Europace. 2023;25:euad252.

pubmed: 37671682 pmcid: 10481252 doi: 10.1093/europace/euad252

Schilling R, Dhillon GS, Tondo C, Riva S, Grimaldi M, Quadrini F, et al. Safety, effectiveness, and quality of life following pulmonary vein isolation with a multielectrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE. Europace. 2021;23:851–60.

pubmed: 33450010 pmcid: 8186540 doi: 10.1093/europace/euaa382

Del Monte A, Almorad A, Pannone L, Della Rocca DG, Bisignani A, Monaco C, et al. Pulmonary vein isolation with the radiofrequency balloon catheter: a single centre prospective study. Europace. 2023;25:896–904.

pubmed: 36738245 pmcid: 10062286 doi: 10.1093/europace/euad017

Reddy VY, Anter E, Rackauskas G, Peichl P, Koruth JS, Petru J, et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial. Circ Arrhythm Electrophysiol. 2020;13: e008718.

pubmed: 32383391 doi: 10.1161/CIRCEP.120.008718

Reddy VY, Peichl P, Anter E, Rackauskas G, Petru J, Funasako M, et al. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol. 2023;9:1786–801.

pubmed: 37227340 doi: 10.1016/j.jacep.2023.04.002

Dubuc M, Khairy P, Rodriguez-Santiago A, Talajic M, Tardif JC, Thibault B, et al. Catheter cryoablation of the atrioventricular node in patients with atrial fibrillation: a novel technology for ablation of cardiac arrhythmias. J Cardiovasc Electrophysiol. 2001;12:439–44.

pubmed: 11332565 doi: 10.1046/j.1540-8167.2001.00439.x

Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140:1779–88.

pubmed: 31630538 doi: 10.1161/CIRCULATIONAHA.119.042622

Furnkranz A, Chun KR, Nuyens D, Metzner A, Koster I, Schmidt B, et al. Characterization of conduction recovery after pulmonary vein isolation using the “single big cryoballoon” technique. Heart Rhythm. 2010;7:184–90.

pubmed: 20129295 doi: 10.1016/j.hrthm.2009.10.038

Martin CA, Tilz RRR, Anic A, Defaye P, Luik A, de Asmundis C, et al. Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: results from the POLAR ICE study. J Cardiovasc Electrophysiol. 2023;34:833–40.

pubmed: 36786515 doi: 10.1111/jce.15861

Tilz RR, Meyer-Saraei R, Eitel C, Fink T, Sciacca V, Lopez LD, et al. Novel cryoballoon ablation system for single shot pulmonary vein isolation- the prospective ICE-AGE-X study. Circ J. 2021;85:1296–304.

pubmed: 33854004 doi: 10.1253/circj.CJ-21-0094

Assaf A, Bhagwandien R, Szili-Torok T, Yap SC. Comparison of procedural efficacy, balloon nadir temperature, and incidence of phrenic nerve palsy between two cryoballoon technologies for pulmonary vein isolation: a systematic review and metaanalysis. J Cardiovasc Electrophysiol. 2021;32:2424–31.

pubmed: 34289198 pmcid: 9292548 doi: 10.1111/jce.15182

Reichlin T, Kaueffer T, Knecht S, Madaffari A, Badertscher P, Maurhofer J, et al. Comparison of the PolarX and the Arctic Front cryoballoon for pulmonary vein isolation in patients with paroxysmal atrial fibrillation (COMPARE CRYO). Presented at ESC Congress 2023, Late Breaking Sciences in Atrial Fibrillation Session 2023.

Kuck KH, Furnkranz A, Chun KR, Metzner A, Ouyang F, Schluter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.

pubmed: 27381589 pmcid: 5070448 doi: 10.1093/eurheartj/ehw285

Bredikis A, Wilber DJ. Cryoablation of Cardiac Arrhythmias. 1st ed. Philadelphia, PA: Elsevier/Saunders; 2011.

De Potter T, Klaver M, Babkin A, Iliodromitis K, Hocini M, Cox J, et al. Ultra-low temperature cryoablation for atrial fibrillation: primary outcomes for efficacy and safety: the cryocure-2 study. JACC Clin Electrophysiol. 2022;8:1034–9.

pubmed: 35907755 doi: 10.1016/j.jacep.2022.05.017

Verma A, Asivatham SJ, Deneke T, Castellvi Q, Neal RE 2nd. Primer on pulsed electrical field ablation: understanding the benefits and limitations. Circ Arrhythm Electrophysiol. 2021;14: e010086.

pubmed: 34538095 doi: 10.1161/CIRCEP.121.010086

Ruzgys P, Novickij V, Novickij J, Satkauskas S. Influence of the electrode material on ROS generation and electroporation efficiency in low and high frequency nanosecond pulse range. Bioelectrochemistry. 2019;127:87–93.

pubmed: 30769178 doi: 10.1016/j.bioelechem.2019.02.002

Rubinsky L, Guenther E, Mikus P, Stehling M, Rubinsky B. Electrolytic effects during tissue ablation by electroporation. Technol Cancer Res Treat. 2016;15:NP95-103.

pubmed: 26323571 doi: 10.1177/1533034615601549

Xie F, Varghese F, Pakhomov AG, Semenov I, Xiao S, Philpott J, et al. Ablation of myocardial tissue with nanosecond pulsed electric fields. PLoS One. 2015;10: e0144833.

pubmed: 26658139 pmcid: 4687652 doi: 10.1371/journal.pone.0144833

Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6:307–12.

pubmed: 17668938 doi: 10.1177/153303460700600407

Scheinman MM, Morady F, Hess DS, Gonzalez R. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA. 1982;248:851–5.

pubmed: 7097946 doi: 10.1001/jama.1982.03330070039027

van den Bos W, Scheffer HJ, Vogel JA, Wagstaff PG, de Bruin DM, de Jong MC, et al. Thermal energy during irreversible electroporation and the influence of different ablation parameters. J Vasc Interv Radiol. 2016;27:433–43.

pubmed: 26703782 doi: 10.1016/j.jvir.2015.10.020

Stewart MT, Haines DE, Miklavcic D, Kos B, Kirchhof N, Barka N, et al. Safety and chronic lesion characterization of pulsed field ablation in a porcine model. J Cardiovasc Electrophysiol. 2021;32:958–69.

pubmed: 33650743 pmcid: 8048690 doi: 10.1111/jce.14980

Meckes D, Emami M, Fong I, Lau DH, Sanders P. Pulsed-field ablation: computational modeling of electric fields for lesion depth analysis. Heart Rhythm. 2022;O2(3):433–40.

doi: 10.1016/j.hroo.2022.05.009

Verma A, Howard BT, Tzou WT, Mattison LM, Kos B, Miklavcic D, et al. Effects of tissue proximity on cardiac lesion formation using pulsed field ablation. Heart Rhythm. 2022;19:S228.

doi: 10.1016/j.hrthm.2022.03.191

Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74:315–26.

pubmed: 31085321 doi: 10.1016/j.jacc.2019.04.021

Verma A, Boersma L, Haines DE, Natale A, Marchlinski FE, Sanders P, et al. First-in-human experience and acute procedural outcomes using a novel pulsed field ablation system: the PULSED AF pilot trial. Circ Arrhythm Electrophysiol. 2022;15: e010168.

pubmed: 34964367 doi: 10.1161/CIRCEP.121.010168

Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Multinational survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022;24:1256–66.

pubmed: 35647644 pmcid: 9435639 doi: 10.1093/europace/euac050

Schmidt B, Bordignon S, Neven K, Reichlin T, Blaauw Y, Hansen J, et al. EUropean real-world outcomes with pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace. 2023;25:euad185.

pubmed: 37379528 pmcid: 10320231 doi: 10.1093/europace/euad185

Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS One. 2009;4: e4757.

pubmed: 19270746 pmcid: 2650260 doi: 10.1371/journal.pone.0004757

Li W, Fan Q, Ji Z, Qiu X, Li Z. The effects of irreversible electroporation (IRE) on nerves. PLoS One. 2011;6: e18831.

pubmed: 21533143 pmcid: 3077412 doi: 10.1371/journal.pone.0018831

Koruth JS, Kuroki K, Kawamura I, Brose R, Viswanathan R, Buck ED, et al. Pulsed field ablation versus radiofrequency ablation: esophageal injury in a novel porcine model. Circ Arrhythm Electrophysiol. 2020;13: e008303.

pubmed: 31977250 pmcid: 7069397 doi: 10.1161/CIRCEP.119.008303

Stewart MT, Haines DE, Verma A, Kirchhof N, Barka N, Grassl E, et al. Intracardiac pulsed field ablation: proof of feasibility in a chronic porcine model. Heart Rhythm. 2019;16:754–64.

pubmed: 30385383 doi: 10.1016/j.hrthm.2018.10.030

Howard B, Haines DE, Verma A, Kirchhof N, Barka N, Onal B, et al. Characterization of phrenic nerve response to pulsed field ablation. Circ Arrhythm Electrophysiol. 2022;15: e010127.

pubmed: 35649121 pmcid: 9213085 doi: 10.1161/CIRCEP.121.010127

Howard B, Haines DE, Verma A, Packer D, Kirchhof N, Barka N, et al. Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model. Circ Arrhythm Electrophysiol. 2020;13: e008337.

pubmed: 32877256 pmcid: 7495982 doi: 10.1161/CIRCEP.120.008337

Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7:614–27.

pubmed: 33933412 doi: 10.1016/j.jacep.2021.02.014

Chung EM, Banahan C, Patel N, Janus J, Marshall D, Horsfield MA, et al. Size distribution of air bubbles entering the brain during cardiac surgery. PLoS One. 2015;10: e0122166.

pubmed: 25837519 pmcid: 4383554 doi: 10.1371/journal.pone.0122166

Reinsch N, Füting A, Höwel D, Bell J, Lin Y, Neven K. Cerebral safety after pulsed field ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2022;19:1813–8.

pubmed: 35718318 doi: 10.1016/j.hrthm.2022.06.018

Loh P, van Es R, Groen MHA, Neven K, Kassenberg W, Wittkampf FHM, et al. Pulmonary vein isolation with single pulse irreversible electroporation: a first in human study in 10 patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13: e008192.

pubmed: 32898450 doi: 10.1161/CIRCEP.119.008192

Gunawardene Melanie A, Schaeffer Benjamin N, Jularic M, Eickholt C, Maurer T, Akbulak Ruken Ö, et al. Coronary spasm during pulsed field ablation of the mitral isthmus line. JACC Clin Electrophysiol. 2021;7:1618–20.

pubmed: 34600850 doi: 10.1016/j.jacep.2021.08.016

Reddy VY, Petru J, Funasako M, Kopriva K, Hala P, Chovanec M, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 2022;146:1808–19.

pubmed: 36134574 doi: 10.1161/CIRCULATIONAHA.122.061497

Reddy VY, Anic A, Koruth J, Petru J, Funasako M, Minami K, et al. Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol. 2020;76:1068–80.

pubmed: 32854842 doi: 10.1016/j.jacc.2020.07.007

Anić A, Phlips T, Brešković T, Koopman P, Girouard S, Mediratta V, et al. Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results. Europace. 2023;25:euad147.

pubmed: 37335976 pmcid: 10279421 doi: 10.1093/europace/euad147

Turagam MK, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation. 2023;148:35–46.

pubmed: 37199171 doi: 10.1161/CIRCULATIONAHA.123.064959

Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE, et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023;147:1422–32.

pubmed: 36877118 pmcid: 10158608 doi: 10.1161/CIRCULATIONAHA.123.063988

Duytschaever M, De Potter T, Grimaldi M, Anic A, Vijgen J, Neuzil P, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16: e011780.

pubmed: 36735937 pmcid: 10026968 doi: 10.1161/CIRCEP.122.011780

Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389:1660–71.

pubmed: 37634148 doi: 10.1056/NEJMoa2307291

Rovaris G, Ciconte G, Schiavone M, Mitacchione G, Gasperetti A, Piazzi E, et al. Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study. Europace. 2021;23:1380–90.

pubmed: 33837418 doi: 10.1093/europace/euab085

Schmidt B, Neuzil P, Luik A, Osca Asensi J, Schrickel JW, Deneke T, et al. Laser balloon or wide-area circumferential irrigated radiofrequency ablation for persistent atrial fibrillation: a multicenter prospective randomized study. Circ Arrhythm Electrophysiol. 2017;10: e005767.

pubmed: 29217521 doi: 10.1161/CIRCEP.117.005767

Chun JKR, Bordignon S, Last J, Mayer L, Tohoku S, Zanchi S, et al. Cryoballoon versus laserballoon: insights from the first prospective randomized balloon trial in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2021;14: e009294.

pubmed: 33417476 doi: 10.1161/CIRCEP.120.009294

Ye W, Chen Q, Fan G, Zhou X, Wang X, Mao W, et al. Efficacy and safety of visually guided laser balloon versus cryoballoon ablation for paroxysmal atrial fibrillation: a systematic review and metaanalysis. Front Cardiovasc Med. 2023;10:1229223.

pubmed: 37674807 pmcid: 10478246 doi: 10.3389/fcvm.2023.1229223

Schiavone M, Gasperetti A, Montemerlo E, Pozzi M, Sabato F, Piazzi E, et al. Long-term comparisons of atrial fibrillation ablation outcomes with a cryoballoon or laser-balloon: a propensity-matched analysis based on continuous rhythm monitoring. Hellenic J Cardiol. 2022;65:1–7.

pubmed: 35331905 doi: 10.1016/j.hjc.2022.03.006

Proietti R, Pecoraro V, Di Biase L, Natale A, Santangeli P, Viecca M, et al. Remote magnetic with open-irrigated catheter vs. manual navigation for ablation of atrial fibrillation: a systematic review and metaanalysis. Europace. 2013;15:1241–8.

pubmed: 23585253 doi: 10.1093/europace/eut058

Jia K, Jin Q, Liu A, Wu L. Remote magnetic navigation versus manual control navigation for atrial fibrillation ablation: a systematic review and metaanalysis. J Electrocardiol. 2019;55:78–86.

pubmed: 31152995 doi: 10.1016/j.jelectrocard.2019.05.001

Li X, Bao Y, Jia K, Zhang N, Lin C, Wei Y, et al. Comparison of the mid-term outcomes of robotic magnetic navigation-guided radiofrequency ablation versus cryoballoon ablation for persistent atrial fibrillation. J Cardiovasc Dev Dis. 2022;9:88.

pubmed: 35323637 pmcid: 8953767

Verma A, Feld GK, Cox JL, Dewland TA, Babkin A, De Potter T, et al. Combined pulsed field ablation with ultra-low temperature cryoablation: a preclinical experience. J Cardiovasc Electrophysiol. 2022;34:2124–33.

pubmed: 36218014 doi: 10.1111/jce.15701

Hilbert S, Sommer P, Gutberlet M, Gaspar T, Foldyna B, Piorkowski C, et al. Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series. Europace. 2016;18:572–7.

pubmed: 26316146 doi: 10.1093/europace/euv249

Lehmann HI, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P, et al. Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams. Sci Rep. 2016;6:38895.

pubmed: 27996023 pmcid: 5171237 doi: 10.1038/srep38895

Ströker E, de Asmundis C, Kupics K, Takarada K, Mugnai G, De Cocker J, et al. Value of ultrasound for access guidance and detection of subclinical vascular complications in the setting of atrial fibrillation cryoballoon ablation. Europace. 2019;21:434–9.

pubmed: 30010776 doi: 10.1093/europace/euy154

Wynn GJ, Haq I, Hung J, Bonnett LJ, Lewis G, Webber M, et al. Improving safety in catheter ablation for atrial fibrillation: a prospective study of the use of ultrasound to guide vascular access. J Cardiovasc Electrophysiol. 2014;25:680–5.

pubmed: 24602050 doi: 10.1111/jce.12404

Yamagata K, Wichterle D, Roubicek T, Jarkovsky P, Sato Y, Kogure T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace. 2018;20:1107–14.

pubmed: 28575490 doi: 10.1093/europace/eux175

Sharma PS, Padala SK, Gunda S, Koneru JN, Ellenbogen KA. Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 2016;27:1160–6.

pubmed: 27433795 doi: 10.1111/jce.13042

Pellegrino PL, Di Monaco A, Santoro F, Grimaldi M, D’Arienzo G, Casavecchia G, et al. Near zero vascular complications using echo-guided puncture during catheter ablation of arrhythmias: a retrospective study and literature review. J Arrhythm. 2022;38:395–9.

pubmed: 35785379 pmcid: 9237317 doi: 10.1002/joa3.12723

Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and metaanalysis. Europace. 2017;19:850–5.

pubmed: 27207813

Wang TKM, Wang MTM, Martin A. Metaanalysis of ultrasound-guided vs conventional vascular access for cardiac electrophysiology procedures. J Arrhythm. 2019;35:858–62.

pubmed: 31844480 pmcid: 6898547 doi: 10.1002/joa3.12236

Verma A, Debruyne P, Nardi S, Deneke T, DeGreef Y, Spitzer S, et al. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol. 2013;6:835–42.

pubmed: 23983245 doi: 10.1161/CIRCEP.113.000612

Yu Y, Wang X, Li X, Zhou X, Liao S, Yang W, et al. Higher incidence of asymptomatic cerebral emboli after atrial fibrillation ablation found with high-resolution diffusion-weighted magnetic resonance imaging. Circ Arrhythm Electrophysiol. 2020;13: e007548.

pubmed: 31937118 doi: 10.1161/CIRCEP.119.007548

Briceno DF, Villablanca PA, Lupercio F, Kargoli F, Jagannath A, Londono A, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: metaanalysis and meta-regression. J Cardiovasc Electrophysiol. 2016;27:683–93.

pubmed: 27004444 doi: 10.1111/jce.12975

Maleki K, Mohammadi R, Hart D, Cotiga D, Farhat N, Steinberg JS. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol. 2005;16:561–5.

pubmed: 15946349 doi: 10.1111/j.1540-8167.2005.40686.x

Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005;16:474–7.

pubmed: 15877616 doi: 10.1046/j.1540-8167.2005.40465.x

Bruce CJ, Friedman PA, Narayan O, Munger TM, Hammill SC, Packer DL, et al. Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. 2008;22:211–9.

pubmed: 18568395 doi: 10.1007/s10840-008-9270-x

Asbach S, Biermann J, Bode C, Faber TS. Early heparin administration reduces risk for left atrial thrombus formation during atrial fibrillation ablation procedures. Cardiol Res Pract. 2011;2011: 615087.

pubmed: 21747989 pmcid: 3130977 doi: 10.4061/2011/615087

Di Biase L, Gaita F, Toso E, Santangeli P, Mohanty P, Rutledge N, et al. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm. 2014;11:791–8.

pubmed: 24607716 doi: 10.1016/j.hrthm.2014.03.003

Meininghaus DG, Blembel K, Waniek C, Kruells-Muench J, Ernst H, Kleemann T, et al. Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: a randomized study controlled by esophagoscopy before and after catheter ablation. Heart Rhythm. 2021;18:926–34.

doi: 10.1016/j.hrthm.2021.02.003

Schoene K, Arya A, Grashoff F, Knopp H, Weber A, Lerche M, et al. Oesophageal probe evaluation in radiofrequency ablation of atrial fibrillation (OPERA): results from a prospective randomized trial. Europace. 2020;22:1487–94.

pubmed: 32820324 doi: 10.1093/europace/euaa209

Deneke T, Nentwich K, Berkovitz A, Sonne K, Ene E, Pavlov B, et al. High-resolution infrared thermal imaging of the esophagus during atrial fibrillation ablation as a predictor of endoscopically detected thermal lesions. Circ Arrhythm Electrophysiol. 2018;11: e006681.

pubmed: 30376732 doi: 10.1161/CIRCEP.118.006681

Ayoub T, El Hajjar AH, Singh Sidhu GD, Bhatnagar A, Zhang Y, Mekhael M, et al. Esophageal temperature during atrial fibrillation ablation poorly predicts esophageal injury: an observational study. Heart Rhythm. 2021;O2(2):570–7.

doi: 10.1016/j.hroo.2021.11.002

Ha FJ, Han HC, Sanders P, Teh AW, O’Donnell D, Farouque O, et al. Prevalence and prevention of oesophageal injury during atrial fibrillation ablation: a systematic review and metaanalysis. Europace. 2019;21:80–90.

pubmed: 29912306 doi: 10.1093/europace/euy121

Chen S, Schmidt B, Seeger A, Bordignon S, Tohoku S, Willems F, et al. Catheter ablation of atrial fibrillation using ablation index-guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II). Heart Rhythm. 2020;17:1833–40.

pubmed: 32470628 doi: 10.1016/j.hrthm.2020.05.029

Garcia R, Waldmann V, Vanduynhoven P, Nesti M, Jansen de Oliveira Figueiredo M, Narayanan K, et al. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. Europace. 2021;23:2039–45.

pubmed: 34308973 doi: 10.1093/europace/euab154

Dada RS, Hayanga JWA, Woods K, Schwartzman D, Thibault D, Ellison M, et al. Anesthetic choice for atrial fibrillation ablation: a national anesthesia clinical outcomes registry analysis. J Cardiothorac Vasc Anesth. 2021;35:2600–6.

pubmed: 33518460 doi: 10.1053/j.jvca.2020.12.046

Di Biase L, Conti S, Mohanty P, Bai R, Sanchez J, Walton D, et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Heart Rhythm. 2011;8:368–72.

pubmed: 21055479 doi: 10.1016/j.hrthm.2010.10.043

Chikata A, Kato T, Yaegashi T, Sakagami S, Kato C, Saeki T, et al. General anesthesia improves contact force and reduces gap formation in pulmonary vein isolation: a comparison with conscious sedation. Heart Vessels. 2017;32:997–1005.

pubmed: 28260190 doi: 10.1007/s00380-017-0961-z

Martin CA, Curtain JP, Gajendragadkar PR, Begley DA, Fynn SP, Grace AA, et al. Improved outcome and cost effectiveness in ablation of persistent atrial fibrillation under general anaesthetic. Europace. 2018;20:935–42.

pubmed: 28444228 doi: 10.1093/europace/eux057

Pang N, Gao J, Zhang N, Zhang B, Wang R. Comparison of the different anesthesia strategies for atrial fibrillation catheter ablation: a systematic review and metaanalysis. Cardiol Res Pract. 2022;2022:1124372.

pubmed: 35356482 pmcid: 8958063 doi: 10.1155/2022/1124372

Weinmann K, Heudorfer R, Lenz A, Aktolga D, Rattka M, Bothner C, et al. Safety of conscious sedation in electroanatomical mapping procedures and cryoballoon pulmonary vein isolation. Heart Vessels. 2021;36:561–7.

pubmed: 33211151 doi: 10.1007/s00380-020-01725-7

Wasserlauf J, Knight BP, Li Z, Andrei AC, Arora R, Chicos AB, et al. Moderate sedation reduces lab time compared to general anesthesia during cryoballoon ablation for AF without compromising safety or long-term efficacy. Pacing Clin Electrophysiol. 2016;39:1359–65.

pubmed: 27747896 doi: 10.1111/pace.12961

Tohoku S, Schmidt B, Bordignon S, Chen S, Bologna F, Chun JK. Initial clinical experience of pulmonary vein isolation using the ultra-low temperature cryoablation catheter for patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2022;33:1371–9.

pubmed: 35488736 doi: 10.1111/jce.15519

Schmidt B, Bordignon S, Tohoku S, Chen S, Bologna F, Urbanek L, et al. 5S study: safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol. 2022;15: e010817.

pubmed: 35617232 doi: 10.1161/CIRCEP.121.010817

Iacopino S, Colella J, Dini D, Mantovani L, Sorrenti PF, Malacrida M, et al. Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration. Europace. 2023;25:euad230.

pubmed: 37494101 pmcid: 10434732 doi: 10.1093/europace/euad230

Grimaldi M, Quadrini F, Caporusso N, Troisi F, Vitulano N, Delmonte V, et al. Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter. Europace. 2023;25:euad222.

pubmed: 37470452 pmcid: 10434733 doi: 10.1093/europace/euad222

Kumar S, Morton JB, Halloran K, Spence SJ, Lee G, Wong MC, et al. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm. 2012;9:1041-7.e1.

pubmed: 22342855 doi: 10.1016/j.hrthm.2012.02.015

Sivasambu B, Hakim JB, Barodka V, Chrispin J, Berger RD, Ashikaga H, et al. Initiation of a high-frequency jet ventilation strategy for catheter ablation for atrial fibrillation: safety and outcomes data. JACC Clin Electrophysiol. 2018;4:1519–25.

pubmed: 30573114 pmcid: 6550456 doi: 10.1016/j.jacep.2018.08.016

Aizer A, Qiu JK, Cheng AV, Wu PB, Barbhaiya CR, Jankelson L, et al. Rapid pacing and high-frequency jet ventilation additively improve catheter stability during atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2020;31:1678–86.

pubmed: 32314841 doi: 10.1111/jce.14507

Fernandez-Bustamante A, Ibañez V, Alfaro JJ, de Miguel E, Germán MJ, Mayo A, et al. High-frequency jet ventilation in interventional bronchoscopy: factors with predictive value on high-frequency jet ventilation complications. J Clin Anesth. 2006;18:349–56.

pubmed: 16905080 doi: 10.1016/j.jclinane.2005.12.011

Babapoor-Farrokhran S, Alzubi J, Port Z, Khraisha O, Mainigi SK. Utility of high-frequency jet ventilation in atrial fibrillation ablation. J Innov Card Rhythm Manag. 2021;12:4590–3.

pubmed: 34327044 pmcid: 8313182 doi: 10.19102/icrm.2021.120708

Osorio J, Varley A, Kreidieh O, Godfrey B, Schrappe G, Rajendra A, et al. High-frequency, low-tidal-volume mechanical ventilation safely improves catheter stability and procedural efficiency during radiofrequency ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2022;15: e010722.

pubmed: 35333095 doi: 10.1161/CIRCEP.121.010722

Gabriels J, Donnelly J, Khan M, Anca D, Beldner S, Willner J, et al. High-frequency, low tidal volume ventilation to improve catheter stability during atrial fibrillation ablation. JACC Clin Electrophysiol. 2019;5:1224–6.

pubmed: 31648748 doi: 10.1016/j.jacep.2019.06.011

Kadado AJ, Gobeil K, Fakhoury F, Pervaiz A, Chalhoub F. Very low tidal volume, high-frequency ventilation in atrial fibrillation ablation: a systematic review. J Interv Card Electrophysiol. 2022;64:539–43.

pubmed: 35029769 doi: 10.1007/s10840-022-01123-1

Osorio J, Zei PC, Díaz JC, Varley AL, Morales GX, Silverstein JR, et al. High-frequency low-tidal-volume ventilation improves long-term outcomes in atrial fibrillation ablation: a multicenter prospective study. JACC Clin Electrophysiol. 2023;9:1543–54.

pubmed: 37294263 doi: 10.1016/j.jacep.2023.05.015

Hoyt H, Bhonsale A, Chilukuri K, Alhumaid F, Needleman M, Edwards D, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8:1869–74.

pubmed: 21798230 doi: 10.1016/j.hrthm.2011.07.025

Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128:2104–12.

pubmed: 24061087 doi: 10.1161/CIRCULATIONAHA.113.003862

Iqbal AM, Li KY, Aznaurov SG, Lugo RM, Venkataraman R, Gautam S. Catheter ablation for atrial fibrillation can be safely performed without invasive hemodynamic monitoring: a multi-center study. J Interv Card Electrophysiol. 2022;64:743–9.

pubmed: 35182273 doi: 10.1007/s10840-022-01151-x

Deneke T, Shin DI, Balta O, Bünz K, Fassbender F, Mügge A, et al. Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm. 2011;8:1705–11.

pubmed: 21726519 doi: 10.1016/j.hrthm.2011.06.030

Maleki K, Mohammadi R, Hart D, Cotiga D, Farhat N, Steinberg JS. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol. 2005;16:561–5.

pubmed: 15946349 doi: 10.1111/j.1540-8167.2005.40686.x

Zhang RF, Ma CM, Wang N, Yang MH, Li WW, Yin XM, et al. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment. BMC Cardiovasc Disord. 2021;21:214.

pubmed: 33906609 pmcid: 8077881 doi: 10.1186/s12872-021-02032-3

Benali K, Verain J, Hammache N, Guenancia C, Hooks D, Magnin-Poull I, et al. Running after activated clotting time values in patients receiving direct oral anticoagulants: a potentially dangerous race. Results from a prospective study in atrial fibrillation catheter ablation procedures. J Clin Med. 2021;10:4240.

pubmed: 34575348 pmcid: 8465849 doi: 10.3390/jcm10184240

Hohnloser SH, Camm AJ, Cappato R, Diener HC, Heidbuchel H, Mont L, et al. Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial. Europace. 2021;23:65–72.

pubmed: 33249467 doi: 10.1093/europace/euaa199

Calkins H, Willems S, Verma A, Schilling R, Hohnloser SH, Okumura K, et al. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study. Europace. 2019;21:879–85.

pubmed: 30982849 pmcid: 6781146 doi: 10.1093/europace/euz057

Payne JE, Koerber SM, Bickel T, Ghadban R, Flaker G, Gautam S. Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2020;58:185–91.

pubmed: 31230179 doi: 10.1007/s10840-019-00579-y

Martin AC, Kyheng M, Foissaud V, Duhamel A, Marijon E, Susen S, et al. Activated clotting time monitoring during atrial fibrillation catheter ablation: does the anticoagulant matter? J Clin Med. 2020;9:350.

pubmed: 32012701 pmcid: 7074080 doi: 10.3390/jcm9020350

Songqun H, Chunling W, Zhifu G, Xinmiao H, Jiang C. Effects of rivaroxaban on activated clotting time in catheter ablation for atrial fibrillation in Chinese patients. J Interv Card Electrophysiol. 2020;59:509–16.

pubmed: 31840206 doi: 10.1007/s10840-019-00650-8

Safani M, Tobias S, Shandling AH, Redmond K, Lee MY. Comprehensive intraprocedural unfractionated heparin protocol during catheter ablation of atrial fibrillation in the presence of direct oral anticoagulants and wide spectrum of body mass index. J Cardiovasc Pharmacol Ther. 2021;26:349–58.

pubmed: 33749350 doi: 10.1177/1074248421998492

Ghannam M, Chugh A, Dillon P, Alyesh D, Kossidas K, Sharma S, et al. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: a randomized controlled trial. Heart Rhythm. 2018;15:1642–7.

pubmed: 30661768 doi: 10.1016/j.hrthm.2018.06.045

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511–20.

pubmed: 26095746 doi: 10.1056/NEJMoa1502000

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413–24.

pubmed: 26559317 doi: 10.1056/NEJMoa1510991

Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23:1612–76.

pubmed: 33895845 doi: 10.1093/europace/euab065

Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, et al. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013;2: e000428.

pubmed: 24045120 pmcid: 3835257 doi: 10.1161/JAHA.113.000428

Andrade JG, Macle L, Bennett MT, Hawkins NM, Essebag V, Champagne J, et al. Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial. J Interv Card Electrophysiol. 2022;65:481–9.

pubmed: 35739438 pmcid: 9640463 doi: 10.1007/s10840-022-01277-y

Tokuda M, Yamashita S, Matsuo S, Kato M, Sato H, Oseto H, et al. Radiofrequency needle for transseptal puncture is associated with lower incidence of thromboembolism during catheter ablation of atrial fibrillation: propensity score-matched analysis. Heart Vessels. 2018;33:1238–44.

pubmed: 29637262 doi: 10.1007/s00380-018-1159-8

Chow AWC, Cobb V, Sepahpour A, McCready JW. Transseptal puncture performed with the new needle-free ‘SafeSept’ guidewire: a multicentre experience. J Interv Card Electrophysiol. 2020;59:29–34.

pubmed: 31655956 doi: 10.1007/s10840-019-00608-w

Maclean E, Mahtani K, Roelas M, Vyas R, Butcher C, Ahluwalia N, et al. Transseptal puncture for left atrial ablation: risk factors for cardiac tamponade and a proposed causative classification system. J Cardiovasc Electrophysiol. 2022;33:1747–55.

pubmed: 35671359 pmcid: 9543389 doi: 10.1111/jce.15590

Stauber A, Kornej J, Sepehri Shamloo A, Dinov B, Bacevicius J, Dagres N, et al. Impact of single versus double transseptal puncture on outcome and complications in pulmonary vein isolation procedures. Cardiol J. 2021;28:671–7.

pubmed: 32207839 doi: 10.5603/CJ.a2020.0037

Deyell MW, Wen G, Laksman Z, Bennett MT, Chakrabarti S, Yeung-Lai-Wah JA, et al. The impact of steerable sheaths on unblinded contact force during catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2020;57:417–24.

pubmed: 30701358 doi: 10.1007/s10840-019-00514-1

Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T, et al. Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol. 2011;4:157–65.

pubmed: 21248246 doi: 10.1161/CIRCEP.110.957761

Janosi K, Debreceni D, Janosa B, Bocz B, Simor T, Kupo P. Visualizable vs. standard, non-visualizable steerable sheath for pulmonary vein isolation procedures: randomized, single-centre trial. Front Cardiovasc Med. 2022;9:1033755.

pubmed: 36465461 pmcid: 9709402 doi: 10.3389/fcvm.2022.1033755

Rajendra A, Hunter TD, Morales GX, Zei P, Boo LM, Varley A, et al. Steerable sheath visualizable under 3D electroanatomical mapping facilitates paroxysmal atrial fibrillation ablation with minimal fluoroscopy. J Interv Card Electrophysiol. 2023;66:381–8.

pubmed: 35947317 doi: 10.1007/s10840-022-01332-8

Fitzpatrick N, Mittal A, Galvin J, Jauvert G, Keaney J, Keelan E, et al. The impact of steerable sheath visualization during catheter ablation for atrial fibrillation. Europace. 2023.

Khalaph M, Sommer P, Lucas P, Guckel D, Fink T, Sciacca V, et al. First clinical experience using a visualized sheath for atrial fibrillation ablation. Pacing Clin Electrophysiol. 2022;45:922–9.

pubmed: 35716400 doi: 10.1111/pace.14555

Goya M, Frame D, Gache L, Ichishima Y, Tayar DO, Goldstein L, et al. The use of intracardiac echocardiography catheters in endocardial ablation of cardiac arrhythmia: metaanalysis of efficiency, effectiveness, and safety outcomes. J Cardiovasc Electrophysiol. 2020;31:664–73.

pubmed: 31976603 pmcid: 7078927 doi: 10.1111/jce.14367

Xu J, Gao Y, Liu C, Wang Y. Radiofrequency ablation for treatment of atrial fibrillation with the use of intracardiac echocardiography versus without intracardiac echocardiography: a metaanalysis of observational and randomized studies. J Cardiovasc Electrophysiol. 2022;33:897–907.

pubmed: 35212079 doi: 10.1111/jce.15423

Pimentel RC, Rahai N, Maccioni S, Khanna R. Differences in outcomes among patients with atrial fibrillation undergoing catheter ablation with versus without intracardiac echocardiography. J Cardiovasc Electrophysiol. 2022;33:2015–47.

pubmed: 35711034 pmcid: 9544828 doi: 10.1111/jce.15599

La Greca C, Cirasa A, Di Modica D, Sorgato A, Simoncelli U, Pecora D. Advantages of the integration of ICE and 3D electroanatomical mapping and ultrasound-guided femoral venipuncture in catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2021;61:559–66.

pubmed: 32809149 doi: 10.1007/s10840-020-00835-6

Isath A, Padmanabhan D, Haider SW, Siroky G, Perimbeti S, Correa A, et al. Does the use of intracardiac echocardiography during atrial fibrillation catheter ablation improve outcomes and cost? A nationwide 14-year analysis from 2001 to 2014. J Interv Card Electrophysiol. 2021;61:461–8.

pubmed: 32743700 doi: 10.1007/s10840-020-00844-5

Deshpande S, Sawatari H, Ahmed R, Nair RG, Khan H, Khanji MY, et al. Impact of intracardiac echocardiography on readmission morbidity and mortality following atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2022;33:2496–503.

pubmed: 36128625 doi: 10.1111/jce.15683

Ren JF, Chen S, Callans DJ, Jiang C, Marchlinski FE. Role of intracardiac echocardiography for catheter ablation of atrial fibrillation: reduction of complications and mortality. J Am Coll Cardiol. 2020;75:1244–5.

pubmed: 32164904 doi: 10.1016/j.jacc.2019.11.067

Catanzariti D, Maines M, Angheben C, Centonze M, Cemin C, Vergara G. Usefulness of contrast intracardiac echocardiography in performing pulmonary vein balloon occlusion during cryo-ablation for atrial fibrillation. Indian Pacing Electrophysiol J. 2012;12:237–49.

pubmed: 23233757 pmcid: 3513238 doi: 10.1016/S0972-6292(16)30563-0

Makino Y, Mizutani Y, Yamashita D, Yonekawa J, Satake A, Kurobe M, et al. Cryoballoon ablation for atrial fibrillation without the use of a contrast medium: a combination of the intracardiac echocardiography and pressure wave monitoring guided approach. Heart Vessels. 2022;37:765–74.

pubmed: 34636968 doi: 10.1007/s00380-021-01963-3

Suzuki A, Fujiwara R, Asada H, Iwasa K, Miyata T, Song WH, et al. Peri-balloon leak flow velocity assessed by intracardiac echography predicts pulmonary vein electrical gap-intracardiac echography-guided contrast-free cryoballoon ablation. Circ J. 2022;86:256–65.

pubmed: 34334554 doi: 10.1253/circj.CJ-21-0423

Kanda T, Masuda M, Kurata N, Asai M, Iida O, Okamoto S, et al. A saline contrast-enhanced echocardiography-guided approach to cryoballoon ablation. Pacing Clin Electrophysiol. 2020;43:664–70.

pubmed: 32420636 doi: 10.1111/pace.13945

Motoike Y, Harada M, Ito T, Nomura Y, Nishimura A, Koshikawa M, et al. Wall thickness-based adjustment of ablation index improves efficacy of pulmonary vein isolation in atrial fibrillation: real-time assessment by intracardiac echocardiography. J Cardiovasc Electrophysiol. 2021;32:1620–30.

pubmed: 33694206 doi: 10.1111/jce.15000

Chen J, Einstein AJ, Fazel R, Krumholz HM, Wang Y, Ross JS, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol. 2010;56:702–11.

pubmed: 20619569 pmcid: 2952402 doi: 10.1016/j.jacc.2010.05.014

Lickfett L, Mahesh M, Vasamreddy C, Bradley D, Jayam V, Eldadah Z, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110:3003–10.

pubmed: 15505084 doi: 10.1161/01.CIR.0000146952.49223.11

Ector J, Dragusin O, Adriaenssens B, Huybrechts W, Willems R, Ector H, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2007;50:234–42.

pubmed: 17631216 doi: 10.1016/j.jacc.2007.03.040

Voskoboinik A, Kalman ES, Savicky Y, Sparks PB, Morton JB, Lee G, et al. Reduction in radiation dose for atrial fibrillation ablation over time: a 12-year single-center experience of 2344 patients. Heart Rhythm. 2017;14:810–6.

pubmed: 28215568 doi: 10.1016/j.hrthm.2017.02.014

Lee G, Hunter RJ, Lovell MJ, Finlay M, Ullah W, Baker V, et al. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation. Europace. 2016;18:211–8.

pubmed: 26318548 doi: 10.1093/europace/euv186

Walters TE, Kistler PM, Morton JB, Sparks PB, Halloran K, Kalman JM. Impact of collimation on radiation exposure during interventional electrophysiology. Europace. 2012;14:1670–3.

pubmed: 22516059 doi: 10.1093/europace/eus095

Schneider R, Lauschke J, Schneider C, Tischer T, Glass A, Bänsch D. Reduction of radiation exposure during ablation of atrial fibrillation. Herz. 2015;40:883–91.

pubmed: 25990625 doi: 10.1007/s00059-015-4307-2

Heidbuchel H, Wittkampf FH, Vano E, Ernst S, Schilling R, Picano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014;16:946–64.

pubmed: 24792380 doi: 10.1093/europace/eut409

Sommer P, Sciacca V, Anselmino M, Tilz R, Bourier F, Lehrmann H, et al. Practical guidance to reduce radiation exposure in electrophysiology applying ultra low-dose protocols: a European heart rhythm association review. Europace. 2023;25:euad191.

pubmed: 37410906 pmcid: 10365833 doi: 10.1093/europace/euad191

Zei PC, Quadros KK, Clopton P, Thosani A, Ferguson J, Brodt C, et al. Safety and efficacy of minimal- versus zero-fluoroscopy radiofrequency catheter ablation for atrial fibrillation: a multicenter, prospective study. J Innov Card Rhythm Manag. 2020;11:4281–91.

pubmed: 33262896 pmcid: 7685314 doi: 10.19102/icrm.2020.111105

Tahin T, Riba A, Nemeth B, Arvai F, Lupkovics G, Szeplaki G, et al. Implementation of a zero fluoroscopic workflow using a simplified intracardiac echocardiography guided method for catheter ablation of atrial fibrillation, including repeat procedures. BMC Cardiovasc Disord. 2021;21:407.

pubmed: 34433424 pmcid: 8390247 doi: 10.1186/s12872-021-02219-8

Lyan E, Tsyganov A, Abdrahmanov A, Morozov A, Bakytzhanuly A, Tursunbekov A, et al. Nonfluoroscopic catheter ablation of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2018;41:611–9.

pubmed: 29566268 doi: 10.1111/pace.13321

Falasconi G, Penela D, Soto-Iglesias D, Jauregui B, Chauca A, Antonio RS, et al. A standardized stepwise zero-fluoroscopy approach with transesophageal echocardiography guidance for atrial fibrillation ablation. J Interv Card Electrophysiol. 2022;64:629–39.

pubmed: 34757547 doi: 10.1007/s10840-021-01086-9

Bulava A, Hanis J, Eisenberger M. Catheter ablation of atrial fibrillation using zero-fluoroscopy technique: a randomized trial. Pacing Clin Electrophysiol. 2015;38:797–806.

pubmed: 25790320 doi: 10.1111/pace.12634

Lurie A, Amit G, Divakaramenon S, Acosta JG, Healey JS, Wong JA. Outcomes and safety of fluoroless catheter ablation for atrial fibrillation. CJC Open. 2021;3:303–10.

pubmed: 33778447 doi: 10.1016/j.cjco.2020.11.002

Sommer P, Bertagnolli L, Kircher S, Arya A, Bollmann A, Richter S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. Europace. 2018;20:1952–8.

pubmed: 29346552 doi: 10.1093/europace/eux378

Enriquez A, Velasco A, Diaz JC, Sadek M, Osorio J, Zei P, et al. Fluoroless catheter ablation of atrial fibrillation: a step-by-step workflow. J Interv Card Electrophysiol. 2023;66:1291–301.

pubmed: 36725820 doi: 10.1007/s10840-023-01469-0

Ahn J, Shin DG, Han S-J, Lim HE. Safety and efficacy of intracardiac echocardiography–guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial. Europace. 2023;25:euad086.

pubmed: 37021403 pmcid: 10228535 doi: 10.1093/europace/euad086

Alyesh D, Venkataraman G, Stucky A, Joyner J, Choe W, Sundaram S. Acute safety and efficacy of fluoroless cryoballoon ablation for atrial fibrillation. J Innov Card Rhythm Manag. 2021;12:4413–20.

pubmed: 33654573 pmcid: 7906563 doi: 10.19102/icrm.2021.120205

Halbfass P, Pavlov B, Müller P, Nentwich K, Sonne K, Barth S, et al. Progression from esophageal thermal asymptomatic lesion to perforation complicating atrial fibrillation ablation: a single-center registry. Circ Arrhythm Electrophysiol. 2017;10: e005233.

pubmed: 28798021 doi: 10.1161/CIRCEP.117.005233

Ripley KL, Gage AA, Olsen DB, Van Vleet JF, Lau CP, Tse HF. Time course of esophageal lesions after catheter ablation with cryothermal and radiofrequency ablation: implication for atrio-esophageal fistula formation after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:642–6.

pubmed: 17428270 doi: 10.1111/j.1540-8167.2007.00790.x

Tschabrunn CM, Silverstein J, Berzin T, Ellis E, Buxton AE, Josephson ME, et al. Comparison between single- and multisensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015;17:891–7.

pubmed: 25777771 doi: 10.1093/europace/euu356

Turagam MK, Miller S, Sharma SP, Prakash P, Gopinathannair R, Lakkireddy P, et al. Differences in transient thermal response of commercial esophageal temperature probes: insights from an experimental study. JACC Clin Electrophysiol. 2019;5:1280–8.

pubmed: 31753433 doi: 10.1016/j.jacep.2019.07.013

Barbhaiya CR, Kogan EV, Jankelson L, Knotts RJ, Spinelli M, Bernstein S, et al. Esophageal temperature dynamics during high-power short-duration posterior wall ablation. Heart Rhythm. 2020;17:721–7.

pubmed: 31978595 doi: 10.1016/j.hrthm.2020.01.014

Bhardwaj R, Naniwadekar A, Whang W, Mittnacht AJ, Palaniswamy C, Koruth JS, et al. Esophageal deviation during atrial fibrillation ablation: clinical experience with a dedicated esophageal balloon retractor. JACC Clin Electrophysiol. 2018;4:1020–30.

pubmed: 30139483 doi: 10.1016/j.jacep.2018.04.001

Hamed M, Elseidy SA, Abdelazeem M, Morcos R, Abdallah A, Sammour Y, et al. Role of oesophageal cooling in the prevention of oesophageal injury in atrial fibrillation catheter ablation: a systematic review and metaanalysis of randomized controlled trials. Europace. 2023;25:euad080.

pubmed: 37021812 pmcid: 10227763 doi: 10.1093/europace/euad080

Leung LWM, Bajpai A, Zuberi Z, Li A, Norman M, Kaba RA, et al. Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study. Europace. 2021;23:205–15.

pubmed: 33205201 doi: 10.1093/europace/euaa276

Joseph C, Nazari J, Zagrodzky J, Brumback B, Sherman J, Zagrodzky W, et al. Improved 1-year outcomes after active cooling during left atrial radiofrequency ablation. J Interv Card Electrophysiol. 2023;66:1621–9.

pubmed: 36670327 pmcid: 10359433 doi: 10.1007/s10840-023-01474-3

Sanchez J, Woods C, Zagrodzky J, Nazari J, Singleton MJ, Schricker A, et al. Atrioesophageal fistula rates before and after adoption of active esophageal cooling during atrial fibrillation ablation. JACC Clin Electrophysiol. 2023;9:2558–70.

pubmed: 37737773 doi: 10.1016/j.jacep.2023.08.022

Teres C, Soto-Iglesias D, Penela D, Falasconi G, Viveros D, Meca-Santamaria J, et al. Relationship between the posterior atrial wall and the esophagus: esophageal position and temperature measurement during atrial fibrillation ablation (AWESOME-AF). A randomized controlled trial. J Interv Card Electrophysiol. 2022;65:651–61.

pubmed: 35861901 doi: 10.1007/s10840-022-01302-0

Zhang X, Kuang X, Gao X, Xiang H, Wei F, Liu T, et al. RESCUE-AF in patients undergoing atrial fibrillation ablation: the RESCUE-AF trial. Circ Arrhythm Electrophysiol. 2019;12: e007044.

pubmed: 32125792 doi: 10.1161/CIRCEP.118.007044

Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque J-P, Kautzner J, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation. 2015;132:907–15.

pubmed: 26260733 doi: 10.1161/CIRCULATIONAHA.114.014092

Arentz T, Jander N, von Rosenthal J, Blum T, Fürmaier R, Görnandt L, et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J. 2003;24:963–9.

pubmed: 12714028 doi: 10.1016/S0195-668X(03)00002-2

Mochizuki A, Nagahara D, Kamiyama N, Fujito T, Miura T. Revaluation of the significance of demonstrable exit block after radiofrequency pulmonary vein isolation. Circ Rep. 2020;2:218–25.

pubmed: 33693233 pmcid: 7921364 doi: 10.1253/circrep.CR-19-0135

Duytschaever M, De Meyer G, Acena M, El-Haddad M, De Greef Y, Van Heuverswyn F, et al. Lessons from dissociated pulmonary vein potentials: entry block implies exit block. Europace. 2013;15:805–12.

pubmed: 23275474 doi: 10.1093/europace/eus353

Chen S, Meng W, Sheng He D, Chen G, Zhang F, Yan Y, et al. Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35:524–31.

pubmed: 22385041 doi: 10.1111/j.1540-8159.2012.03343.x

Wang X-h, Liu X, Sun Y-m, Gu J-n, Shi H-f, Zhou L, et al. Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace. 2007;9:481–6.

pubmed: 17522081 doi: 10.1093/europace/eum101

Jiang CY, Jiang RH, Matsuo S, Liu Q, Fan YQ, Zhang ZW, et al. Early detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation: a comparison of ATP-induction and reassessment at 30 minutes postisolation. J Cardiovasc Electrophysiol. 2009;20:1382–7.

pubmed: 19656250 doi: 10.1111/j.1540-8167.2009.01564.x

Cheema A, Dong J, Dalal D, Marine JE, Henrikson CA, Spragg D, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:387–91.

pubmed: 17394453 doi: 10.1111/j.1540-8167.2007.00760.x

Brunelli M, Raffa S, Große A, Hanazawa K, Sammut M, Roos M, et al. Residual conduction after pulmonary vein isolation with a circular multielectrode radiofrequency ablation catheter: the role of adenosine and orciprenalin during a prolonged observation time. Int J Cardiol. 2013;168:4122–31.

pubmed: 23920058 doi: 10.1016/j.ijcard.2013.07.071

Efremidis M, Letsas K, Giannopoulos G, Lioni L, Vlachos K, Asvestas D, et al. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2015;17:741–6.

pubmed: 25687747 doi: 10.1093/europace/euu216

Andrade JG, Deyell MW, Nattel S, Khairy P, Dubuc M, Champagne J, et al. Prevalence and clinical impact of spontaneous and adenosine-induced pulmonary vein reconduction in the contact-force vs. cryoballoon atrial fibrillation ablation (CIRCA-DOSE) study. Heart Rhythm. 2020;17:897–904.

pubmed: 31978593 doi: 10.1016/j.hrthm.2020.01.017

Jiang R, Chen M, Yang B, Liu Q, Zhang Z, Zhang F, et al. Intraprocedural endpoints to predict durable pulmonary vein isolation: a randomized trial of four postablation techniques. Europace. 2020;22:567–75.

pubmed: 32249915 doi: 10.1093/europace/euz301

Sousa PA, Barra S, Adão L, Primo J, Khoueiry Z, Puga L, et al. Assessment of the need of a waiting period after pulmonary vein isolation with the ablation index software. J Cardiovasc Electrophysiol. 2022;33:1725–33.

pubmed: 35637604 doi: 10.1111/jce.15568

Miller MA, d’Avila A, Dukkipati SR, Koruth JS, Viles-Gonzalez J, Napolitano C, et al. Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap. Europace. 2012;14:653–60.

pubmed: 22417723 doi: 10.1093/europace/eus048

Macle L, Khairy P, Weerasooriya R, Novak P, Verma A, Willems S, et al. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet. 2015;386:672–9.

pubmed: 26211828 doi: 10.1016/S0140-6736(15)60026-5

Kapa S, Killu A, Deshmukh A, Mulpuru SK, Asirvatham SJ. Dose-dependent pulmonary vein reconnection in response to adenosine: relevance of atrioventricular block during infusion. J Interv Card Electrophysiol. 2016;47:117–23.

pubmed: 27236655 doi: 10.1007/s10840-016-0149-y

Teunissen C, Clappers N, Kassenberg W, Hassink RJ, van der Heijden JF, Loh P. Time matters: adenosine testing immediately after pulmonary vein isolation does not substitute a waiting period. Europace. 2017;19:1140–5.

pubmed: 27702849 doi: 10.1093/europace/euw173

McLellan AJA, Kumar S, Smith C, Ling LH, Prabhu S, Kalman JM, et al. The role of adenosine challenge in catheter ablation for atrial fibrillation: a systematic review and metaanalysis. Int J Cardiol. 2017;236:253–61.

pubmed: 28089454 doi: 10.1016/j.ijcard.2017.01.070

Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, et al. Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the unmasking dormant electrical reconduction by adenosine triphosphate (UNDER-ATP) trial. Eur Heart J. 2015;36:3276–87.

pubmed: 26321237

Zeng LJ, Shi L, Tian Y, Wang YJ, Yin XD, Liu XQ, et al. Pace capture and adenosine triphosphate provocation are complementary rather than mutually exclusive methods to ensure durable pulmonary vein isolation. J Cardiovasc Electrophysiol. 2019;30:815–23.

pubmed: 30891845 doi: 10.1111/jce.13901

Moser J, Sultan A, Luker J, Servatius H, Salzbrunn T, Altenburg M, et al. 5-Year outcome of pulmonary vein isolation by loss of pace capture on the ablation line versus electrical circumferential pulmonary vein isolation. JACC Clin Electrophysiol. 2017;3:1262–71.

pubmed: 29759622 doi: 10.1016/j.jacep.2017.04.019

Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. Pace-capture-guided ablation after contact-force-guided pulmonary vein isolation: results of the randomized controlled DRAGON trial. Europace. 2018;20:1451–8.

pubmed: 29161369 doi: 10.1093/europace/eux319

Steven D, Sultan A, Reddy V, Luker J, Altenburg M, Hoffmann B, et al. Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial. J Am Coll Cardiol. 2013;62:44–50.

pubmed: 23644091 doi: 10.1016/j.jacc.2013.03.059

Sawhney N, Anousheh R, Chen W, Feld GK. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:243–8.

pubmed: 20339034 doi: 10.1161/CIRCEP.109.924878

Ouyang F, Ernst S, Vogtmann T, Goya M, Volkmer M, Schaumann A, et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation. 2002;105:1934–42.

pubmed: 11997280 doi: 10.1161/01.CIR.0000015077.12680.2E

Mujović N, Marinković M, Marković N, Stanković G, Lip GYH, Blomstrom-Lundqvist C, et al. Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: data from an invasive follow-up electrophysiology study. J Cardiovasc Electrophysiol. 2017;28:1403–14.

pubmed: 28836709 doi: 10.1111/jce.13322

Sanchez-Somonte P, Jiang CY, Betts TR, Chen J, Mantovan R, Macle L, et al. Completeness of linear or fractionated electrogram ablation in addition to pulmonary vein isolation on ablation outcome: a substudy of the STAR AF II trial. Circ Arrhythm Electrophysiol. 2021;14: e010146.

pubmed: 34488431 doi: 10.1161/CIRCEP.121.010146

Chae S, Oral H, Good E, Dey S, Wimmer A, Crawford T, et al. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J Am Coll Cardiol. 2007;50:1781–7.

pubmed: 17964043 doi: 10.1016/j.jacc.2007.07.044

Tzeis S, Luik A, Jilek C, Schmitt C, Estner HL, Wu J, et al. The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol. 2010;21:665–70.

pubmed: 20050958 doi: 10.1111/j.1540-8167.2009.01681.x

Pappone C, Manguso F, Vicedomini G, Gugliotta F, Santinelli O, Ferro A, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation. 2004;110:3036–42.

pubmed: 15520310 doi: 10.1161/01.CIR.0000147186.83715.95

Takagi T, Derval N, Duchateau J, Chauvel R, Tixier R, Marchand H, et al. Gaps after linear ablation of persistent atrial fibrillation (Marshall-PLAN): clinical implication. Heart Rhythm. 2023;20:14–21.

pubmed: 36115541 doi: 10.1016/j.hrthm.2022.09.009

Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–18.

pubmed: 20606120 doi: 10.1161/CIRCULATIONAHA.109.928903

Ikenouchi T, Nitta J, Inaba O, Kono T, Murata K, Takamiya T, et al. Effect of isolation feasibility of non-pulmonary vein foci on efficacy of ablation for atrial fibrillation: comparison of the isolation and focal ablation methods. J Interv Card Electrophysiol. 2022;65:441–51.

pubmed: 35445888 doi: 10.1007/s10840-022-01217-w

Della Rocca DG, Di Biase L, Mohanty S, Trivedi C, Gianni C, Romero J, et al. Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry. Europace. 2021;23:1939–49.

pubmed: 34417816 doi: 10.1093/europace/euab161

Takamiya T, Nitta J, Inaba O, Sato A, Ikenouchi T, Murata K, et al. One-year outcomes after pulmonary vein isolation plus posterior wall isolation and additional non-pulmonary vein trigger ablation for persistent atrial fibrillation with or without contact force sensing: a propensity score-matched comparison. J Interv Card Electrophysiol. 2020;59:585–93.

pubmed: 31907832 doi: 10.1007/s10840-019-00700-1

Zhao Y, Di Biase L, Trivedi C, Mohanty S, Bai R, Mohanty P, et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13:141–9.

pubmed: 26304713 doi: 10.1016/j.hrthm.2015.08.029

Nakashima T, Pambrun T, Vlachos K, Goujeau C, André C, Krisai P, et al. Impact of vein of Marshall ethanol infusion on mitral isthmus block: efficacy and durability. Circ Arrhythm Electrophysiol. 2020;13: e008884.

pubmed: 33197321 doi: 10.1161/CIRCEP.120.008884

Valderrábano M, Liu X, Sasaridis C, Sidhu J, Little S, Khoury DS. Ethanol infusion in the vein of Marshall: adjunctive effects during ablation of atrial fibrillation. Heart Rhythm. 2009;6:1552–8.

pubmed: 19786370 pmcid: 2949355 doi: 10.1016/j.hrthm.2009.07.036

Gillis K, O’Neill L, Wielandts JY, Hilfiker G, Almorad A, Lycke M, et al. Vein of Marshall ethanol infusion as first step for mitral isthmus linear ablation. JACC Clin Electrophysiol. 2022;8:367–76.

pubmed: 35331432 doi: 10.1016/j.jacep.2021.11.019

Yang G, Zheng L, Jiang C, Fan J, Liu X, Zhan X, et al. Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial. JACC Clin Electrophysiol. 2022;8:882–91.

pubmed: 35863814 doi: 10.1016/j.jacep.2022.03.012

Huo Y, Gaspar T, Schönbauer R, Wójcik M, Fiedler L, Roithinger Franz X, et al. Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation. NEJM Evidence. 2022;1:EVIDoa2200141.

pubmed: 38319851 doi: 10.1056/EVIDoa2200141

Kottkamp H, Berg J, Bender R, Rieger A, Schreiber D. Box isolation of fibrotic areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:22–30.

pubmed: 26511713 doi: 10.1111/jce.12870

Valderrábano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial. JAMA. 2020;324:1620–8.

pubmed: 33107945 doi: 10.1001/jama.2020.16195

Huang L, Gao M, Lai Y, Guo Q, Li S, Li C, et al. The adjunctive effect for left pulmonary vein isolation of vein of Marshall ethanol infusion in persistent atrial fibrillation. Europace. 2023;25:441–9.

pubmed: 36504017 doi: 10.1093/europace/euac219

Nakashima T, Pambrun T, Vlachos K, Goujeau C, André C, Krisai P, et al. Strategy for repeat procedures in patients with persistent atrial fibrillation: systematic linear ablation with adjunctive ethanol infusion into the vein of Marshall versus electrophysiology-guided ablation. J Cardiovasc Electrophysiol. 2022;33:1116–24.

pubmed: 35347799 doi: 10.1111/jce.15472

Lador A, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, et al. Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: a secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021;18:1045–54.

pubmed: 33482387 pmcid: 8254797 doi: 10.1016/j.hrthm.2021.01.005

Derval N, Duchateau J, Denis A, Ramirez FD, Mahida S, André C, et al. Marshall bundle elimination, pulmonary vein isolation, and line completion for ANATOmical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study. Heart Rhythm. 2021;18:529–37.

pubmed: 33383226 doi: 10.1016/j.hrthm.2020.12.023

Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287–94.

pubmed: 22139886 doi: 10.1161/CIRCEP.111.966226

Bai R, Di Biase L, Mohanty P, Trivedi C, Dello Russo A, Themistoclakis S, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13:132–40.

pubmed: 26277862 doi: 10.1016/j.hrthm.2015.08.019

Lee JM, Shim J, Park J, Yu HT, Kim TH, Park JK, et al. The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation. JACC Clin Electrophysiol. 2019;5:1253–61.

pubmed: 31753429 doi: 10.1016/j.jacep.2019.08.021

Kistler PM, Chieng D, Sugumar H, Ling LH, Segan L, Azzopardi S, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA. 2023;329:127–35.

pubmed: 36625809 pmcid: 9856612 doi: 10.1001/jama.2022.23722

Jiang X, Liao J, Ling Z, Meyer C, Sommer P, Futyma P, et al. Adjunctive left atrial posterior wall isolation in treating atrial fibrillation: insight from a large secondary analysis. JACC Clin Electrophysiol. 2022;8:605–18.

pubmed: 35589173 doi: 10.1016/j.jacep.2022.02.001

Sirico G, Sirico D, Montisci A, Cerrato E, Morosato M, Panigada S, et al. Contact-Force guided posterior wall isolation as an adjunctive ablation strategy for persistent atrial fibrillation. J Atr Fibrillation. 2021;14:20200475.

pubmed: 34950369 pmcid: 8691276 doi: 10.4022/jafib.20200475

Tokioka S, Fukamizu S, Kimura T, Takahashi M, Kitamura T, Hojo R. The effect of posterior wall isolation for persistent atrial fibrillation on recurrent arrhythmia. J Cardiovasc Electrophysiol. 2021;32:597–604.

pubmed: 33484213 doi: 10.1111/jce.14906

Pothineni NVK, Lin A, Frankel DS, Supple GE, Garcia FC, Lin D, et al. Impact of left atrial posterior wall isolation on arrhythmia outcomes in patients with atrial fibrillation undergoing repeat ablation. Heart Rhythm. 2021;O2(2):489–97.

doi: 10.1016/j.hroo.2021.07.004

Salih M, Darrat Y, Ibrahim AM, Al-Akchar M, Bhattarai M, Koester C, et al. Clinical outcomes of adjunctive posterior wall isolation in persistent atrial fibrillation: a metaanalysis. J Cardiovasc Electrophysiol. 2020;31:1394–402.

pubmed: 32270562 doi: 10.1111/jce.14480

Sutter JS, Lokhnygina Y, Daubert JP, Bahnson T, Jackson K, Koontz JI, et al. Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation. Am Heart J. 2020;220:89–96.

pubmed: 31805423 doi: 10.1016/j.ahj.2019.11.010

Yamaji H, Higashiya S, Murakami T, Hina K, Kawamura H, Murakami M, et al. Efficacy of an adjunctive electrophysiological test-guided left atrial posterior wall isolation in persistent atrial fibrillation without a left atrial low-voltage area. Circ Arrhythm Electrophysiol. 2020;13: e008191.

pubmed: 32660260 doi: 10.1161/CIRCEP.119.008191

McLellan AJA, Prabhu S, Voskoboinik A, Wong MCG, Walters TE, Pathik B, et al. Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long-term outcome. Europace. 2017;19:1958–66.

pubmed: 28204434 doi: 10.1093/europace/euw231

Kim JS, Shin SY, Na JO, Choi CU, Kim SH, Kim JW, et al. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation?: a prospective randomized clinical trial. Int J Cardiol. 2015;181:277–83.

pubmed: 25535691 doi: 10.1016/j.ijcard.2014.12.035

Bisbal F, Benito E, Teis A, Alarcón F, Sarrias A, Caixal G, et al. Magnetic resonance imaging-guided fibrosis ablation for the treatment of atrial fibrillation: the ALICIA trial. Circ Arrhythm Electrophysiol. 2020;13: e008707.

pubmed: 33031713 doi: 10.1161/CIRCEP.120.008707

Marrouche NF, Wazni O, McGann C, Greene T, Dean JM, Dagher L, et al. Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial. JAMA. 2022;327:2296–305.

pubmed: 35727277 pmcid: 9214588 doi: 10.1001/jama.2022.8831

Ip JE, Markowitz SM, Cheung JW, Liu CF, Thomas G, Lessner SJ, et al. Method for differentiating left superior pulmonary vein exit conduction from pseudo-exit conduction. Pacing Clin Electrophysiol. 2013;36:299–308.

pubmed: 23461559 doi: 10.1111/pace.12062

Vijayaraman P, Dandamudi G, Naperkowski A, Oren J, Storm R, Ellenbogen KA. Assessment of exit block following pulmonary vein isolation: far-field capture masquerading as entrance without exit block. Heart Rhythm. 2012;9:1653–9.

pubmed: 22683746 doi: 10.1016/j.hrthm.2012.06.004

Squara F, Liuba I, Chik W, Santangeli P, Zado ES, Callans DJ, et al. Loss of local capture of the pulmonary vein myocardium after antral isolation: prevalence and clinical significance. J Cardiovasc Electrophysiol. 2015;26:242–50.

pubmed: 25404507 doi: 10.1111/jce.12585

Gerstenfeld EP, Dixit S, Callans D, Rho R, Rajawat Y, Zado E, et al. Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol. 2002;13:971–9.

pubmed: 12435181 doi: 10.1046/j.1540-8167.2002.00971.x

Tada H, Oral H, Wasmer K, Greenstein R, Pelosi F, Knight BP, et al. Pulmonary vein isolation: comparison of bipolar and unipolar electrograms at successful and unsuccessful ostial ablation sites. J Cardiovasc Electrophysiol. 2002;13:13–9.

pubmed: 11843477 doi: 10.1046/j.1540-8167.2002.00013.x

Tada H, Oral H, Knight BP, Ozaydin M, Chugh A, Scharf C, et al. Randomized comparison of bipolar versus unipolar plus bipolar recordings during segmental ostial ablation of pulmonary veins. J Cardiovasc Electrophysiol. 2002;13:851–6.

pubmed: 12380919 doi: 10.1046/j.1540-8167.2002.00851.x

Michowitz Y, Buch E, Bourke T, Tung R, Bradfield J, Mathuria N, et al. Unipolar and bipolar electrogram characteristics predict exit block during pulmonary vein antral isolation. Pacing Clin Electrophysiol. 2012;35:1294–301.

pubmed: 22897649 doi: 10.1111/j.1540-8159.2012.03499.x

Bortone A, Appetiti A, Bouzeman A, Maupas E, Ciobotaru V, Boulenc JM, et al. Unipolar signal modification as a guide for lesion creation during radiofrequency application in the left atrium: prospective study in humans in the setting of paroxysmal atrial fibrillation catheter ablation. Circ Arrhythm Electrophysiol. 2013;6:1095–102.

pubmed: 24097371 doi: 10.1161/CIRCEP.113.000749

Bortone A, Brault-Noble G, Appetiti A, Marijon E. Elimination of the negative component of the unipolar atrial electrogram as an in vivo marker of transmural lesion creation: acute study in canines. Circ Arrhythm Electrophysiol. 2015;8:905–11.

pubmed: 26092576 doi: 10.1161/CIRCEP.115.002894

Bortone A, Lagrange P, Cauchemez B, Durand C, Dieuzaide P, Prévot S, et al. Elimination of the negative component of the unipolar electrogram as a local procedural endpoint during paroxysmal atrial fibrillation catheter ablation using contact-force sensing: the UNIFORCE study. J Interv Card Electrophysiol. 2017;49:299–306.

pubmed: 28643171 doi: 10.1007/s10840-017-0264-4

Ejima K, Kato K, Okada A, Wakisaka O, Kimura R, Ishizawa M, et al. Comparison between contact force monitoring and unipolar signal modification as a guide for catheter ablation of atrial fibrillation: prospective multi-center randomized study. Circ Arrhythm Electrophysiol. 2019;12: e007311.

pubmed: 31345092 doi: 10.1161/CIRCEP.119.007311

Fu G, He B, Wang B, Feng M, Du X, Liu J, et al. Unipolar electrogram-guided versus lesion size index-guided catheter ablation in patients with paroxysmal atrial fibrillation. J Cardiovasc Dev Dis. 2022;9:229.

pubmed: 35877591 pmcid: 9320701

Coeman M, Haddad ME, Wol M, Choudhury R, Vandekerckhove Y, Choudhury R, et al. ‘CLOSE’-guided pulmonary vein isolation and changes in local bipolar and unipolar atrial electrograms: observations from the EP lab. J Atr Fibrillation. 2018;10:1794.

pubmed: 29988234 pmcid: 6006975 doi: 10.4022/jafib.1794

Tomlinson DR, Myles M, Stevens KN, Streeter AJ. Transmural unipolar electrogram change occurs within 7 s at the left atrial posterior wall during pulmonary vein isolation. Pacing Clin Electrophysiol. 2019;42:922–9.

pubmed: 31127636 doi: 10.1111/pace.13729

Zheng X, Walcott GP, Hall JA, Rollins DL, Smith WM, Kay GN, et al. Electrode impedance: an indicator of electrode-tissue contact and lesion dimensions during linear ablation. J Interv Card Electrophysiol. 2000;4:645–54.

pubmed: 11141212 doi: 10.1023/A:1026586119600

Chinitz JS, Kapur S, Barbhaiya C, Kumar S, John R, Epstein LM, et al. Sites with small impedance decrease during catheter ablation for atrial fibrillation are associated with recovery of pulmonary vein conduction. J Cardiovasc Electrophysiol. 2016;27:1390–8.

pubmed: 27581553 doi: 10.1111/jce.13095

Reichlin T, Knecht S, Lane C, Kuhne M, Nof E, Chopra N, et al. Initial impedance decrease as an indicator of good catheter contact: insights from radiofrequency ablation with force sensing catheters. Heart Rhythm. 2014;11:194–201.

pubmed: 24177370 doi: 10.1016/j.hrthm.2013.10.048

Wakili R, Clauss S, Schmidt V, Ulbrich M, Hahnefeld A, Schüssler F, et al. Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation. Clin Res Cardiol. 2014;103:97–106.

pubmed: 24096555 doi: 10.1007/s00392-013-0625-7

Park HS, Kim IC, Cho YK, Yoon HJ, Kim H, Nam CW, et al. Comparison of the efficacy between impedance-guided and contact force-guided atrial fibrillation ablation using an automated annotation system. J Arrhythm. 2018;34:239–46.

pubmed: 29951138 pmcid: 6010015 doi: 10.1002/joa3.12054

Knecht S, Reichlin T, Pavlovic N, Schaer B, Osswald S, Sticherling C, et al. Contact force and impedance decrease during ablation depends on catheter location and orientation: insights from pulmonary vein isolation using a contact force-sensing catheter. J Interv Card Electrophysiol. 2015;43:297–306.

pubmed: 25925494 doi: 10.1007/s10840-015-0002-8

Yasumoto K, Egami Y, Kawanami S, Sugae H, Ukita K, Kawamura A, et al. The correlation between local impedance drop and catheter contact in clinical pulmonary vein isolation use. Pacing Clin Electrophysiol. 2022;45:984–92.

pubmed: 35363376 doi: 10.1111/pace.14500

Segreti L, De Simone A, Schillaci V, Bongiorni MG, Pelargonio G, Pandozi C, et al. A novel local impedance algorithm to guide effective pulmonary vein isolation in atrial fibrillation patients: preliminary experience across different ablation sites from the CHARISMA pilot study. J Cardiovasc Electrophysiol. 2020;31:2319–27.

pubmed: 32613661 doi: 10.1111/jce.14647

Hashimoto K, Tsuzuki I, Seki Y, Ibe S, Yamashita T, Miyama H, et al. Change in the local impedance and electrograms recorded by a micro-electrode tip catheter during initial atrial fibrillation ablation. Journal of Arrhythmia. 2021;37:566–73.

pubmed: 34141009 pmcid: 8207389 doi: 10.1002/joa3.12535

Solimene F, Giannotti Santoro M, De Simone A, Malacrida M, Stabile G, Pandozi C, et al. Pulmonary vein isolation in atrial fibrillation patients guided by a novel local impedance algorithm: 1-year outcome from the CHARISMA study. J Cardiovasc Electrophysiol. 2021;32:1540–8.

pubmed: 33851484 doi: 10.1111/jce.15041

Yokoyama K, Nakagawa H, Shah DC, Lambert H, Leo G, Aeby N, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1:354–62.

pubmed: 19808430 doi: 10.1161/CIRCEP.108.803650

Kumar S, Morton JB, Lee J, Halloran K, Spence SJ, Gorelik A, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5:1124–9.

pubmed: 23087399 doi: 10.1161/CIRCEP.112.972208

Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9:1789–95.

pubmed: 22820056 doi: 10.1016/j.hrthm.2012.07.016

Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6:327–33.

pubmed: 23515263 doi: 10.1161/CIRCEP.113.000374

Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015;17:1229–35.

pubmed: 26041872 pmcid: 4535556 doi: 10.1093/europace/euv057

Shah DC, Lambert H, Nakagawa H, Langenkamp A, Aeby N, Leo G. Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model. J Cardiovasc Electrophysiol. 2010;21:1038–43.

pubmed: 20367658 doi: 10.1111/j.1540-8167.2010.01750.x

Kuck K-H, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, et al. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm. 2012;9:18–23.

pubmed: 21872560 doi: 10.1016/j.hrthm.2011.08.021

Kumar S, Morton JB, Halloran K, Spence SJ, Lee G, Wong MCG, et al. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm. 2012;9:1041-47.e1.

pubmed: 22342855 doi: 10.1016/j.hrthm.2012.02.015

El Haddad E, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythm Electrophysiol. 2017;10: e004867.

pubmed: 28381417 doi: 10.1161/CIRCEP.116.004867

Nakagawa H, Ikeda A, Govari A, Papaioannou T, Constantine G, Bar-Tal M, et al. Abstract 12104: prospective study using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) for quantifying lesion formation to guide long continuous atrial lesions in the beating canine heart. Circulation. 2013;128:A12104–A12104.

Ullah W, Hunter RJ, Finlay MC, McLean A, Dhinoja MB, Sporton S, et al. Ablation index and surround flow catheter irrigation: impedance-based appraisal in clinical ablation. JACC Clin Electrophysiol. 2017;3:1080–8.

pubmed: 29759489 doi: 10.1016/j.jacep.2017.03.011

Teres C, Soto-Iglesias D, Penela D, Jáuregui B, Ordoñez A, Chauca A, et al. Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘ablate by-LAW’ single-centre study-a pilot study. Europace. 2022;24:390–9.

pubmed: 34480548 doi: 10.1093/europace/euab216

Kyriakopoulou M, Strisciuglio T, El Haddad M, De Pooter J, Almorad A, Van Beeumen K, et al. Evaluation of a simple technique aiming at optimizing point-by-point isolation of the left pulmonary veins: a randomized study. Europace. 2019;21:1185–92.

pubmed: 31056640 doi: 10.1093/europace/euz115

Berte B, Hilfiker G, Moccetti F, Schefer T, Weberndörfer V, Cuculi F, et al. Pulmonary vein isolation using ablation index vs. CLOSE protocol with a surround flow ablation catheter. Europace. 2020;22:84–9.

pubmed: 31518403 doi: 10.1093/europace/euz244

Hoffmann P, Diaz Ramirez I, Baldenhofer G, Stangl K, Mont L, Althoff TF. Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation. Europace. 2020;22:1480–6.

pubmed: 32729896 doi: 10.1093/europace/euaa147

Kobayashi S, Fukaya H, Oikawa J, Saito D, Sato T, Matsuura G, et al. Optimal interlesion distance in ablation index-guided pulmonary vein isolation for atrial fibrillation. J Interv Card Electrophysiol. 2021;62:123–31.

pubmed: 32975734 doi: 10.1007/s10840-020-00881-0

Francke A, Taha NS, Scharfe F, Schoen S, Wunderlich C, Christoph M. Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high-power short-duration pulmonary vein isolation and substrate modification using the CLOSE protocol. J Cardiovasc Electrophysiol. 2021;32:2408–17.

pubmed: 34252990 doi: 10.1111/jce.15158

Francke A, Scharfe F, Schoen S, Wunderlich C, Christoph M. Reconnection patterns after CLOSE-guided 50 W high-power-short-duration circumferential pulmonary vein isolation and substrate modification-PV reconnection might no longer be an issue. J Cardiovasc Electrophysiol. 2022;33:1136–45.

pubmed: 35118734 doi: 10.1111/jce.15396

Chen S, Schmidt B, Bordignon S, Tohoku S, Urban VC, Schulte-Hahn B, et al. Catheter ablation of atrial fibrillation using ablation index-guided high-power technique: Frankfurt AI high-power 15-month follow-up. J Cardiovasc Electrophysiol. 2021;32:616–24.

pubmed: 33484215 doi: 10.1111/jce.14912

Jiang C-Y, Jiang R-H, Matsuo S, Liu Q, Fan Y-Q, Zhang Z-W, et al. Early detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation: a comparison of ATP-induction and reassessment at 30 minutes postisolation. J Cardiovasc Electrophysiol. 2009;20:1382–7.

pubmed: 19656250 doi: 10.1111/j.1540-8167.2009.01564.x

Cheema A, Dong J, Dalal D, Marine JE, Henrikson CA, Spragg D, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:387–91.

pubmed: 17394453 doi: 10.1111/j.1540-8167.2007.00760.x

Brunelli M, Raffa S, Große A, Hanazawa K, Sammut M, Roos M, et al. Residual conduction after pulmonary vein isolation with a circular multielectrode radiofrequency ablation catheter: the role of adenosine and orciprenalin during a prolonged observation time. Int J Cardiol. 2013;168:4122–31.

pubmed: 23920058 doi: 10.1016/j.ijcard.2013.07.071

Dallaglio PD, Betts TR, Ginks M, Bashir Y, Anguera I, Rajappan K. The role of adenosine in pulmonary vein isolation: a critical review. Cardiol Res Pract. 2016;2016:8632509.

pubmed: 26981309 pmcid: 4770126 doi: 10.1155/2016/8632509

le Polain de Waroux J-B, Weerasooriya R, Anvardeen K, Barbraud C, Marchandise S, De Meester C, et al. Low contact force and force-time integral predict early recovery and dormant conduction revealed by adenosine after pulmonary vein isolation. Europace. 2015;17:877–83.

pubmed: 25618742 pmcid: 4447053 doi: 10.1093/europace/euu329

Datino T, Macle L, Qi XY, Maguy A, Comtois P, Chartier D, et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation. 2010;121:963–72.

pubmed: 20159830 doi: 10.1161/CIRCULATIONAHA.109.893107

Tokuda M, Matsuo S, Isogai R, Uno G, Tokutake K, Yokoyama K, et al. Adenosine testing during cryoballoon ablation and radiofrequency ablation of atrial fibrillation: a propensity score-matched analysis. Heart Rhythm. 2016;13:2128–34.

pubmed: 27520540 doi: 10.1016/j.hrthm.2016.08.018

Ghanbari H, Jani R, Hussain-Amin A, Al-Assad W, Huether E, Ansari S, et al. Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: a randomized controlled trial. Heart Rhythm. 2016;13:407–15.

pubmed: 26455342 doi: 10.1016/j.hrthm.2015.10.016

Prabhu S, Mackin V, McLellan AJ, Phan T, McGlade D, Ling LH, et al. Determining the optimal dose of adenosine for unmasking dormant pulmonary vein conduction following atrial fibrillation ablation: electrophysiological and hemodynamic assessment. DORMANT-AF study J Cardiovasc Electrophysiol. 2017;28:13–22.

pubmed: 27759898 doi: 10.1111/jce.13107

Osorio J, Hunter TD, Rajendra A, Zei P, Silverstein J, Morales G. Predictors of clinical success after paroxysmal atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2021;32:1814–21.

pubmed: 33825242 doi: 10.1111/jce.15028

Ninomiya Y, Inoue K, Tanaka N, Okada M, Tanaka K, Onishi T, et al. Absence of first-pass isolation is associated with poor pulmonary vein isolation durability and atrial fibrillation ablation outcomes. J Arrhythm. 2021;37:1468–76.

pubmed: 34887951 pmcid: 8637089 doi: 10.1002/joa3.12629

Barbhaiya CR, Aizer A, Knotts R, Bernstein S, Park D, Holmes D, et al. Simultaneous pace-ablate during CARTO-guided pulmonary vein isolation with a contact-force sensing radiofrequency ablation catheter. J Interv Card Electrophysiol. 2019;54:119–24.

pubmed: 30264289 doi: 10.1007/s10840-018-0455-7

Kogawa R, Okumura Y, Watanabe I, Sonoda K, Sasaki N, Takahashi K, et al. Difference between dormant conduction sites revealed by adenosine triphosphate provocation and unipolar pace-capture sites along the ablation line after pulmonary vein isolation. Int Heart J. 2016;57:25–9.

pubmed: 26673441 doi: 10.1536/ihj.15-231

Okumura Y, Watanabe I, Nagashima K, Sonoda K, Mano H, Sasaki N, et al. The effects of standard electrical PV isolation vs. “pace and ablate” on ATP-provoked PV reconnections. J Interv Card Electrophysiol. 2014;40:39–45.

pubmed: 24566990 doi: 10.1007/s10840-013-9869-4

Kumar S, Kalman JM, Sutherland F, Spence SJ, Finch S, Sparks PB. Atrial fibrillation inducibility in the absence of structural heart disease or clinical atrial fibrillation: critical dependence on induction protocol, inducibility definition, and number of inductions. Circ Arrhythm Electrophysiol. 2012;5:531–6.

pubmed: 22528047 doi: 10.1161/CIRCEP.111.968859

Darma A, Daneschnejad SS, Gaspar T, Huo Y, Wetzel U, Dagres N, et al. Role of inducibility and its dynamic change in the outcome of catheter ablation of atrial fibrillation: a single center prospective study. J Cardiovasc Electrophysiol. 2020;31:705–11.

pubmed: 31943494 doi: 10.1111/jce.14355

Santangeli P, Zado ES, Garcia FC, Riley MP, Lin D, Frankel DS, et al. Lack of prognostic value of atrial arrhythmia inducibility and change in inducibility status after catheter ablation of atrial fibrillation. Heart Rhythm. 2018;15:660–5.

pubmed: 29056544 doi: 10.1016/j.hrthm.2017.10.023

Leong-Sit P, Robinson M, Zado ES, Callans DJ, Garcia F, Lin D, et al. Inducibility of atrial fibrillation and flutter following pulmonary vein ablation. J Cardiovasc Electrophysiol. 2013;24:617–23.

pubmed: 23387879 doi: 10.1111/jce.12088

Millenaar D, Becker N, Pavlicek V, Wintrich J, Böhm M, Mahfoud F, et al. Inducibility of atrial fibrillation after catheter ablation predicts recurrences of atrial fibrillation: a metaanalysis. Pacing Clin Electrophysiol. 2021;44:667–76.

pubmed: 33686680 doi: 10.1111/pace.14216

Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol. 2008;52:273–8.

pubmed: 18634982 doi: 10.1016/j.jacc.2008.04.021

Alyesh D, Frederick J, Choe W, Sundaram S. Step by step: how to perform a fluoroless cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2022;33:2351–5.

pubmed: 35437834 doi: 10.1111/jce.15502

Siklódy CH, Minners J, Allgeier M, Allgeier HJ, Jander N, Keyl C, et al. Pressure-guided cryoballoon isolation of the pulmonary veins for the treatment of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:120–5.

pubmed: 19793145 doi: 10.1111/j.1540-8167.2009.01600.x

Rottner L, Sinning C, Reissmann B, Schleberger R, Dinshaw L, Münkler P, et al. Wide-band dielectric imaging and the novel cryoballoon-occlusion tool to guide cryoballoon-based pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2020;13: e008507.

pubmed: 32631093 doi: 10.1161/CIRCEP.120.008507

Takami M, Lehmann HI, Misiri J, Parker KD, Sarmiento RI, Johnson SB, et al. Impact of freezing time and balloon size on the thermodynamics and isolation efficacy during pulmonary vein isolation using the second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:836–45.

pubmed: 26082516 doi: 10.1161/CIRCEP.115.002725

Andrade JG, Dubuc M, Guerra PG, Landry E, Coulombe N, Leduc H, et al. Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol. 2013;24:692–8.

pubmed: 23489648 doi: 10.1111/jce.12114

Cheung CC, Deyell MW, Macle L, Verma A, Champagne J, Leong-Sit P, et al. Repeat atrial fibrillation ablation procedures in the CIRCA-DOSE study. Circ Arrhythm Electrophysiol. 2020;13: e008480.

pubmed: 32701361 doi: 10.1161/CIRCEP.120.008480

Chun KR, Stich M, Fürnkranz A, Bordignon S, Perrotta L, Dugo D, et al. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm. 2017;14:495–500.

pubmed: 27956248 doi: 10.1016/j.hrthm.2016.12.014

Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, et al. One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace. 2015;17:1236–40.

pubmed: 25868468 doi: 10.1093/europace/euv024

Farkowski MM, Karlinski M, Barra S, Providencia R, Golicki D, Pytkowski M, et al. Effectiveness and safety of a single freeze strategy of cryoballoon ablation of atrial fibrillation: an EHRA systematic review and metaanalysis. Europace. 2022;24:58–69.

pubmed: 34297839 doi: 10.1093/europace/euab133

Bordignon S, Chen S, Bologna F, Thohoku S, Urbanek L, Willems F, et al. Optimizing cryoballoon pulmonary vein isolation: lessons from >1000 procedures- the Frankfurt approach. Europace. 2021;23:868–77.

pubmed: 33458770 doi: 10.1093/europace/euaa406

Chen S, Schmidt B, Bordignon S, Perrotta L, Bologna F, Chun KRJ. Impact of cryoballoon freeze duration on long-term durability of pulmonary vein isolation: ICE re-map study. JACC Clin Electrophysiol. 2019;5:551–9.

pubmed: 31122376 doi: 10.1016/j.jacep.2019.03.012

Heeger CH, Popescu SS, Saraei R, Kirstein B, Hatahet S, Samara O, et al. Individualized or fixed approach to pulmonary vein isolation utilizing the fourth-generation cryoballoon in patients with paroxysmal atrial fibrillation: the randomized INDI-FREEZE trial. Europace. 2022;24:921–7.

pubmed: 34907431 doi: 10.1093/europace/euab305

Ferrero-de-Loma-Osorio Á, García-Fernández A, Castillo-Castillo J, Izquierdo-de-Francisco M, Ibáñez-Críado A, Moreno-Arribas J, et al. Time-to-effect-based dosing strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation: results of the plusONE multicenter randomized controlled noninferiority trial. Circ Arrhythm Electrophysiol. 2017;10: e005318.

pubmed: 29247029 doi: 10.1161/CIRCEP.117.005318

Ciconte G, Mugnai G, Sieira J, Velagić V, Saitoh Y, Irfan G, et al. On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation. Circ Arrhythm Electrophysiol. 2015;8:1359–65.

pubmed: 26527624 doi: 10.1161/CIRCEP.115.002966

Aryana A, Mugnai G, Singh SM, Pujara DK, de Asmundis C, Singh SK, et al. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation. Heart Rhythm. 2016;13:424–32.

pubmed: 26520204 doi: 10.1016/j.hrthm.2015.10.033

Ghosh J, Martin A, Keech AC, Chan KH, Gomes S, Singarayar S, et al. Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm. 2013;10:1311–7.

pubmed: 23792110 doi: 10.1016/j.hrthm.2013.06.014

Bose A, Chevli PA, Berberian G, Januszkiewicz J, Ahmad G, Hashmath Z, et al. Presence of a left common pulmonary vein and pulmonary vein anatomical characteristics as predictors of outcome following cryoballoon ablation for paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2021;62:409–17.

pubmed: 33206281 doi: 10.1007/s10840-020-00916-6

Coutiño HE, Ströker E, Takarada K, Mugnai G, Abugattas JP, Sieira J, et al. Radiofrequency versus cryoballoon ablation for atrial fibrillation in the setting of left common pulmonary veins. Pacing Clin Electrophysiol. 2019;42:1456–62.

pubmed: 31579929 doi: 10.1111/pace.13810

Yamaguchi M, Miyazaki S, Kajiyama T, Hada M, Nakamura H, Hachiya H, et al. Pulmonary vein isolation in patients with a left common pulmonary vein: comparison between second-generation cryoballoon and radiofrequency ablation. J Cardiol. 2019;73:292–8.

pubmed: 30583987 doi: 10.1016/j.jjcc.2018.12.004

Shigeta T, Okishige K, Yamauchi Y, Aoyagi H, Nakamura T, Yamashita M, et al. Clinical assessment of cryoballoon ablation in cases with atrial fibrillation and a left common pulmonary vein. J Cardiovasc Electrophysiol. 2017;28:1021–7.

pubmed: 28570019 doi: 10.1111/jce.13267

Asvestas D, Sousonis V, Kotsovolis G, Karanikas S, Xintarakou A, Sakadakis E, et al. Cavotricuspid isthmus ablation guided by force-time integral – a randomized study. Clin Cardiol. 2022;45:503–8.

pubmed: 35301726 pmcid: 9045076 doi: 10.1002/clc.23805

Sakama S, Yagishita A, Sakai T, Morise M, Ayabe K, Amino M, et al. Ablation index-guided cavotricuspid isthmus ablation with contiguous lesions using fluoroscopy integrated 3D mapping in atrial flutter. J Interv Card Electrophysiol. 2022;64:217–22.

pubmed: 35294705 pmcid: 9236984 doi: 10.1007/s10840-022-01182-4

Sasaki T, Nakamura K, Inoue M, Minami K, Miki Y, Goto K, et al. Optimal local impedance drops for an effective radiofrequency ablation during cavo-tricuspid isthmus ablation. J Arrhythm. 2020;36:905–11.

pubmed: 33024468 pmcid: 7532274 doi: 10.1002/joa3.12403

Sau A, Kapadia S, Al-Aidarous S, Howard J, Sohaib A, Sikkel MB, et al. Temporal trends and lesion sets for persistent atrial fibrillation ablation: a metaanalysis with trial sequential analysis and meta-regression. Circ Arrhythm Electrophysiol. 2023;16: e011861.

pubmed: 37589197 pmcid: 10510845 doi: 10.1161/CIRCEP.123.011861

Clarnette JA, Brooks AG, Mahajan R, Elliott AD, Twomey DJ, Pathak RK, et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and metaanalysis. Europace. 2018;20:f366-76.

pubmed: 29267853 doi: 10.1093/europace/eux297

Bergonti M, Spera FR, Ferrero TG, Nsahlai M, Bonomi A, Boris W, et al. Anterior mitral line in patients with persistent atrial fibrillation and anterior scar: a multicenter matched comparison-The MiLine study. Heart Rhythm. 2023;20:658–65.

pubmed: 36640853 doi: 10.1016/j.hrthm.2023.01.009

Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044–53.

pubmed: 15172410 doi: 10.1016/j.jacc.2003.12.054

Lau DH, Maesen B, Zeemering S, Verheule S, Crijns HJ, Schotten U. Stability of complex fractionated atrial electrograms: a systematic review. J Cardiovasc Electrophysiol. 2012;23:980–7.

pubmed: 22554025 doi: 10.1111/j.1540-8167.2012.02335.x

Vogler J, Willems S, Sultan A, Schreiber D, Lüker J, Servatius H, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66:2743–52.

pubmed: 26700836 doi: 10.1016/j.jacc.2015.09.088

Providência R, Lambiase PD, Srinivasan N, Ganesh Babu G, Bronis K, Ahsan S, et al. Is there still a role for complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation? Metaanalysis of 1415 patients. Circ Arrhythm Electrophysiol. 2015;8:1017–29.

pubmed: 26082515 doi: 10.1161/CIRCEP.115.003019

O’Neill MD, Wright M, Knecht S, Jaïs P, Hocini M, Takahashi Y, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J. 2009;30:1105–12.

pubmed: 19270341 doi: 10.1093/eurheartj/ehp063

Schreiber D, Rostock T, Fröhlich M, Sultan A, Servatius H, Hoffmann BA, et al. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol. 2015;8:308–17.

pubmed: 25744570 doi: 10.1161/CIRCEP.114.001672

Suenari K, Chen YC, Kao YH, Cheng CC, Lin YK, Chen YJ, et al. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Basic Res Cardiol. 2011;106:65–74.

pubmed: 21072524 doi: 10.1007/s00395-010-0132-1

Markides V, Schilling RJ, Ho SY, Chow AW, Davies DW, Peters NS. Characterization of left atrial activation in the intact human heart. Circulation. 2003;107:733–9.

pubmed: 12578877 doi: 10.1161/01.CIR.0000048140.31785.02

Pauza DH, Skripka V, Pauziene N. Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histochemical staining with acetylcholinesterase. Cells Tissues Organs. 2002;172:297–320.

pubmed: 12566631 doi: 10.1159/000067198

Thiyagarajah A, Mahajan R, Iwai S, Griffin A, Mishima RS, Linz D, et al. Single ring isolation with inferior line sparing for atrial fibrillation: a proof-of-concept study. Circ Arrhythm Electrophysiol. 2021;14: e009552.

pubmed: 33858182 doi: 10.1161/CIRCEP.120.009552

Thomas SP, Lim TW, McCall R, Seow SC, Ross DL. Electrical isolation of the posterior left atrial wall and pulmonary veins for atrial fibrillation: feasibility of and rationale for a single-ring approach. Heart Rhythm. 2007;4:722–30.

pubmed: 17556191 doi: 10.1016/j.hrthm.2007.01.034

Bisignani A, Pannone L, Miraglia V, Sieira J, Iacopino S, Bala G, et al. Feasibility and safety of left atrial posterior wall isolation with a new Cryoballoon technology in patients with persistent atrial fibrillation. Pacing Clin Electrophysiol. 2022;45:605–11.

pubmed: 35352363 pmcid: 9325381 doi: 10.1111/pace.14495

Aryana A, Baker JH, Espinosa Ginic MA, Pujara DK, Bowers MR, O’Neill PG, et al. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: a multicenter experience. Heart Rhythm. 2018;15:1121–9.

pubmed: 30060879 doi: 10.1016/j.hrthm.2018.05.014

Aryana A, Allen SL, Pujara DK, Bowers MR, O’Neill PG, Yamauchi Y, et al. Concomitant pulmonary vein and posterior wall isolation using cryoballoon with adjunct radiofrequency in persistent atrial fibrillation. JACC Clin Electrophysiol. 2021;7:187–96.

pubmed: 33602399 doi: 10.1016/j.jacep.2020.08.016

Ahn J, Shin DG, Han SJ, Lim HE. Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial Europace. 2022;24:1093–101.

pubmed: 35138376

Gunawardene MA, Frommeyer G, Ellermann C, Jularic M, Leitz P, Hartmann J, et al. Left atrial posterior wall isolation with pulsed field ablation in persistent atrial fibrillation. J Clin Med. 2023;12:6304.

pubmed: 37834948 pmcid: 10573684 doi: 10.3390/jcm12196304

Sohns C, Fink T, Braun M, Sciacca V, Piran M, Khalaph M, et al. Lesion formation following pulsed field ablation for pulmonary vein and posterior wall isolation. Pacing Clin Electrophysiol. 2023;46:714–6.

pubmed: 37247251 doi: 10.1111/pace.14727

Yu HT, Shim J, Park J, Kim IS, Kim TH, Uhm JS, et al. Pulmonary vein isolation alone versus additional linear ablation in patients with persistent atrial fibrillation converted to paroxysmal type with antiarrhythmic drug therapy: a multicenter, prospective, randomized study. Circ Arrhythm Electrophysiol. 2017;10: e004915.

pubmed: 28611206 doi: 10.1161/CIRCEP.116.004915

Wong K, Schricker AA, Nerlekar R, Feng Z, Sudat S, Cook K, et al. The posterior wall isolation for persistent atrial fibrillation high-power short duration (PEF-HOT) trial. JACC Clin Electrophysiol. 2023;9:2166–8.

pubmed: 37589645 doi: 10.1016/j.jacep.2023.07.006

Jankelson L, Garber L, Shulman E, Cohen RB, Peterson C, Wadhwani L, et al. Outcomes of posterior wall isolation with pulmonary vein isolation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2022;33:209–17.

pubmed: 34911157 doi: 10.1111/jce.15325

Sugumar H, Thomas SP, Prabhu S, Voskoboinik A, Kistler PM. How to perform posterior wall isolation in catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:345–52.

pubmed: 29178497 doi: 10.1111/jce.13397

Tran VN, Kusa S, Smietana J, Tsai WC, Bhasin K, Teh A, et al. The relationship between oesophageal heating during left atrial posterior wall ablation and the durability of pulmonary vein isolation. Europace. 2017;19:1664–9.

pubmed: 28204456 doi: 10.1093/europace/euw232

Markman TM, Hyman MC, Kumareswaran R, Arkles JS, Santangeli P, Schaller RD, et al. Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation. Heart Rhythm. 2020;17:1740–4.

pubmed: 32389682 doi: 10.1016/j.hrthm.2020.05.005

Kumar P, Bamimore AM, Schwartz JD, Chung EH, Gehi AK, Kiser AC, et al. Challenges and outcomes of posterior wall isolation for ablation of atrial fibrillation. J Am Heart Assoc. 2016;5: e003885.

pubmed: 27663412 pmcid: 5079038 doi: 10.1161/JAHA.116.003885

Segan L, Chieng D, Prabhu S, Hunt A, Watts T, Klys B, et al. Posterior wall isolation improves outcomes for persistent AF with rapid posterior wall activity: a CAPLA substudy. Clin Electrophysiol. 2023;9:2536–46.

doi: 10.1016/j.jacep.2023.08.018

Al-Kaisey AM, Parameswaran R, Kalman JM. Atrial fibrillation structural substrates: aetiology, identification and implications. Arrhythm Electrophysiol Rev. 2020;9:113–20.

pubmed: 33240506 pmcid: 7675137

Prabhu S, Voskoboinik A, McLellan AJA, Peck KY, Pathik B, Nalliah CJ, et al. Biatrial electrical and structural atrial changes in heart failure: electroanatomic mapping in persistent atrial fibrillation in humans. JACC Clin Electrophysiol. 2018;4:87–96.

pubmed: 29600790 doi: 10.1016/j.jacep.2017.08.012

Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44:109–16.

pubmed: 15234418 doi: 10.1016/j.jacc.2004.03.044

Mahajan R, Lau DH, Brooks AG, Shipp NJ, Wood JPM, Manavis J, et al. Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction. JACC Clin Electrophysiol. 2021;7:630–41.

pubmed: 33640353 doi: 10.1016/j.jacep.2020.11.015

Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, et al. Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020;382:20–8.

pubmed: 31893513 doi: 10.1056/NEJMoa1817591

Trivedi SJ, Claessen G, Stefani L, Flannery MD, Brown P, Janssens K, et al. Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function. Eur Heart J Cardiovasc Imaging. 2020;21:1374–83.

pubmed: 32757003 doi: 10.1093/ehjci/jeaa183

Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation: how to modify the substrate? J Am Coll Cardiol. 2015;65:196–206.

pubmed: 25593061 doi: 10.1016/j.jacc.2014.10.034

Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:825–33.

pubmed: 25151631 doi: 10.1161/CIRCEP.113.001251

Cutler MJ, Johnson J, Abozguia K, Rowan S, Lewis W, Costantini O, et al. Impact of voltage mapping to guide whether to perform ablation of the posterior wall in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:13–21.

pubmed: 26515166 doi: 10.1111/jce.12830

Yang G, Yang B, Wei Y, Zhang F, Ju W, Chen H, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2016;9: e003382.

pubmed: 26857907 doi: 10.1161/CIRCEP.115.003382

Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation: results of the randomized controlled VOLCANO trial. J Am Heart Assoc. 2020;9: e015927.

pubmed: 32578466 pmcid: 7670527 doi: 10.1161/JAHA.120.015927

Chen H, Li C, Han B, Xiao F, Yi F, Wei Y, et al. Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation: a randomized clinical trial. JAMA Cardiol. 2023;8:765–72.

pubmed: 37378966 doi: 10.1001/jamacardio.2023.1749

Wong GR, Nalliah CJ, Lee G, Voskoboinik A, Prabhu S, Parameswaran R, et al. Dynamic atrial substrate during high-density mapping of paroxysmal and persistent AF: implications for substrate ablation. JACC Clin Electrophysiol. 2019;5:1265–77.

pubmed: 31753431 doi: 10.1016/j.jacep.2019.06.002

Kapa S, Desjardins B, Callans DJ, Marchlinski FE, Dixit S. Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25:1044–52.

pubmed: 24832482 doi: 10.1111/jce.12452

Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Shinzato K, Osako R, et al. Histological validation of atrial structural remodelling in patients with atrial fibrillation. Eur Heart J. 2023;44:3339–53.

pubmed: 37350738 pmcid: 10499545 doi: 10.1093/eurheartj/ehad396

Vlachos K, Derval N, Pambrun T, Duchateau J, Martin CA, Bazoukis G, et al. Ligament of Marshall ablation for persistent atrial fibrillation. Pacing Clin Electrophysiol. 2021;44:782–91.

pubmed: 33687764 doi: 10.1111/pace.14208

Kamakura T, Derval N, Duchateau J, Denis A, Nakashima T, Takagi T, et al. Vein of Marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients. Circ Arrhythm Electrophysiol. 2021;14: e010001.

pubmed: 34280029 pmcid: 8376276 doi: 10.1161/CIRCEP.121.010001

Gianni C, Mohanty S, Trivedi C, Di Biase L, Natale A. Novel concepts and approaches in ablation of atrial fibrillation: the role of non-pulmonary vein triggers. Europace. 2018;20:1566–76.

pubmed: 29697759 doi: 10.1093/europace/euy034

Mohanty S, Trivedi C, Horton P, Della Rocca DG, Gianni C, MacDonald B, et al. Natural history of arrhythmia after successful isolation of pulmonary veins, left atrial posterior wall, and superior vena cava in patients with paroxysmal atrial fibrillation: a multi-center experience. J Am Heart Assoc. 2021;10: e020563.

pubmed: 33998277 pmcid: 8483530 doi: 10.1161/JAHA.120.020563

Sørensen SK, Johannessen A, Worck R, Hansen ML, Hansen J. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation: durability of pulmonary vein isolation and effect on atrial fibrillation burden: the RACE-AF randomized controlled trial. Circ Arrhythm Electrophysiol. 2021;14: e009573.

pubmed: 33835823 pmcid: 8136462 doi: 10.1161/CIRCEP.120.009573

Della Rocca DG, Tarantino N, Trivedi C, Mohanty S, Anannab A, Salwan AS, et al. Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: implications of pathophysiology for catheter ablation. J Cardiovasc Electrophysiol. 2020;31:2154–67.

pubmed: 32583488 doi: 10.1111/jce.14638

Hsu LF, Jaïs P, Keane D, Wharton JM, Deisenhofer I, Hocini M, et al. Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004;109:828–32.

pubmed: 14757689 doi: 10.1161/01.CIR.0000116753.56467.BC

Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68:1929–40.

pubmed: 27788847 doi: 10.1016/j.jacc.2016.07.770

Romero J, Di Biase L, Mohanty S, Trivedi C, Patel K, Parides M, et al. Long-term outcomes of left atrial appendage electrical isolation in patients with nonparoxysmal atrial fibrillation: a propensity score-matched analysis. Circ Arrhythm Electrophysiol. 2020;13: e008390.

pubmed: 32998529 doi: 10.1161/CIRCEP.120.008390

Romero J, Gabr M, Patel K, Briceno D, Diaz JC, Alviz I, et al. Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated metaanalysis. Europace. 2021;23:226–37.

pubmed: 33324978 doi: 10.1093/europace/euaa266

Friedman DJ, Black-Maier EW, Barnett AS, Pokorney SD, Al-Khatib SM, Jackson KP, et al. Left atrial appendage electrical isolation for treatment of recurrent atrial fibrillation: a metaanalysis. JACC Clin Electrophysiol. 2018;4:112–20.

pubmed: 29600775 doi: 10.1016/j.jacep.2017.07.007

Bavry A. Outcomes of adjunctive left atrial appendage ligation utilizing the LARIAT compared to pulmonary vein antral isolation alone - aMAZE. Presented by Dr. David J. Wilber at the american heart association virtual annual scientific sessions (AHA 2021), 2021.

Fink T, Vogler J, Heeger CH, Sano M, Sciacca V, Reissmann B, et al. Impact of left atrial appendage closure on LAA thrombus formation and thromboembolism after LAA isolation. JACC Clin Electrophysiol. 2020;6:1687–97.

pubmed: 33334448 doi: 10.1016/j.jacep.2020.07.003

Rillig A, Tilz RR, Lin T, Fink T, Heeger CH, Arya A, et al. Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2016;9: e003461.

pubmed: 27153877 doi: 10.1161/CIRCEP.115.003461

Kim YG, Shim J, Oh SK, Lee KN, Choi JI, Kim YH. Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity. Heart Rhythm. 2018;15:1746–53.

pubmed: 30502771 doi: 10.1016/j.hrthm.2018.09.012

Zender N, Weise FK, Bordignon S, Herrmann E, Konstantinou A, Bologna F, et al. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure? Europace. 2019;21:1502–8.

pubmed: 31230078 doi: 10.1093/europace/euz161

Dixit S, Lin D, Frankel DS, Marchlinski FE. Catheter ablation for persistent atrial fibrillation: antral pulmonary vein isolation and elimination of nonpulmonary vein triggers are sufficient. Circ Arrhythm Electrophysiol. 2012;5:1216–23; discussion 1223.

Inoue K, Kurotobi T, Kimura R, Toyoshima Y, Itoh N, Masuda M, et al. Trigger-based mechanism of the persistence of atrial fibrillation and its impact on the efficacy of catheter ablation. Circ Arrhythm Electrophysiol. 2012;5:295–301.

pubmed: 22042883 doi: 10.1161/CIRCEP.111.964080

Santangeli P, Di Biase L, Mohanty P, Burkhardt JD, Horton R, Bai R, et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23:687–93.

pubmed: 22494628 doi: 10.1111/j.1540-8167.2012.02293.x

Choi EK, Shen MJ, Han S, Kim D, Hwang S, Sayfo S, et al. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs. Circulation. 2010;121:2615–23.

pubmed: 20529998 pmcid: 2890034 doi: 10.1161/CIRCULATIONAHA.109.919829

Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6:S26-34.

pubmed: 19959140 doi: 10.1016/j.hrthm.2009.07.029

Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259:353–82.

pubmed: 10903529 doi: 10.1002/1097-0185(20000801)259:4<353::AID-AR10>3.0.CO;2-R

Patterson E, Lazzara R, Szabo B, Liu H, Tang D, Li YH, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47:1196–206.

pubmed: 16545652 doi: 10.1016/j.jacc.2005.12.023

Lemola K, Chartier D, Yeh YH, Dubuc M, Cartier R, Armour A, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation. 2008;117:470–7.

pubmed: 18195170 doi: 10.1161/CIRCULATIONAHA.107.737023

Nishida K, Maguy A, Sakabe M, Comtois P, Inoue H, Nattel S. The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation. Cardiovasc Res. 2011;89:825–33.

pubmed: 20962102 doi: 10.1093/cvr/cvq332

Nishida K, Datino T, Macle L, Nattel S. Atrial fibrillation ablation: translating basic mechanistic insights to the patient. J Am Coll Cardiol. 2014;64:823–31.

pubmed: 25145528 doi: 10.1016/j.jacc.2014.06.1172

Stavrakis S, Nakagawa H, Po SS, Scherlag BJ, Lazzara R, Jackman WM. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015;1:1–13.

pubmed: 26301262 pmcid: 4540352 doi: 10.1016/j.jacep.2015.01.005

Katritsis DG, Pokushalov E, Romanov A, Giazitzoglou E, Siontis GC, Po SS, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62:2318–25.

pubmed: 23973694 doi: 10.1016/j.jacc.2013.06.053

Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Shirokova N, Karaskov A, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10:1280–6.

pubmed: 23608592 doi: 10.1016/j.hrthm.2013.04.016

Driessen AHG, Berger WR, Krul SPJ, van den Berg NWE, Neefs J, Piersma FR, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study. J Am Coll Cardiol. 2016;68:1155–65.

pubmed: 27609676 doi: 10.1016/j.jacc.2016.06.036

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.

pubmed: 19717844 doi: 10.1056/NEJMoa0905561

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.

pubmed: 21830957 doi: 10.1056/NEJMoa1009638

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.

pubmed: 21870978 doi: 10.1056/NEJMoa1107039

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–104.

pubmed: 24251359 doi: 10.1056/NEJMoa1310907

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials. Lancet. 2014;383:955–62.

pubmed: 24315724 doi: 10.1016/S0140-6736(13)62343-0

Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, et al. Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial. Eur Heart J. 2016;37:610–8.

pubmed: 26417061 doi: 10.1093/eurheartj/ehv501

Darkner S, Chen X, Hansen J, Pehrson S, Johannessen A, Nielsen JB, et al. Recurrence of arrhythmia following short-term oral amiodarone after catheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). Eur Heart J. 2014;35:3356–64.

pubmed: 25182250 doi: 10.1093/eurheartj/ehu354

Hayashi M, Miyauchi Y, Iwasaki YK, Yodogawa K, Tsuboi I, Uetake S, et al. Three-month lower-dose flecainide after catheter ablation of atrial fibrillation. Europace. 2014;16:1160–7.

pubmed: 24706088 doi: 10.1093/europace/euu041

Roux JF, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, et al. Antiarrhythmics after ablation of atrial fibrillation (5A study). Circulation. 2009;120:1036–40.

pubmed: 19738139 doi: 10.1161/CIRCULATIONAHA.108.839639

Leong-Sit P, Roux JF, Zado E, Callans DJ, Garcia F, Lin D, et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol. 2011;4:11–4.

pubmed: 21076158 doi: 10.1161/CIRCEP.110.955393

Gu J, Liu X, Tan H, Zhou L, Gu J, Jiang W, et al. Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation. Acta Cardiol. 2012;67:407–14.

pubmed: 22997994 doi: 10.1080/AC.67.4.2170681

Chen W, Liu H, Ling Z, Xu Y, Fan J, Du H, et al. Efficacy of short-term antiarrhythmic drugs use after catheter ablation of atrial fibrillation-a systematic review with metaanalyses and trial sequential analyses of randomized controlled trials. PLoS One. 2016;11: e0156121.

pubmed: 27224469 pmcid: 4880320 doi: 10.1371/journal.pone.0156121

Goldenberg GR, Burd D, Lodzinski P, Stabile G, Udell JA, Newman D, et al. Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success—a metaanalysis. J Interv Card Electrophysiol. 2016;47:171–6.

pubmed: 27357216 doi: 10.1007/s10840-016-0157-y

Deyell MW, Leather RA, Macle L, Forman J, Khairy P, Zhang R, et al. Efficacy and safety of same-day discharge for atrial fibrillation ablation. JACC Clin Electrophysiol. 2020;6:609–19.

pubmed: 32553209 doi: 10.1016/j.jacep.2020.02.009

Creta A, Ventrella N, Providência R, Earley MJ, Sporton S, Dhillon G, et al. Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach. J Cardiovasc Electrophysiol. 2020;31:3097–103.

pubmed: 33107171 doi: 10.1111/jce.14789

Kowalski M, Parikh V, Salcido JR, Chalfoun N, Albano A, O’Neill PG, et al. Same-day discharge after cryoballoon ablation of atrial fibrillation: a multicenter experience. J Cardiovasc Electrophysiol. 2021;32:183–90.

pubmed: 33345408 doi: 10.1111/jce.14843

Tang PT, Davies M, Bashir Y, Betts TR, Pedersen M, Rajappan K, et al. Efficacy and safety of same-day discharge after atrial fibrillation ablation compared with postprocedural overnight stay: a systematic review and metaanalysis. Europace. 2022;24:1569–84.

pubmed: 35640891 doi: 10.1093/europace/euac068

Jafry AH, Akhtar KH, Khan JA, Clifton S, Reese J, Sami KN, et al. Safety and feasibility of same-day discharge for catheter ablation of atrial fibrillation: a systematic review and metaanalysis. J Interv Card Electrophysiol. 2022;65:803–11.

pubmed: 35147827 doi: 10.1007/s10840-022-01145-9

Sangrigoli R, Harding J, Venkataraman G, Tomaiko-Clark E, Bai R, Su W. Randomized prospective evaluation of same-day discharge after cryoballoon ablation of atrial fibrillation: results of the EASY PVI study. J Interv Card Electrophysiol. 2023;66:1601–7.

pubmed: 36604354 doi: 10.1007/s10840-022-01465-w

Deyell MW, Hoskin K, Forman J, Laksman ZW, Hawkins NM, Bennett MT, et al. Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality. Europace. 2023;25:400–7.

pubmed: 36164922 doi: 10.1093/europace/euac170

Rajendra A, Osorio J, Diaz JC, Hoyos C, Rivera E, Matos CD, et al. Performance of the REAL-AF same-day discharge protocol in patients undergoing catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2023;9:1515–26.

pubmed: 37204358 doi: 10.1016/j.jacep.2023.04.014

Jimenez-Candil J, Hernandez Hernandez J, Cruz Galban A, Blanco F, Moriñigo JL, Sanchez García M, et al. Clinical and economic outcomes of a systematic same-day discharge programme after pulmonary vein isolation: comparison between cryoballoon vs radiofrequency ablation. Europace. 2023;25:euad265.

pubmed: 37669318 pmcid: 10498138 doi: 10.1093/europace/euad265

Zellerhoff S, Lenze F, Eckardt L. Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence? Europace. 2011;13:1219–21.

pubmed: 21561905 doi: 10.1093/europace/eur139

Yokoyama K, Nakagawa H, Seres KA, Jung E, Merino J, Zou Y, et al. Canine model of esophageal injury and atrial-esophageal fistula after applications of forward-firing high-intensity focused ultrasound and side-firing unfocused ultrasound in the left atrium and inside the pulmonary vein. Circ Arrhythm Electrophysiol. 2009;2:41–9.

pubmed: 19808443 doi: 10.1161/CIRCEP.108.807925

Cordes F, Ellermann C, Dechering DG, Frommeyer G, Kochhäuser S, Lange PS, et al. Preprocedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation. Sci Rep. 2021;11:4728.

pubmed: 33633186 pmcid: 7907235 doi: 10.1038/s41598-021-83928-0

Rolantova L, Bulava A, Eisenberger M, Chloubova I, Tothova V, Hanis J. Nurse-performed venous sheath removal in patients undergoing radiofrequency catheter ablation for atrial fibrillation: a randomised study. Eur J Cardiovasc Nurs. 2019;18:332–9.

pubmed: 30726109 doi: 10.1177/1474515119830297

Kewcharoen J, Shah K, Bhardwaj R, Contractor T, Turagam MK, Mandapati R, et al. Periprocedural outcomes of protamine administration after catheter ablation of atrial fibrillation. Rev Cardiovasc Med. 2022;23:34.

pubmed: 35092226 doi: 10.31083/j.rcm2301034

Chilukuri K, Henrikson CA, Dalal D, Scherr D, MacPherson EC, Cheng A, et al. Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2009;25:175–81.

pubmed: 19263201 doi: 10.1007/s10840-009-9364-0

Traullé S, Kubala M, Doucy A, Quenum S, Hermida JS. Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation. Europace. 2016;18:815–9.

pubmed: 26467404 doi: 10.1093/europace/euv266

Kumar V, Wish M, Venkataraman G, Bliden K, Jindal M, Strickberger A. A randomized comparison of manual pressure versus figure-of-eight suture for hemostasis after cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:2806–10.

pubmed: 31661171 doi: 10.1111/jce.14252

Aytemir K, Canpolat U, Yorgun H, Evranos B, Kaya EB, Şahiner ML, et al. Usefulness of ‘figure-of-eight’ suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2016;18:1545–50.

pubmed: 26705565 doi: 10.1093/europace/euv375

Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio David B, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures. JACC Clin Electrophysiol. 2020;6:111–24.

pubmed: 31971899 doi: 10.1016/j.jacep.2019.08.013

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:e1-160.

pubmed: 29016840 doi: 10.1093/europace/eux274

Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. 2013;173:149–56.

pubmed: 23266597 doi: 10.1001/jamainternmed.2013.1561

Bunch TJ, May HT, Bair TL, Weiss JP, Crandall BG, Osborn JS, et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm. 2013;10:1272–7.

pubmed: 23835257 doi: 10.1016/j.hrthm.2013.07.002

Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016;37:2478–87.

pubmed: 26984861 doi: 10.1093/eurheartj/ehw087

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261–74.

pubmed: 30874766 pmcid: 6450284 doi: 10.1001/jama.2019.0693

Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm. 2011;8:1416–23.

pubmed: 21699833 doi: 10.1016/j.hrthm.2011.04.022

Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129:2094–9.

pubmed: 24633881 doi: 10.1161/CIRCULATIONAHA.113.007825

Camen S, Ojeda FM, Niiranen T, Gianfagna F, Vishram-Nielsen JK, Costanzo S, et al. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality. Europace. 2020;22:522–9.

pubmed: 31740944 doi: 10.1093/europace/euz312

Romero J, Cerrud-Rodriguez RC, Diaz JC, Rodriguez D, Arshad S, Alviz I, et al. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and metaanalysis. J Cardiovasc Electrophysiol. 2019;30:1250–7.

pubmed: 31257677 doi: 10.1111/jce.14052

Proietti R, AlTurki A, Di Biase L, China P, Forleo G, Corrado A, et al. Anticoagulation after catheter ablation of atrial fibrillation: an unnecessary evil? A systematic review and metaanalysis. J Cardiovasc Electrophysiol. 2019;30:468–78.

pubmed: 30575175 doi: 10.1111/jce.13822

Liang JJ, Elafros MA, Mullen MT, Muser D, Hayashi T, Enriquez A, et al. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:823–32.

pubmed: 29513397 doi: 10.1111/jce.13476

Verma A, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, et al. The optimal anti-coagulation for enhanced-risk patients post-catheter ablation for atrial fibrillation (OCEAN) trial. Am Heart J. 2018;197:124–32.

pubmed: 29447772 doi: 10.1016/j.ahj.2017.12.007

Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–9.

pubmed: 22236222 doi: 10.1056/NEJMoa1105575

Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474–80.

pubmed: 19843914 doi: 10.1161/CIRCEP.109.849638

Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36:1660–8.

pubmed: 25908774 doi: 10.1093/eurheartj/ehv115

Waks JW, Passman RS, Matos J, Reynolds M, Thosani A, Mela T, et al. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: results from the tailored anticoagulation for non-continuous atrial fibrillation (TACTIC-AF) pilot study. Heart Rhythm. 2018;15:1601–7.

pubmed: 29981863 doi: 10.1016/j.hrthm.2018.06.027

Passman R, Leong-Sit P, Andrei AC, Huskin A, Tomson TT, Bernstein R, et al. Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the rhythm evaluation for anticoagulation with continuous monitoring (REACT.COM) pilot study. J Cardiovasc Electrophysiol. 2016;27:264–70.

pubmed: 26511221 doi: 10.1111/jce.12864

Barbhaiya CR, Kumar S, John RM, Tedrow UB, Koplan BA, Epstein LM, et al. Global survey of esophageal and gastric injury in atrial fibrillation ablation: incidence, time to presentation, and outcomes. J Am Coll Cardiol. 2015;65:1377–8.

pubmed: 25835452 doi: 10.1016/j.jacc.2014.12.053

Piccini JP, Braegelmann KM, Simma S, Koneru JN, Ellenbogen KA. Risk of atrioesophageal fistula with cryoballoon ablation of atrial fibrillation. Heart Rhythm. 2020;O2(1):173–9.

doi: 10.1016/j.hroo.2020.05.007

Tilz RR, Schmidt V, Pürerfellner H, Maury P, Chun KJ, Martinek M, et al. A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023;44:2458–69.

pubmed: 37062040 pmcid: 10344651 doi: 10.1093/eurheartj/ehad250

Barbhaiya Chirag R, Kumar S, Guo Y, Zhong J, John Roy M, Tedrow Usha B, et al. Global survey of esophageal injury in atrial fibrillation ablation. JACC Clin Electrophysiol. 2016;2:143–50.

pubmed: 29766863 doi: 10.1016/j.jacep.2015.10.013

Gandjbakhch E, Mandel F, Dagher Y, Hidden-Lucet F, Rollin A, Maury P. Incidence, epidemiology, diagnosis and prognosis of atriooesophageal fistula following percutaneous catheter ablation: a French nationwide survey. Europace. 2021;23:557–64.

pubmed: 33221901 doi: 10.1093/europace/euaa278

Della Rocca DG, Magnocavallo M, Natale VN, Gianni C, Mohanty S, Trivedi C, et al. Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2021;32:2441–50.

pubmed: 34260115 doi: 10.1111/jce.15168

Dagres N, Kottkamp H, Piorkowski C, Doll N, Mohr F, Horlitz M, et al. Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases. J Cardiovasc Electrophysiol. 2006;17:1213–5.

pubmed: 16987382 doi: 10.1111/j.1540-8167.2006.00611.x

Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol. 2009;20:1014–9.

pubmed: 19490383 doi: 10.1111/j.1540-8167.2009.01493.x

Arbelo E, Brugada J, Blomström-Lundqvist C, Laroche C, Kautzner J, Pokushalov E, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38:1303–16.

pubmed: 28104790

Markar SR, Koehler R, Low DE, Ross A. Novel multimodality endoscopic closure of postoperative esophageal fistula. Int J Surg Case Rep. 2012;3:577–9.

pubmed: 22943885 pmcid: 3437386 doi: 10.1016/j.ijscr.2012.08.001

Kapur S, Barbhaiya C, Deneke T, Michaud GF. Esophageal injury and atrioesophageal fistula caused by ablation for atrial fibrillation. Circulation. 2017;136:1247–55.

pubmed: 28947480 doi: 10.1161/CIRCULATIONAHA.117.025827

Ugata Y, Michihata N, Matsui H, Fushimi K, Yasunaga H. Impact of proton pump inhibitors on mortality and severe esophageal injury after catheter ablation for atrial fibrillation: a nationwide retrospective study using propensity score matching. Heart Vessels. 2021;36:1730–8.

pubmed: 33929573 doi: 10.1007/s00380-021-01860-9

Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60:1790–6.

pubmed: 23040570 doi: 10.1016/j.jacc.2012.07.031

Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11:620–8.

pubmed: 24508207 doi: 10.1016/j.hrthm.2014.02.002

Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J Am Coll Cardiol. 2010;56:1463–72.

pubmed: 20951321 doi: 10.1016/j.jacc.2010.04.057

Kim YR, Nam GB, Han S, Kim SH, Kim KH, Lee S, et al. Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2015;8:1366–72.

pubmed: 26541350 doi: 10.1161/CIRCEP.115.002957

Iskandar S, Reddy M, Afzal MR, Rajasingh J, Atoui M, Lavu M, et al. Use of oral steroid and its effects on atrial fibrillation recurrence and inflammatory cytokines post ablation – the steroid AF study. J Atr Fibrillation. 2017;9:1604.

pubmed: 29250282 pmcid: 5673398 doi: 10.4022/jafib.1604

Kim DR, Won H, Uhm JS, Kim JY, Sung JH, Pak HN, et al. Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation. Yonsei Med J. 2015;56:324–31.

pubmed: 25683977 pmcid: 4329340 doi: 10.3349/ymj.2015.56.2.324

Won H, Kim JY, Shim J, Uhm JS, Pak HN, Lee MH, et al. Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation. Circ J. 2013;77:53–9.

pubmed: 23006726 doi: 10.1253/circj.CJ-12-0728

Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006;17:134–9.

pubmed: 16533249 doi: 10.1111/j.1540-8167.2006.00359.x

Janse PA, van Belle YL, Theuns DA, Rivero-Ayerza M, Scholten MF, Jordaens LJ. Symptoms versus objective rhythm monitoring in patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation. Eur J Cardiovasc Nurs. 2008;7:147–51.

pubmed: 17942370 doi: 10.1016/j.ejcnurse.2007.08.004

Piorkowski C, Kottkamp H, Tanner H, Kobza R, Nielsen JC, Arya A, et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16:1286–92.

pubmed: 16403058 doi: 10.1111/j.1540-8167.2005.00245.x

Klemm HU, Ventura R, Rostock T, Brandstrup B, Risius T, Meinertz T, et al. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2006;17:146–50.

pubmed: 16533251 doi: 10.1111/j.1540-8167.2005.00288.x

Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakaramenon S, Mairesse GH, et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm. 2012;9:1241–6.

pubmed: 22440154 doi: 10.1016/j.hrthm.2012.03.017

Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3:141–7.

pubmed: 20160169 doi: 10.1161/CIRCEP.109.877852

Xing LY, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Olesen MS, et al. Electrocardiographic markers of subclinical atrial fibrillation detected by implantable loop recorder: insights from the LOOP Study. Europace. 2023;25:euad014.

Charitos EI, Ziegler PD, Stierle U, Graf B, Sievers HH, Hanke T. Long-term outcomes after surgical ablation for atrial fibrillation in patients with continuous heart rhythm monitoring devices. Interact Cardiovasc Thorac Surg. 2015;21:712–21.

pubmed: 26362625

Perez-Castellano N, Fernandez-Cavazos R, Moreno J, Canadas V, Conde A, Gonzalez-Ferrer JJ, et al. The COR trial: a randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation. Heart Rhythm. 2014;11:8–14.

pubmed: 24103221 doi: 10.1016/j.hrthm.2013.10.014

Kapa S, Epstein AE, Callans DJ, Garcia FC, Lin D, Bala R, et al. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol. 2013;24:875–81.

pubmed: 23577826 doi: 10.1111/jce.12141

Damiano RJ Jr, Lawrance CP, Saint LL, Henn MC, Sinn LA, Kruse J, et al. Detection of atrial fibrillation after surgical ablation: conventional versus continuous monitoring. Ann Thorac Surg. 2016;101:42–7; discussion 47–8.

Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384:305–15.

pubmed: 33197159 doi: 10.1056/NEJMoa2029980

Goldenthal IL, Sciacca RR, Riga T, Bakken S, Baumeister M, Biviano AB, et al. Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results. J Cardiovasc Electrophysiol. 2019;30:2220–8.

pubmed: 31507001 pmcid: 6819233 doi: 10.1111/jce.14160

Tarakji KG, Wazni OM, Callahan T, Kanj M, Hakim AH, Wolski K, et al. Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study. Heart Rhythm. 2015;12:554–9.

pubmed: 25460854 doi: 10.1016/j.hrthm.2014.11.015

Rizas KD, Freyer L, Sappler N, von Stülpnagel L, Spielbichler P, Krasniqi A, et al. Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial. Nat Med. 2022;28:1823–30.

pubmed: 36031651 doi: 10.1038/s41591-022-01979-w

Svennberg E, Tjong F, Goette A, Akoum N, Di Biase L, Bordachar P, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022;24:979–1005.

pubmed: 35368065 doi: 10.1093/europace/euac038

Lambert CT, Patel D, Bumgarner JM, Kanj M, Cantillon D, Saliba W, et al. Atrial fibrillation future clinic. Novel platform to integrate smart device electrocardiogram into clinical practice. Cardiovasc Digit Health J. 2021;2:92–100.

pubmed: 35265896 pmcid: 8890049 doi: 10.1016/j.cvdhj.2021.02.002

Hermans ANL, Gawalko M, Pluymaekers N, Dinh T, Weijs B, van Mourik MJW, et al. Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation. Int J Cardiol. 2021;329:105–12.

pubmed: 33412184 doi: 10.1016/j.ijcard.2020.12.077

Gawałko M, Duncker D, Manninger M, van der Velden RMJ, Hermans ANL, Verhaert DVM, et al. The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences. Europace. 2021;23:1003–15.

pubmed: 33822029 pmcid: 8083545 doi: 10.1093/europace/euab050

Unni RR, Prager RT, Odabashian R, Zhang JJ, Fat Hing NN, Nery PB, et al. Rhythm-monitoring strategy and arrhythmia recurrence in atrial fibrillation ablation trials: a systematic review. CJC Open. 2022;4:488–96.

pubmed: 35607484 pmcid: 9123375 doi: 10.1016/j.cjco.2022.02.001

Andrade JG, Khairy P, Verma A, Guerra PG, Dubuc M, Rivard L, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35:106–16.

pubmed: 22054110 doi: 10.1111/j.1540-8159.2011.03256.x

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20:157–208.

pubmed: 29016841 doi: 10.1093/europace/eux275

Gottlieb LA, Dekker LRC, Coronel R. The blinding period following ablation therapy for atrial fibrillation: proarrhythmic and antiarrhythmic pathophysiological mechanisms. JACC Clin Electrophysiol. 2021;7:416–30.

pubmed: 33736761 doi: 10.1016/j.jacep.2021.01.011

Opacic D, van Bragt KA, Nasrallah HM, Schotten U, Verheule S. Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation. Cardiovasc Res. 2016;109:527–41.

pubmed: 26786160 doi: 10.1093/cvr/cvw007

Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:83–9.

pubmed: 24446024 doi: 10.1161/CIRCEP.113.000876

Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol. 2012;101:217–25.

pubmed: 22102100 doi: 10.1007/s00392-011-0383-3

Sepehri Shamloo A, Bollmann A, Dagres N, Hindricks G, Arya A. Natriuretic peptides: biomarkers for atrial fibrillation management. Clin Res Cardiol. 2020;109:957–66.

pubmed: 32002634 doi: 10.1007/s00392-020-01608-x

Liang JJ, Dixit S, Santangeli P. Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation. World J Cardiol. 2016;8:638–46.

pubmed: 27957250 pmcid: 5124722 doi: 10.4330/wjc.v8.i11.638

Grégoire JM, Gilon C, Carlier S, Bersini H. Role of the autonomic nervous system and premature atrial contractions in short-term paroxysmal atrial fibrillation forecasting: insights from machine learning models. Arch Cardiovasc Dis. 2022;115:377–87.

pubmed: 35672220 doi: 10.1016/j.acvd.2022.04.006

Scherschel K, Hedenus K, Jungen C, Lemoine MD, Rübsamen N, Veldkamp MW, et al. Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation. Sci Transl Med. 2019;11:eaav7770.

pubmed: 31118294 doi: 10.1126/scitranslmed.aav7770

Sasaki N, Okumura Y, Watanabe I, Nagashima K, Sonoda K, Kogawa R, et al. Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation. Int J Cardiol. 2014;176:1064–6.

pubmed: 25129276 doi: 10.1016/j.ijcard.2014.07.138

McGann C, Kholmovski E, Blauer J, Vijayakumar S, Haslam T, Cates J, et al. Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation. J Am Coll Cardiol. 2011;58:177–85.

pubmed: 21718914 pmcid: 3746015 doi: 10.1016/j.jacc.2011.04.008

Peters DC, Wylie JV, Hauser TH, Nezafat R, Han Y, Woo JJ, et al. Recurrence of atrial fibrillation correlates with the extent of postprocedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging. 2009;2:308–16.

pubmed: 19356576 pmcid: 2703450 doi: 10.1016/j.jcmg.2008.10.016

Steinberg C, Champagne J, Deyell MW, Dubuc M, Leong-Sit P, Calkins H, et al. Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the cryoballoon vs irrigated radiofrequency catheter ablation (CIRCA-DOSE) study. Heart Rhythm. 2021;18:1463–70.

pubmed: 34126269 doi: 10.1016/j.hrthm.2021.06.1172

Charitakis E, Metelli S, Karlsson LO, Antoniadis AP, Rizas KD, Liuba I, et al. Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: a network metaanalysis. BMC Med. 2022;20:193.

pubmed: 35637488 pmcid: 9153169 doi: 10.1186/s12916-022-02385-2

Andrade JG, Khairy P, Verma A, Guerra PG, Dubuc M, Rivard L, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35:106–16.

pubmed: 22054110 doi: 10.1111/j.1540-8159.2011.03256.x

Baimbetov AK, Bizhanov KA, Jukenova AM, Aubakirova AT, Ualiyeva AY, Sagatov IY. Comparative effectiveness and safety of cryoablation versus radiofrequency ablation treatments for persistent atrial fibrillation. Am J Cardiol. 2022;184:22–30.

pubmed: 36184349 doi: 10.1016/j.amjcard.2022.08.031

Choi J-H, Kwon H-J, Kim HR, Park S-J, Kim JS, On YK, et al. Electrocardiographic predictors of early recurrence of atrial fibrillation. Ann Noninvasive Electrocardiol. 2021;26: e12884.

pubmed: 34333816 pmcid: 8588373 doi: 10.1111/anec.12884

Ribeiro Da Silva M, Santos Silva G, Ribeiro Queiros P, Teixeira R, Almeida J, Fonseca P, et al. Predictors of early and late recurrence of atrial fibrillation after catheter ablation: two sides of the same coin? Eur Heart J. 2021;42:ehab724.

doi: 10.1093/eurheartj/ehab724.0527

Kim Yun G, Boo Ki Y, Choi J-I, Choi Yun Y, Choi Ha Y, Roh S-Y, et al. Early recurrence is reliable predictor of late recurrence after radiofrequency catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2021;7:343–51.

pubmed: 33516711 doi: 10.1016/j.jacep.2020.09.029

Calkins H, Gache L, Frame D, Boo LM, Ghaly N, Schilling R, et al. Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period. Heart Rhythm. 2021;18:366–73.

pubmed: 33242668 doi: 10.1016/j.hrthm.2020.11.020

Filipovic K, Dittrich S, Scheurlen C, Arica Z, Erlhoefer S, Woermann J, et al. Validation of seven risk scores in a prospective and independent cohort: the challenge of predicting recurrence after atrial fibrillation ablation. Europace. 2022;24:euac053.191.

doi: 10.1093/europace/euac053.191

Dretzke J, Chuchu N, Agarwal R, Herd C, Chua W, Fabritz L, et al. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace. 2020;22:748–60.

pubmed: 32227238 pmcid: 7203634 doi: 10.1093/europace/euaa041

Winkle RA, Jarman JW, Mead RH, Engel G, Kong MH, Fleming W, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13:2119–25.

pubmed: 27435586 doi: 10.1016/j.hrthm.2016.07.018

Kornej J, Hindricks G, Arya A, Sommer P, Husser D, Bollmann A. The APPLE score – a novel score for the prediction of rhythm outcomes after repeat catheter ablation of atrial fibrillation. PLOS ONE. 2017;12: e0169933.

pubmed: 28085921 pmcid: 5235369 doi: 10.1371/journal.pone.0169933

Jud FN, Obeid S, Duru F, Haegeli LM. A novel score in the prediction of rhythm outcome after ablation of atrial fibrillation: the SUCCESS score. Anatol J Cardiol. 2019;21:142–9.

pubmed: 30821714 pmcid: 6457407

Mesquita J, Ferreira AM, Cavaco D, Moscoso Costa F, Carmo P, Marques H, et al. Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure – ATLAS score. Europace. 2018;20:f428-35.

pubmed: 29016770 doi: 10.1093/europace/eux265

Nielsen JC, Lin Y-J, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace. 2020;22:1147–8.

pubmed: 32538434 pmcid: 7400488 doi: 10.1093/europace/euaa065

Lee S-H, Tai C-T, Hsieh M-H, Tsai C-F, Lin Y-K, Tsao H-M, et al. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2004;10:221–6.

pubmed: 15133358 doi: 10.1023/B:JICE.0000026915.02503.92

Kuck K-H, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation–German atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol. 2016;9: e003337.

pubmed: 26763226 doi: 10.1161/CIRCEP.115.003337

Liu H, Yuan P, Zhu X, Fu L, Hong K, Hu J. Is atrial fibrillation noninducibility by burst pacing after catheter ablation associated with reduced clinical recurrence? A systematic review and meta-analysis. J Am Heart Assoc. 2020;9: e015260.

pubmed: 32654581 pmcid: 7660710 doi: 10.1161/JAHA.119.015260

Okada M, Inoue K, Tanaka N, Masuda M, Furukawa Y, Hirata A, et al. Reappraising the role of baseline plasma C-reactive protein levels on recurrence after catheter ablation of persistent atrial fibrillation: insight from EARNEST-PVI trial. Eur Heart J. 2021;42(ehab724):0507.

Charalampidis P, Teperikidis E, Boulmpou A, Papadopoulos CE, Potoupni V, Tsioni K, et al. Homocysteine as a predictor of paroxysmal atrial fibrillation-related events: a scoping review of the literature. Diagnostics. 2022;12:2192.

pubmed: 36140593 pmcid: 9498051 doi: 10.3390/diagnostics12092192

Liang JJ, Elafros MA, Chik WW, Santangeli P, Zado ES, Frankel DS, et al. Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: timing and frequency of early recurrences predicts long-term ablation success. Heart Rhythm. 2015;12:2461–8.

pubmed: 26187447 doi: 10.1016/j.hrthm.2015.07.015

Amankwah NA, Pothineni NVK, Guandalini G, Santangeli P, Schaller R, Supple GE, et al. Impact of atrial fibrillation recurrences during the blanking period following catheter ablation on long-term arrhythmia-free survival: a prospective study with continuous monitoring. J Interv Card Electrophysiol. 2022;65:519–25.

pubmed: 35794440 doi: 10.1007/s10840-022-01291-0

Mugnai G, de Asmundis C, Hünük B, Ströker E, Velagic V, Moran D, et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences. Heart Rhythm. 2016;13:845–51.

pubmed: 26724490 doi: 10.1016/j.hrthm.2015.12.034

Stabile G, Iacopino S, Verlato R, Arena G, Pieragnoli P, Molon G, et al. Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation. Europace. 2020;22:1798–804.

pubmed: 33006599 doi: 10.1093/europace/euaa239

Willems S, Khairy P, Andrade JG, Hoffmann BA, Levesque S, Verma A, et al. Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (adenosine following pulmonary vein isolation to target dormant conduction elimination) trial. Circ Arrhythm Electrophysiol. 2016;9: e003909.

pubmed: 27516462 doi: 10.1161/CIRCEP.115.003909

Alipour P, Azizi Z, Pirbaglou M, Ritvo P, Pantano A, Verma A, et al. Defining blanking period post-pulmonary vein antrum isolation. JACC Clin Electrophysiol. 2017;3:568–76.

pubmed: 29759429 doi: 10.1016/j.jacep.2017.01.006

Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008;5:679–85.

pubmed: 18325850 doi: 10.1016/j.hrthm.2008.01.031

Noujaim C, Lim C, Mekhael M, Feng H, Chouman N, Younes H, et al. Identifying the prognostic significance of early arrhythmia recurrence during the blanking period and the optimal blanking period duration: insights from the DECAAF II study. Europace. 2023;25:euad173.

pubmed: 37337683 pmcid: 10292951 doi: 10.1093/europace/euad173

Cosio FG, Aliot E, Botto GL, Heidbüchel H, Geller CJ, Kirchhof P, et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace. 2007;10:21–7.

pubmed: 18086696 doi: 10.1093/europace/eum276

Chilukuri K, Dukes J, Dalal D, Marine JE, Henrikson CA, Scherr D, et al. Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:27–32.

pubmed: 19793148 doi: 10.1111/j.1540-8167.2009.01593.x

Ebert M, Stegmann C, Kosiuk J, Dinov B, Richter S, Arya A, et al. Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation. Europace. 2018;20:1428–34.

pubmed: 29165582 doi: 10.1093/europace/eux327

Dong Z, Du X, Hou XX, He L, Dong JZ, Ma CS. Effect of electrical cardioversion on 1-year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation. Clin Cardiol. 2021;44:1128–38.

pubmed: 34101841 pmcid: 8364725 doi: 10.1002/clc.23663

Malasana G, Day JD, Weiss JP, Crandall BG, Bair TL, May HT, et al. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:761–6.

pubmed: 21385263 doi: 10.1111/j.1540-8167.2010.02005.x

Sponga S, Leoni L, Buja G, Nalli C, Voisine P, Gerosa G. Role of an aggressive rhythm control strategy on sinus rhythm maintenance following intraoperative radiofrequency ablation of atrial fibrillation in patients undergoing surgical correction of valvular disease. J Cardiol. 2012;60:316–20.

pubmed: 22898332 doi: 10.1016/j.jjcc.2012.07.003

Baman TS, Gupta SK, Billakanty SR, Ilg KJ, Good E, Crawford T, et al. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome. J Cardiovasc Electrophysiol. 2009;20:1321–5.

pubmed: 19602031 doi: 10.1111/j.1540-8167.2009.01553.x

Lellouche N, Jaïs P, Nault I, Wright M, Bevilacqua M, Knecht S, et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol. 2008;19:599–605.

pubmed: 18462321 doi: 10.1111/j.1540-8167.2008.01188.x

Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter sustained treatment of paroxysmal atrial fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol. 2014;7:69–75.

pubmed: 24446022 doi: 10.1161/CIRCEP.113.000586

Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (atrial fibrillation better care) pathway. Am J Med. 2018;131:1359-66.e6.

pubmed: 30153428 doi: 10.1016/j.amjmed.2018.06.012

Rivera-Caravaca JM, Roldán V, Martínez-Montesinos L, Vicente V, Lip GYH, Marín F. The atrial fibrillation better care (ABC) pathway and clinical outcomes in patients with atrial fibrillation: the prospective murcia AF project phase II cohort. J Gen Intern Med. 2023;38:315–23.

pubmed: 35411538 doi: 10.1007/s11606-022-07567-5

Kotalczyk A, Guo Y, Stefil M, Wang Y, Lip GYH. Effects of the atrial fibrillation better care pathway on outcomes among clinically complex Chinese patients with atrial fibrillation with multimorbidity and polypharmacy: a report from the ChiOTEAF registry. J Am Heart Assoc. 2022;11: e024319.

pubmed: 35377169 pmcid: 9075471 doi: 10.1161/JAHA.121.024319

Patel SM, Palazzolo MG, Murphy SA, Antman EM, Braunwald E, Lanz HJ, et al. Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. Europace. 2022;24:1730–8.

pubmed: 36017608 doi: 10.1093/europace/euac082

Stevens D, Harrison SL, Kolamunnage-Dona R, Lip GYH, Lane DA. The atrial fibrillation better care pathway for managing atrial fibrillation: a review. Europace. 2021;23:1511–27.

pubmed: 34125202 pmcid: 8502499 doi: 10.1093/europace/euab092

Proietti M, Lip GYH, Laroche C, Fauchier L, Marin F, Nabauer M, et al. Relation of outcomes to ABC (atrial fibrillation better care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) registry. Europace. 2021;23:174–83.

pubmed: 33006613 doi: 10.1093/europace/euaa274

Gerstenfeld EP, Callans DJ, Dixit S, Russo AM, Nayak H, Lin D, et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation. 2004;110:1351–7.

pubmed: 15353501 doi: 10.1161/01.CIR.0000141369.50476.D3

Chugh A, Oral H, Good E, Han J, Tamirisa K, Lemola K, et al. Catheter ablation of atypical atrial flutter and atrial tachycardia within the coronary sinus after left atrial ablation for atrial fibrillation. J Am Coll Cardiol. 2005;46:83–91.

pubmed: 15992640 doi: 10.1016/j.jacc.2005.03.053

Deisenhofer I, Estner H, Zrenner B, Schreieck J, Weyerbrock S, Hessling G, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace. 2006;8:573–82.

pubmed: 16864612 doi: 10.1093/europace/eul077

Gerstenfeld EP, Callans DJ, Sauer W, Jacobson J, Marchlinski FE. Reentrant and nonreentrant focal left atrial tachycardias occur after pulmonary vein isolation. Heart Rhythm. 2005;2:1195–202.

pubmed: 16253909 doi: 10.1016/j.hrthm.2005.08.020

Gerstenfeld EP, Marchlinski FE. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm. 2007;4:S65-72.

pubmed: 17336888 doi: 10.1016/j.hrthm.2007.01.024

Lim TW, Koay CH, McCall R, See VA, Ross DL, Thomas SP. Atrial arrhythmias after single-ring isolation of the posterior left atrium and pulmonary veins for atrial fibrillation: mechanisms and management. Circ Arrhythm Electrophysiol. 2008;1:120–6.

pubmed: 19808402 doi: 10.1161/CIRCEP.108.769752

Anousheh R, Sawhney NS, Panutich M, Tate C, Chen WC, Feld GK. Effect of mitral isthmus block on development of atrial tachycardia following ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2010;33:460–8.

pubmed: 19954501 doi: 10.1111/j.1540-8159.2009.02625.x

Wasmer K, Monnig G, Bittner A, Dechering D, Zellerhoff S, Milberg P, et al. Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation. Heart Rhythm. 2012;9:1660–6.

pubmed: 22683745 doi: 10.1016/j.hrthm.2012.06.007

Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005;111:2875–80.

pubmed: 15927974 doi: 10.1161/CIRCULATIONAHA.104.491530

Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation. 2005;111:127–35.

pubmed: 15623542 doi: 10.1161/01.CIR.0000151289.73085.36

Yamashita S, Takigawa M, Denis A, Derval N, Sakamoto Y, Masuda M, et al. Pulmonary vein-gap reentrant atrial tachycardia following atrial fibrillation ablation: an electrophysiological insight with high-resolution mapping. Europace. 2019;21:1039–47.

pubmed: 30891597 doi: 10.1093/europace/euz034

Wojcik M, Berkowitsch A, Zaltsberg S, Hamm CW, Pitschner HF, Kuniss M, et al. Predictors of early and late left atrial tachycardia and left atrial flutter after catheter ablation of atrial fibrillation: long-term follow-up. Cardiol J. 2015;22:557–66.

pubmed: 26202652 doi: 10.5603/CJ.a2015.0040

Mesas CE, Pappone C, Lang CC, Gugliotta F, Tomita T, Vicedomini G, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol. 2004;44:1071–9.

pubmed: 15337221 doi: 10.1016/j.jacc.2004.05.072

Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007;115:2606–12.

pubmed: 17502567 doi: 10.1161/CIRCULATIONAHA.107.691386

Mikhaylov EN, Bhagwandien R, Janse PA, Theuns DA, Szili-Torok T. Regular atrial tachycardias developing after cryoballoon pulmonary vein isolation: incidence, characteristics, and predictors. Europace. 2013;15:1710–7.

pubmed: 23689485 doi: 10.1093/europace/eut129

Hermida A, Kubala M, Traulle S, Buiciuc O, Quenum S, Hermida JS. Prevalence and predictive factors of left atrial tachycardia occurring after second-generation cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:46–54.

pubmed: 29024212 doi: 10.1111/jce.13364

Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423–7.

pubmed: 26757058 doi: 10.1111/jce.12924

Lyan E, Yalin K, Abdin A, Sawan N, Liosis S, Lange SA, et al. Mechanism, underlying substrate and predictors of atrial tachycardia following atrial fibrillation ablation using the second-generation cryoballoon. J Cardiol. 2019;73:497–506.

pubmed: 30878353 doi: 10.1016/j.jjcc.2019.02.006

Julia J, Chierchia GB, de Asmundis C, Mugnai G, Sieira J, Ciconte G, et al. Regular atrial tachycardias following pulmonary vein isolation for paroxysmal atrial fibrillation: a retrospective comparison between the cryoballoon and conventional focal tip radiofrequency techniques. J Interv Card Electrophysiol. 2015;42:161–9.

pubmed: 25597847 doi: 10.1007/s10840-014-9961-4

Akerstrom F, Bastani H, Insulander P, Schwieler J, Arias MA, Jensen-Urstad M. Comparison of regular atrial tachycardia incidence after circumferential radiofrequency versus cryoballoon pulmonary vein isolation in real-life practice. J Cardiovasc Electrophysiol. 2014;25:948–52.

pubmed: 24698206 doi: 10.1111/jce.12423

Van Belle Y, Knops P, Janse P, Rivero-Ayerza M, Jessurun E, Szili-Torok T, et al. Electro-anatomical mapping of the left atrium before and after cryothermal balloon isolation of the pulmonary veins. J Interv Card Electrophysiol. 2009;25:59–65.

pubmed: 19148721 doi: 10.1007/s10840-008-9344-9

Kenigsberg DN, Martin N, Lim HW, Kowalski M, Ellenbogen KA. Quantification of the cryoablation zone demarcated by pre- and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2015;12:283–90.

pubmed: 25460865 doi: 10.1016/j.hrthm.2014.11.012

Gopinathannair R, Mar PL, Afzal MR, Di Biase L, Tu Y, Lakkireddy T, et al. Atrial tachycardias after surgical atrial fibrillation ablation: clinical characteristics, electrophysiological mechanisms, and ablation outcomes from a large, multicenter study. JACC Clin Electrophysiol. 2017;3:865–74.

pubmed: 29759784 doi: 10.1016/j.jacep.2017.02.018

Huo Y, Schoenbauer R, Richter S, Rolf S, Sommer P, Arya A, et al. Atrial arrhythmias following surgical AF ablation: electrophysiological findings, ablation strategies, and clinical outcome. J Cardiovasc Electrophysiol. 2014;25:725–38.

pubmed: 24602079 doi: 10.1111/jce.12406

Takigawa M, Derval N, Frontera A, Martin R, Yamashita S, Cheniti G, et al. Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: implications for ablation. Heart Rhythm. 2018;15:326–33.

pubmed: 29081399 doi: 10.1016/j.hrthm.2017.10.029

Pascale P, Shah AJ, Roten L, Scherr D, Komatsu Y, Jadidi AS, et al. Pattern and timing of the coronary sinus activation to guide rapid diagnosis of atrial tachycardia after atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2013;6:481–90.

pubmed: 23629735 doi: 10.1161/CIRCEP.113.000182

Arroyo RC, Latcu DG, Maeda S, Kubala M, Santangeli P, Garcia FC, et al. Coronary sinus activation and ECG characteristics of roof-dependent left atrial flutter after pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2018;11: e005948.

doi: 10.1161/CIRCEP.117.005948

Vlachos K, Efremidis M, Derval N, Martin CA, Takigawa M, Bazoukis G, et al. Use of high-density activation and voltage mapping in combination with entrainment to delineate gap-related atrial tachycardias post atrial fibrillation ablation. Europace. 2021;23:1052–62.

pubmed: 33564832 doi: 10.1093/europace/euaa394

Sundaram S, Choe W, Ryan Jordan J, Mullins N, Boorman C, Kessler EJ, et al. Catheter ablation of atypical atrial flutter: a novel 3D anatomic mapping approach to quickly localize and terminate atypical atrial flutter. J Interv Card Electrophysiol. 2017;49:307–18.

pubmed: 28664343 doi: 10.1007/s10840-017-0269-z

Luik A, Schmidt K, Haas A, Unger L, Tzamalis P, Brüggenjürgen B. Ablation of left atrial tachycardia following catheter ablation of atrial fibrillation: 12-month success rates. J Clin Med. 2022;11:1047.

pubmed: 35207318 pmcid: 8874450 doi: 10.3390/jcm11041047

Lupercio F, Lin AY, Aldaas OM, Romero J, Briceno D, Hoffmayer KS, et al. Role of adjunctive posterior wall isolation in patients undergoing atrial fibrillation ablation: a systematic review and metaanalysis. J Interv Card Electrophysiol. 2020;58:77–86.

pubmed: 31673901 doi: 10.1007/s10840-019-00634-8

Kim MY, Coyle C, Tomlinson DR, Sikkel MB, Sohaib A, Luther V, et al. Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study. Heart Rhythm. 2022;19:516–24.

pubmed: 34915187 pmcid: 8976158 doi: 10.1016/j.hrthm.2021.12.010

Gianni C, Mohanty S, Di Biase L, Metz T, Trivedi C, Gokoglan Y, et al. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016;13:830–5.

pubmed: 26706193 doi: 10.1016/j.hrthm.2015.12.028

Perera KS, Sharma M, Connolly SJ, Wang J, Gold MR, Hohnloser SH, et al. Stroke type and severity in patients with subclinical atrial fibrillation: an analysis from the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial (ASSERT). Am Heart J. 2018;201:160–3.

pubmed: 29764671 doi: 10.1016/j.ahj.2018.03.027

Andrade JG, Deyell MW, Macle L, Steinberg JS, Glotzer TV, Hawkins NM, et al. Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study. Eur Heart J. 2023;44:765–76.

pubmed: 36459112 doi: 10.1093/eurheartj/ehac692

Blomstrom-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kenneback G, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. JAMA. 2019;321:1059–68.

pubmed: 30874754 pmcid: 6439911 doi: 10.1001/jama.2019.0335

Brachmann J, Sohns C, Andresen D, Siebels J, Sehner S, Boersma L, et al. Atrial fibrillation burden and clinical outcomes in heart failure: the CASTLE-AF trial. JACC Clin Electrophysiol. 2021;7:594–603.

pubmed: 33640355 doi: 10.1016/j.jacep.2020.11.021

Kuck KH, Lebedev DS, Mikhaylov EN, Romanov A, Geller L, Kalejs O, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23:362–9.

pubmed: 33330909 doi: 10.1093/europace/euaa298

Packer D, Monahan K, Piccini J, Al-Khalidi H, Silverstein A, Poole J, et al. Impact of treatment strategies for AF on the progression and regression of AF type in the CABANA trial. Eur Heart J. 2020;41:ehaa946.0680.

doi: 10.1093/ehjci/ehaa946.0680

Gupta D, Vijgen J, Potter T, Scherr D, Van Herendael H, Knecht S, et al. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation. Heart. 2021;107:1296–302.

pubmed: 33952593 doi: 10.1136/heartjnl-2020-318676

Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1275–85.

pubmed: 30874716 pmcid: 6450275 doi: 10.1001/jama.2019.0692

Samuel M, Khairy P, Champagne J, Deyell MW, Macle L, Leong-Sit P, et al. Association of atrial fibrillation burden with health-related quality of life after atrial fibrillation ablation: substudy of the cryoballoon vs contact-force atrial fibrillation ablation (CIRCA-DOSE) randomized clinical trial. JAMA Cardiol. 2021;6:1324–8.

pubmed: 34406350 doi: 10.1001/jamacardio.2021.3063

Wazni O, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, et al. Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy. Heart Rhythm. 2022;19:197–205.

pubmed: 34666139 doi: 10.1016/j.hrthm.2021.10.009

Wu L, Narasimhan B, Ho KS, Zheng Y, Shah AN, Kantharia BK. Safety and complications of catheter ablation for atrial fibrillation: predictors of complications from an updated analysis the national inpatient database. J Cardiovasc Electrophysiol. 2021;32:1024–34.

pubmed: 33650749 doi: 10.1111/jce.14979

Ngo L, Ali A, Ganesan A, Woodman R, Adams R, Ranasinghe I. Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022;8:398–408.

pubmed: 34982824 doi: 10.1093/ehjqcco/qcab102

Benali K, Khairy P, Hammache N, Petzl A, Da Costa A, Verma A, et al. Procedure-related complications of catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2023;81:2089–99.

pubmed: 37225362 doi: 10.1016/j.jacc.2023.03.418

Hsu JC, Darden D, Du C, Marine JE, Nichols S, Marcus GM, et al. Initial findings from the national cardiovascular data registry of atrial fibrillation ablation procedures. J Am Coll Cardiol. 2023;81:867–78.

pubmed: 36858707 doi: 10.1016/j.jacc.2022.11.060

König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, et al. In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. Eur Heart J. 2018;39:3947–57.

pubmed: 30165430 doi: 10.1093/eurheartj/ehy528

Mszar R, Friedman DJ, Ong E, Du C, Wang Y, Zeitler EP, et al. Sex-based differences in atrial fibrillation ablation adverse events. Heart. 2023;109:595–605.

pubmed: 36104219 doi: 10.1136/heartjnl-2022-321192

Forleo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9:613–20.

pubmed: 17636302 doi: 10.1093/europace/eum144

Ngo L, Ali A, Ganesan A, Woodman R, Adams R, Ranasinghe I. Gender differences in complications following catheter ablation of atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2021;7:458–67.

pubmed: 33963402 doi: 10.1093/ehjqcco/qcab035

Tonchev IR, Nam MCY, Gorelik A, Kumar S, Haqqani H, Sanders P, et al. Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and metaanalysis. Europace. 2021;23:1024–32.

pubmed: 33595063 doi: 10.1093/europace/euaa415

Cheung JW, Yeo I, Cheng EP, Ip JE, Thomas G, Liu CF, et al. Inpatient hospital procedural volume and outcomes following catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31:1908–19.

pubmed: 32449825 doi: 10.1111/jce.14584

Mörtsell D, Arbelo E, Dagres N, Brugada J, Laroche C, Trines SA, et al. Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry. Europace. 2019;21:581–9.

pubmed: 30376055 doi: 10.1093/europace/euy239

Buiatti A, von Olshausen G, Barthel P, Schneider S, Luik A, Kaess B, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated metaanalysis of randomized and observational studies. Europace. 2017;19:378–84.

pubmed: 27702864 doi: 10.1093/europace/euw262

Ravi V, Poudyal A, Abid QU, Larsen T, Krishnan K, Sharma PS, et al. High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and metaanalysis. Europace. 2021;23:710–21.

pubmed: 33523184 doi: 10.1093/europace/euaa327

Hansom SP, Alqarawi W, Birnie DH, Golian M, Nery PB, Redpath CJ, et al. High-power, short-duration atrial fibrillation ablation compared with a conventional approach: outcomes and reconnection patterns. J Cardiovasc Electrophysiol. 2021;32:1219–28.

pubmed: 33751694 doi: 10.1111/jce.14989

Mueller J, Halbfass P, Sonne K, Nentwich K, Ene E, Berkovitz A, et al. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: single-center experience. J Cardiovasc Electrophysiol. 2022;33:920–7.

pubmed: 35233883 doi: 10.1111/jce.15433

Chieng D, Segan L, Sugumar H, Al-Kaisey A, Hawson J, Moore BM, et al. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). Europace. 2023;25:417–24.

pubmed: 36305561 doi: 10.1093/europace/euac190

Lee AC, Voskoboinik A, Cheung CC, Yogi S, Tseng ZH, Moss JD, et al. A randomized trial of high vs standard power radiofrequency ablation for pulmonary vein isolation. JACC Clin Electrophysiol. 2023;9:1038–47.

pubmed: 37495318 doi: 10.1016/j.jacep.2022.12.020

Paul Nordin A, Drca N, Insulander P, Bastani H, Bourke T, Braunschweig F, et al. Low incidence of major complications after the first six hours post atrial fibrillation ablation: is same-day discharge safe and feasible in most patients? J Cardiovasc Electrophysiol. 2021;32:2953–60.

pubmed: 34535936 doi: 10.1111/jce.15243

Opel A, Mansell J, Butler A, Schwartz R, Fannon M, Finlay M, et al. Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care. Europace. 2019;21:440–4.

pubmed: 30085050 doi: 10.1093/europace/euy153

Dagres N, Anastasiou-Nana M. Prevention of atrial-esophageal fistula after catheter ablation of atrial fibrillation. Curr Opin Cardiol. 2011;26:1–5.

pubmed: 21099683 doi: 10.1097/HCO.0b013e328341387d

Cochet H, Nakatani Y, Sridi-Cheniti S, Cheniti G, Ramirez FD, Nakashima T, et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace. 2021;23:1391–9.

pubmed: 33961027 pmcid: 8427383 doi: 10.1093/europace/euab090

Marashly Q, Gopinath C, Baher A, Acharya M, Kheirkhahan M, Hardisty B, et al. Late gadolinium enhancement magnetic resonance imaging evaluation of post-atrial fibrillation ablation esophageal thermal injury across the spectrum of severity. J Am Heart Assoc. 2021;10: e018924.

pubmed: 33759540 pmcid: 8174315 doi: 10.1161/JAHA.120.018924

Di Biase L, Saenz LC, Burkhardt DJ, Vacca M, Elayi CS, Barrett CD, et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythm Electrophysiol. 2009;2:108–12.

pubmed: 19808454 doi: 10.1161/CIRCEP.108.815266

Martinek M, Meyer C, Hassanein S, Aichinger J, Bencsik G, Schoefl R, et al. Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. Heart Rhythm. 2010;7:1224–30.

pubmed: 20188859 doi: 10.1016/j.hrthm.2010.02.027

Singh SM, d’Avila A, Singh SK, Stelzer P, Saad EB, Skanes A, et al. Clinical outcomes after repair of left atrial esophageal fistulas occurring after atrial fibrillation ablation procedures. Heart Rhythm. 2013;10:1591–7.

pubmed: 23954269 doi: 10.1016/j.hrthm.2013.08.012

Mohanty S, Santangeli P, Mohanty P, Di Biase L, Trivedi C, Bai R, et al. Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. J Cardiovasc Electrophysiol. 2014;25:579–84.

pubmed: 25013875 doi: 10.1111/jce.12386

Mohanty S, Santangeli P, Mohanty P, Di Biase L, Holcomb S, Trivedi C, et al. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014;25:1057–64.

pubmed: 24903064 doi: 10.1111/jce.12467

Eitel C, Rolf S, Zachäus M, John S, Sommer P, Bollmann A, et al. Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythm Electrophysiol. 2013;6:675–81.

pubmed: 23728944 doi: 10.1161/CIRCEP.113.000384

Bunch TJ, Nelson J, Foley T, Allison S, Crandall BG, Osborn JS, et al. Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol. 2006;17:435–9.

pubmed: 16643370 doi: 10.1111/j.1540-8167.2006.00464.x

Liu Y, Zhan X, Xue Y, Deng H, Fang X, Liao H, et al. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation. Europace. 2016;18:1357–65.

pubmed: 26705560 doi: 10.1093/europace/euv356

Kosiuk J, Kornej J, Bollmann A, Piorkowski C, Myrda K, Arya A, et al. Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm. 2014;11:1934–40.

pubmed: 25086257 doi: 10.1016/j.hrthm.2014.07.039

Deneke T, Jais P, Scaglione M, Schmitt RLDIB, Christopoulos G, Schade A, et al. Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol. 2015;26:455–63.

pubmed: 25556518 doi: 10.1111/jce.12608

Kimura T, Kashimura S, Nishiyama T, Katsumata Y, Inagawa K, Ikegami Y, et al. Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN). JACC Clin Electrophysiol. 2018;4:1598–609.

pubmed: 30573125 doi: 10.1016/j.jacep.2018.08.003

Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, et al. Subtle postprocedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62:531–9.

pubmed: 23684686 doi: 10.1016/j.jacc.2013.03.073

Al-Kaisey AM, Parameswaran R, Bryant C, Anderson RD, Hawson J, Chieng D, et al. Impact of catheter ablation on cognitive function in atrial fibrillation: a randomized control trial. JACC Clin Electrophysiol. 2023;9:1024–34.

pubmed: 37227345 doi: 10.1016/j.jacep.2023.02.020

Kato N, Muraga K, Hirata Y, Shindo A, Matsuura K, Ii Y, et al. Brain magnetic resonance imaging and cognitive alterations after ablation in patients with atrial fibrillation. Sci Rep. 2021;11:18995.

pubmed: 34556757 pmcid: 8460624 doi: 10.1038/s41598-021-98484-w

Haeusler KG, Eichner FA, Heuschmann PU, Fiebach JB, Engelhorn T, Blank B, et al. MRI-detected brain lesions and cognitive function in patients with atrial fibrillation undergoing left atrial catheter ablation in the randomized AXAFA-AFNET 5 trial. Circulation. 2022;145:906–15.

pubmed: 35135308 doi: 10.1161/CIRCULATIONAHA.121.056320

Grecu M, Blomström-Lundqvist C, Kautzner J, Laroche C, Van Gelder IC, Jordaens L, et al. In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA atrial fibrillation ablation long-term registry: sex differences. Europace. 2020;22:66–73.

pubmed: 31504431 doi: 10.1093/europace/euz225

Santangeli P, Di Biase L, Al-Ahmad A, Horton R, Burkhardt JD, Sanchez JE, et al. Ablation for atrial fibrillation: termination of atrial fibrillation is not the end point. Card Electrophysiol Clin. 2012;4:343–52.

pubmed: 26939954 doi: 10.1016/j.ccep.2012.06.005

Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Metaanalysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015;187:426–9.

pubmed: 25841141 doi: 10.1016/j.ijcard.2015.03.376

Ezekowitz MD, Pollack CV Jr, Halperin JL, England RD, VanPelt Nguyen S, Spahr J, et al. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial. Eur Heart J. 2018;39:2959–71.

pubmed: 29659797 pmcid: 6110194 doi: 10.1093/eurheartj/ehy148

Lin H, Chen YH, Hou JW, Lu ZY, Xiang Y, Li YG. Role of contact force-guided radiofrequency catheter ablation for treatment of atrial fibrillation: a systematic review and metaanalysis. J Cardiovasc Electrophysiol. 2017;28:994–1005.

pubmed: 28569422 doi: 10.1111/jce.13264

Friedman DJ, Pokorney SD, Ghanem A, Marcello S, Kalsekar I, Yadalam S, et al. Predictors of cardiac perforation with catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2020;6:636–45.

pubmed: 32553212 doi: 10.1016/j.jacep.2020.01.011

Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011;58:2696–7.

pubmed: 22152959 doi: 10.1016/j.jacc.2011.09.028

Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53:1798–803.

pubmed: 19422987 doi: 10.1016/j.jacc.2009.02.022

Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77:429–36.

pubmed: 12004992 doi: 10.1016/S0025-6196(11)62211-8

Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF, et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol. 2005;16:1172–9.

pubmed: 16302900 doi: 10.1111/j.1540-8167.2005.50135.x

Michowitz Y, Rahkovich M, Oral H, Zado ES, Tilz R, John S, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2014;7:274–80.

pubmed: 24519888 doi: 10.1161/CIRCEP.113.000760

Zhao Q, Li L, Liu N, Zhang M, Wu K, Ruan Y, et al. Early versus delayed removal of the pericardial drain in patients with cardiac tamponade complicating radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31:597–603.

pubmed: 31904158 doi: 10.1111/jce.14332

Zhao X, Liu JF, Su X, Long DY, Sang CH, Tang RB, et al. Direct autotransfusion in the management of acute pericardial tamponade during catheter ablation for atrial fibrillation: an imperfect but practical method. Front Cardiovasc Med. 2022;9: 984251.

pubmed: 36211564 pmcid: 9537684 doi: 10.3389/fcvm.2022.984251

Pedersen MEF, Leo M, Kalla M, Malhotra A, Stone M, Wong K, et al. Management of tamponade complicating catheter ablation for atrial fibrillation: early removal of pericardial drains is safe and effective and reduces analgesic requirements and hospital stay compared to conventional delayed removal. JACC Clin Electrophysiol. 2017;3:367–73.

pubmed: 29759449 doi: 10.1016/j.jacep.2016.09.016

Raeisi-Giglou P, Wazni OM, Saliba WI, Barakat A, Tarakji KG, Rickard J, et al. Outcomes and management of patients with severe pulmonary vein stenosis from prior atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2018;11: e006001.

pubmed: 29752377 doi: 10.1161/CIRCEP.117.006001

Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8:1444–51.

pubmed: 21457789 doi: 10.1016/j.hrthm.2011.03.050

Fender EA, Packer DL, Holmes DR Jr. Pulmonary vein stenosis after atrial fibrillation ablation. EuroIntervention. 2016;12:X31-4.

pubmed: 27174109 doi: 10.4244/EIJV12SXA7

Saad EB, Marrouche NF, Saad CP, Ha E, Bash D, White RD, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med. 2003;138:634–8.

pubmed: 12693885 doi: 10.7326/0003-4819-138-8-200304150-00010

Tokutake K, Tokuda M, Yamashita S, Sato H, Ikewaki H, Okajima E, et al. Anatomical and procedural factors of severe pulmonary vein stenosis after cryoballoon pulmonary vein ablation. JACC Clin Electrophysiol. 2019;5:1303–15.

pubmed: 31753437 doi: 10.1016/j.jacep.2019.08.003

Kim J, Kim D, Yu HT, Kim TH, Joung B, Lee MH, et al. Revisiting symptomatic pulmonary vein stenosis after high-power short-duration radiofrequency ablation in patients with atrial fibrillation. Europace. 2023;25:euad296.

pubmed: 37757850 pmcid: 10558058 doi: 10.1093/europace/euad296

Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000;36:468–71.

pubmed: 10933359 doi: 10.1016/S0735-1097(00)00765-8

Fender EA, Widmer RJ, Hodge DO, Cooper GM, Monahan KH, Peterson LA, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation. 2016;134:1812–21.

pubmed: 27793993 doi: 10.1161/CIRCULATIONAHA.116.021949

Fender EA, Widmer RJ, Hodge DO, Packer DL, Holmes DR Jr. Assessment and management of pulmonary vein occlusion after atrial fibrillation ablation. JACC Cardiovasc Interv. 2018;11:1633–9.

pubmed: 30139471 doi: 10.1016/j.jcin.2018.05.020

Hilbert S, Paetsch I, Bollmann A, Jahnke C. Pulmonary vein collateral formation as a long-term result of post-interventional pulmonary vein stenosis. Eur Heart J. 2016;37:2474.

pubmed: 26795444 doi: 10.1093/eurheartj/ehv753

Hilbert S, Sommer P, Bollmann A. Pulmonary vein dilatation in a case of total pulmonary vein occlusion: contemporary approach using a combination of 3D-mapping system and image integration. Catheter Cardiovasc Interv. 2016;88:E227-32.

pubmed: 26399777 doi: 10.1002/ccd.26251

Holmes DR Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009;2:267–76.

pubmed: 19463436 doi: 10.1016/j.jcin.2008.12.014

Fender EA, Widmer RJ, Mahowald MK, Hodge DO, Packer DL, Holmes DR Jr. Recurrent pulmonary vein stenosis after successful intervention: prognosis and management of restenosis. Catheter Cardiovasc Interv. 2020;95:954–8.

pubmed: 31854110 doi: 10.1002/ccd.28645

Mol D, Renskers L, Balt JC, Bhagwandien RE, Blaauw Y, van Driel V, et al. Persistent phrenic nerve palsy after atrial fibrillation ablation: follow-up data from The Netherlands Heart Registration. J Cardiovasc Electrophysiol. 2022;33:559–64.

pubmed: 35040534 pmcid: 9303579 doi: 10.1111/jce.15368

Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F, et al. Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: results of the worldwide YETI registry. Circ Arrhythm Electrophysiol. 2022;15: e010516.

pubmed: 34962134 doi: 10.1161/CIRCEP.121.010516

Sacher F, Monahan KH, Thomas SP, Davidson N, Adragao P, Sanders P, et al. Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol. 2006;47:2498–503.

pubmed: 16781380 doi: 10.1016/j.jacc.2006.02.050

Yong Ji S, Dewire J, Barcelon B, Philips B, Catanzaro J, Nazarian S, et al. Phrenic nerve injury: an underrecognized and potentially preventable complication of pulmonary vein isolation using a wide-area circumferential ablation approach. J Cardiovasc Electrophysiol. 2013;24:1086–91.

pubmed: 23869718 doi: 10.1111/jce.12210

Franceschi F, Dubuc M, Guerra PG, Khairy P. Phrenic nerve monitoring with diaphragmatic electromyography during cryoballoon ablation for atrial fibrillation: the first human application. Heart Rhythm. 2011;8:1068–71.

pubmed: 21315843 doi: 10.1016/j.hrthm.2011.01.047

Miyazaki S, Hachiya H, Taniguchi H, Nakamura H, Ichihara N, Usui E, et al. Prospective evaluation of bilateral diaphragmatic electromyograms during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26:622–8.

pubmed: 25810018 doi: 10.1111/jce.12671

Mondésert B, Andrade JG, Khairy P, Guerra PG, Dyrda K, Macle L, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605–11.

pubmed: 25017398 doi: 10.1161/CIRCEP.113.001238

Palaniswamy C, Kolte D, Harikrishnan P, Khera S, Aronow WS, Mujib M, et al. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm. 2014;11:2056–63.

pubmed: 25016150 doi: 10.1016/j.hrthm.2014.07.012

Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol. 2014;7:684–90.

pubmed: 24958396 doi: 10.1161/CIRCEP.114.001530

Waigand J, Uhlich F, Gross CM, Thalhammer C, Dietz R. Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Catheter Cardiovasc Interv. 1999;47:157–64.

pubmed: 10376495 doi: 10.1002/(SICI)1522-726X(199906)47:2<157::AID-CCD5>3.0.CO;2-Y

Kuwahara T, Takahashi A, Takahashi Y, Kobori A, Miyazaki S, Takei A, et al. Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation: lessons from five cases. Europace. 2012;14:204–8.

pubmed: 21937478 doi: 10.1093/europace/eur314

Krivonyak GS, Warren SG. Cerebral arterial air embolism treated by a vertical head-down maneuver. Catheter Cardiovasc Interv. 2000;49:185–7.

pubmed: 10642770 doi: 10.1002/(SICI)1522-726X(200002)49:2<185::AID-CCD15>3.0.CO;2-C

Franzen OW, Klemm H, Hamann F, Koschyk D, von Kodolitsch Y, Weil J, et al. Mechanisms underlying air aspiration in patients undergoing left atrial catheterization. Catheter Cardiovasc Interv. 2008;71:553–8.

pubmed: 18307231 doi: 10.1002/ccd.21445

Chugh A, Makkar A, Yen Ho S, Yokokawa M, Sundaram B, Pelosi F, et al. Manifestations of coronary arterial injury during catheter ablation of atrial fibrillation and related arrhythmias. Heart Rhythm. 2013;10:1638–45.

pubmed: 24012853 doi: 10.1016/j.hrthm.2013.09.001

Takahashi Y, Jaïs P, Hocini M, Sanders P, Rotter M, Rostock T, et al. Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol. 2005;16:1104–7.

pubmed: 16191121 doi: 10.1111/j.1540-8167.2005.50124.x

Kitamura T, Fukamizu S, Arai K, Hojo R, Aoyama Y, Komiyama K, et al. Transient sinus node dysfunction following sinus node artery occlusion due to radiofrequency catheter ablation of the septal superior vena cava-right atrium junction. J Electrocardiol. 2016;49:18–22.

pubmed: 26607406 doi: 10.1016/j.jelectrocard.2015.11.001

Higuchi S, Im SI, Stillson C, Buck ED, Jerrell S, Schneider CW, et al. Effect of epicardial pulsed field ablation directly on coronary arteries. JACC Clin Electrophysiol. 2022;8:1486–96.

pubmed: 36779624 doi: 10.1016/j.jacep.2022.09.003

Kesek M, Englund A, Jensen SM, Jensen-Urstad M. Entrapment of circular mapping catheter in the mitral valve. Heart Rhythm. 2007;4:17–9.

pubmed: 17198983 doi: 10.1016/j.hrthm.2006.09.016

Grove R, Kranig W, Coppoolse R, Lüdorff G, Wolff E, Warnecke H, et al. Demand for open heart surgery due to entrapment of a circular mapping catheter in the mitral valve in a patient undergoing atrial fibrillation ablation. Clin Res Cardiol. 2008;97:628–9.

pubmed: 18633567 doi: 10.1007/s00392-008-0677-2

Lakkireddy D, Nagarajan D, Di Biase L, Vanga SR, Mahapatra S, Jared Bunch T, et al. Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm. 2011;8:975–80.

pubmed: 21316485 doi: 10.1016/j.hrthm.2011.02.012

Zeljko HM, Mont L, Sitges M, Tolosana JM, Nadal M, Castella M, et al. Entrapment of the circular mapping catheter in the mitral valve in two patients undergoing atrial fibrillation ablation. Europace. 2011;13:132–3.

pubmed: 21149514 doi: 10.1093/europace/euq309

Wu RC, Brinker JA, Yuh DD, Berger RD, Calkins HG. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2002;13:819–21.

pubmed: 12212705 doi: 10.1046/j.1540-8167.2002.00819.x

Kim EJ, Gerstenfeld EP, Pellegrini CN. Use of adenosine to release an entrapped catheter during ablation of premature ventricular complexes. JACC Case Rep. 2021;3:610–3.

pubmed: 34317587 pmcid: 8302799 doi: 10.1016/j.jaccas.2021.02.011

Tavernier R, Duytschaever M, Taeymans Y. Fracture of a circular mapping catheter after entrapment in the mitral valve apparatus during segmental pulmonary vein isolation. Pacing Clin Electrophysiol. 2003;26:1774–5.

pubmed: 12877716 doi: 10.1046/j.1460-9592.2003.t01-1-00268.x

Gurbuz O, Ercan A, Ozkan H, Kumtepe G, Karal IH, Ener S. Case report: paravalvular leak as a complication of percutaneous catheter ablation for atrial fibrillation. J Cardiothorac Surg. 2014;9:187.

pubmed: 25515423 pmcid: 4279701 doi: 10.1186/s13019-014-0187-4

Kawaji T, Kato M, Yokomatsu T. How to release PentaRay catheter entrapped in the hinge point of mechanical mitral valve? Europace. 2020;22:204.

pubmed: 31419293

Yagishita A, Ayabe K, Sakama S, Morise M, Amino M, Ikari Y, et al. A novel technique to release a PentaRay entrapped in a mechanical mitral valve using an ablation catheter. JACC Clin Electrophysiol. 2020;6:1597–8.

pubmed: 33213821 doi: 10.1016/j.jacep.2020.08.017

Lopes J, Sousa PA, Elvas L, Gonçalves L. Successful retrieval of a broken PentaRay catheter spine in a patient with mechanic mitral valve prosthesis. J Interv Card Electrophysiol. 2021;61:625–6.

pubmed: 33638778 doi: 10.1007/s10840-021-00965-5

Cochet H, Scherr D, Zellerhoff S, Sacher F, Derval N, Denis A, et al. Atrial structure and function 5 years after successful ablation for persistent atrial fibrillation: an MRI study. J Cardiovasc Electrophysiol. 2014;25:671–9.

pubmed: 24798070 doi: 10.1111/jce.12449

Gibson DN, Di Biase L, Mohanty P, Patel JD, Bai R, Sanchez J, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011;8:1364–71.

pubmed: 21354332 doi: 10.1016/j.hrthm.2011.02.026

Shoemaker MB, Hemnes AR, Robbins IM, Langberg JJ, Ellis CR, Aznaurov SG, et al. Left atrial hypertension after repeated catheter ablations for atrial fibrillation. J Am Coll Cardiol. 2011;57:1918–9.

pubmed: 21545950 doi: 10.1016/j.jacc.2011.01.021

Welch TD, Coylewright M, Powell BD, Asirvatham SJ, Gersh BJ, Dearani JA, et al. Symptomatic pulmonary hypertension with giant left atrial v waves after surgical maze procedures: evaluation by comprehensive hemodynamic catheterization. Heart Rhythm. 2013;10:1839–42.

pubmed: 24050987 doi: 10.1016/j.hrthm.2013.09.010

Moon I, Lee SY, Lee E, Lee SR, Cha MJ, Choi EK, et al. Extensive left atrial ablation was associated with exacerbation of left atrial stiffness and dyspnea. J Cardiovasc Electrophysiol. 2019;30:2782–9.

pubmed: 31637795 doi: 10.1111/jce.14241

Witt C, Powell B, Holmes D, Alli O. Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the “stiff left atrial syndrome”. Catheter Cardiovasc Interv. 2013;82:E747-9.

pubmed: 22777844 doi: 10.1002/ccd.24556

Wong GR, Lau DH, Baillie TJ, Middeldorp ME, Steele PM, Sanders P. Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation ‘stiff left atrial syndrome’. Int J Cardiol. 2015;181:55–6.

pubmed: 25482279 doi: 10.1016/j.ijcard.2014.12.012

Lakkireddy D, Reddy YM, Atkins D, Rajasingh J, Kanmanthareddy A, Olyaee M, et al. Effect of atrial fibrillation ablation on gastric motility: the atrial fibrillation gut study. Circ Arrhythm Electrophysiol. 2015;8:531–6.

pubmed: 25772541 doi: 10.1161/CIRCEP.114.002508

Kuwahara T, Takahashi A, Takahashi Y, Kobori A, Miyazaki S, Takei A, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24:847–51.

pubmed: 23551640 doi: 10.1111/jce.12130

Knopp H, Halm U, Lamberts R, Knigge I, Zachäus M, Sommer P, et al. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014;11:574–8.

pubmed: 24418167 doi: 10.1016/j.hrthm.2014.01.010

Miyazaki S, Nakamura H, Taniguchi H, Hachiya H, Takagi T, Igarashi M, et al. Gastric hypomotility after second-generation cryoballoon ablation-unrecognized silent nerve injury after cryoballoon ablation. Heart Rhythm. 2017;14:670–7.

pubmed: 28434448 doi: 10.1016/j.hrthm.2017.01.028

Aksu T, Golcuk S, Guler TE, Yalin K, Erden I. Gastroparesis as a complication of atrial fibrillation ablation. Am J Cardiol. 2015;116:92–7.

pubmed: 25933733 doi: 10.1016/j.amjcard.2015.03.045

Shigeta T, Okishige K, Aoyagi H, Nishimura T, Nakamura RA, Ito N, et al. Clinical investigation of esophageal injury from cryoballoon ablation of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2019;42:230–7.

pubmed: 30549044 doi: 10.1111/pace.13578

Bunch TJ, Ellenbogen KA, Packer DL, Asirvatham SJ. Vagus nerve injury after posterior atrial radiofrequency ablation. Heart Rhythm. 2008;5:1327–30.

pubmed: 18774112 doi: 10.1016/j.hrthm.2008.05.014

Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T, et al. Factors associated with periesophageal vagal nerve injury after pulmonary vein antrum isolation. J Am Heart Assoc. 2014;3: e001209.

pubmed: 25249299 pmcid: 4323793 doi: 10.1161/JAHA.114.001209

Pisani CF, Hachul D, Sosa E, Scanavacca M. Gastric hypomotility following epicardial vagal denervation ablation to treat atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:211–3.

pubmed: 17711431 doi: 10.1111/j.1540-8167.2007.00937.x

Schwartz TW, Rehfeld JF, Stadil F, Larson LI, Chance RE, Moon N. Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet. 1976;307:1102–5.

doi: 10.1016/S0140-6736(76)90065-9

Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies N Engl J Med. 1990;322:1028–31.

pubmed: 2320062 doi: 10.1056/NEJM199004123221502

Camilleri M, Atieh J. New developments in prokinetic therapy for gastric motility disorders. Front Pharmacol. 2021;12: 711500.

pubmed: 34504426 pmcid: 8421525 doi: 10.3389/fphar.2021.711500

Zheng T, Camilleri M. Management of gastroparesis. Gastroenterol Hepatol (N Y). 2021;17:515–25.

pubmed: 35466306

Badhwar V, Rankin JS, Ad N, Grau-Sepulveda M, Damiano RJ, Gillinov AM, et al. Surgical ablation of atrial fibrillation in the United States: trends and propensity matched outcomes. Ann Thorac Surg. 2017;104:493–500.

pubmed: 28669501 doi: 10.1016/j.athoracsur.2017.05.016

Budera P, Straka Z, Osmančík P, Vaněk T, Jelínek Š, Hlavička J, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644–52.

pubmed: 22930458 pmcid: 3485575 doi: 10.1093/eurheartj/ehs290

Nashef SAM, Fynn S, Abu-Omar Y, Spyt TJ, Mills C, Everett CC, et al. Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation. Eur J Cardiothorac Surg. 2018;54:729–37.

pubmed: 29672731 pmcid: 6134441 doi: 10.1093/ejcts/ezy165

Osmancik P, Budera P, Talavera D, Hlavicka J, Herman D, Holy J, et al. Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 study. Heart Rhythm. 2019;16:1334–40.

pubmed: 31082538 doi: 10.1016/j.hrthm.2019.05.001

Wong JW, Mak KH. Impact of maze and concomitant mitral valve surgery on clinical outcomes. Ann Thorac Surg. 2006;82:1938–47.

pubmed: 17062288 doi: 10.1016/j.athoracsur.2006.05.108

Lee R, McCarthy PM, Wang EC, Vaduganathan M, Kruse J, Malaisrie SC Jr, et al. Midterm survival in patients treated for atrial fibrillation: a propensity-matched comparison to patients without a history of atrial fibrillation. J Thorac Cardiovasc Surg. 2012;143:1341–51; discussion 1350–1.

Musharbash FN, Schill MR, Sinn LA, Schuessler RB, Maniar HS, Moon MR, et al. Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:159–70.

pubmed: 29056264 doi: 10.1016/j.jtcvs.2017.09.095

Iribarne A, DiScipio AW, McCullough JN, Quinn R, Leavitt BJ, Westbrook BM, et al. Surgical atrial fibrillation ablation improves long-term survival: a multicenter analysis. Ann Thorac Surg. 2019;107:135–42.

pubmed: 30300644 doi: 10.1016/j.athoracsur.2018.08.022

Kowalewski M, Pasierski M, Kołodziejczak M, Litwinowicz R, Kowalówka A, Wańha W, et al. Atrial fibrillation ablation improves late survival after concomitant cardiac surgery. J Thorac Cardiovasc Surg. 2023;166:1656-68.e8.

pubmed: 35965139 doi: 10.1016/j.jtcvs.2022.04.035

Kim HJ, Kim YJ, Kim M, Yoo JS, Kim DH, Park DW, et al. Surgical ablation for atrial fibrillation during aortic and mitral valve surgery: a nationwide population-based cohort study. J Thorac Cardiovasc Surg. 2022.

Suwalski P, Kowalewski M, Jasiński M, Staromłyński J, Zembala M, Widenka K, et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: analysis from the polish national registry of cardiac surgery procedures (KROK). J Thorac Cardiovasc Surg. 2019;157:1007-18.e4.

pubmed: 30314688 doi: 10.1016/j.jtcvs.2018.07.099

Gemelli M, Gallo M, Addonizio M, Van den Eynde J, Pradegan N, Danesi TH, et al. Surgical ablation for atrial fibrillation during mitral valve surgery: a systematic review and metaanalysis of randomized controlled trials. Am J Cardiol. 2023;209:104–13.

pubmed: 37848175 doi: 10.1016/j.amjcard.2023.09.088

Reston JT, Shuhaiber JH. Metaanalysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation. Eur J Cardiothorac Surg. 2005;28:724–30.

pubmed: 16143540 doi: 10.1016/j.ejcts.2005.07.012

Rankin JS, Lerner DJ, Braid-Forbes MJ, McCrea MM, Badhwar V. Surgical ablation of atrial fibrillation concomitant to coronary-artery bypass grafting provides cost-effective mortality reduction. J Thorac Cardiovasc Surg. 2020;160:675-86.e13.

pubmed: 31610956 doi: 10.1016/j.jtcvs.2019.07.131

Suwalski P, Kowalewski M, Jasiński M, Staromłyński J, Zembala M, Widenka K, et al. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery. Eur J Cardiothorac Surg. 2020;57:691–700.

pubmed: 31665277

MacGregor RM, Bakir NH, Pedamallu H, Sinn LA, Maniar HS, Melby SJ, et al. Late results after stand-alone surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2022;164:1515-28.e8.

pubmed: 34045056 doi: 10.1016/j.jtcvs.2021.03.109

Lapenna E, De Bonis M, Giambuzzi I, Del Forno B, Ruggeri S, Cireddu M, et al. Long-term outcomes of stand-alone maze IV for persistent or long-standing persistent atrial fibrillation. Ann Thorac Surg. 2020;109:124–31.

pubmed: 31325420 doi: 10.1016/j.athoracsur.2019.05.061

Ad N, Holmes SD, Friehling T. Minimally invasive stand-alone cox maze procedure for persistent and long-standing persistent atrial fibrillation: perioperative safety and 5-year outcomes. Circ Arrhythm Electrophysiol. 2017;10: e005352.

pubmed: 29138143 doi: 10.1161/CIRCEP.117.005352

Henn MC, Lancaster TS, Miller JR, Sinn LA, Schuessler RB, Moon MR, et al. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2015;150(1168–76):1178.e1-2.

Gammie JS, Haddad M, Milford-Beland S, Welke KF, Ferguson TB Jr, O’Brien SM, et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2008;85:909–14.

pubmed: 18291169 doi: 10.1016/j.athoracsur.2007.10.097

Gillinov AM, Gelijns AC, Parides MK, DeRose JJ Jr, Moskowitz AJ, Voisine P, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372:1399–409.

pubmed: 25853744 pmcid: 4664179 doi: 10.1056/NEJMoa1500528

Mokracek A, Kurfirst V, Bulava A, Hanis J, Tesarik R, Pesl L. Thoracoscopic occlusion of the left atrial appendage. Innovations. 2015;10:179–82.

pubmed: 26181584

Wang J-L, Zhou K, Qin Z, Cheng W-J, Zhang L-Z, Zhou Y-J. Minimally invasive thoracoscopic left atrial appendage occlusion compared with transcatheter left atrial appendage closure for stroke prevention in recurrent nonvalvular atrial fibrillation patients after radiofrequency ablation: a prospective cohort study. J Geriatr Cardiol. 2021;18:877–85.

pubmed: 34908925 pmcid: 8648546

Fu M, Qin Z, Zheng S, Li Y, Yang S, Zhao Y, et al. Thoracoscopic left atrial appendage occlusion for stroke prevention compared with long-term warfarin therapy in patients with nonvalvular atrial fibrillation. Am J Cardiol. 2019;123:50–6.

pubmed: 30385030 doi: 10.1016/j.amjcard.2018.09.025

Kim JY, Jeong DS, Park S-J, Park K-M, Kim JS, On YK. Long-term efficacy and anticoagulation strategy of left atrial appendage occlusion during total thoracoscopic ablation of atrial fibrillation to prevent ischemic stroke. Front Cardiovasc Med. 2022;9: 853299.

pubmed: 35433859 pmcid: 9008268 doi: 10.3389/fcvm.2022.853299

Branzoli S, Marini M, Guarracini F, Pederzolli C, Pomarolli C, D’Onghia G, et al. Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation. J Cardiovasc Electrophysiol. 2020;31:2187–91.

pubmed: 32495408 doi: 10.1111/jce.14599

Cartledge R, Suwalski G, Witkowska A, Gottlieb G, Cioci A, Chidiac G, et al. Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation. Interact Cardiovasc Thorac Surg. 2022;34:548–55.

pubmed: 34871377 doi: 10.1093/icvts/ivab334

Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384:2081–91.

pubmed: 33999547 doi: 10.1056/NEJMoa2101897

Quader MA, McCarthy PM, Gillinov AM, Alster JM, Cosgrove DM 3rd, Lytle BW, et al. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg. 2004;77:1514–22; discussion 1522–4.

Ad N, Damiano RJ Jr, Badhwar V, Calkins H, La Meir M, Nitta T, et al. Expert consensus guidelines: examining surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2017;153:1330-54.e1.

pubmed: 28390766 doi: 10.1016/j.jtcvs.2017.02.027

Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:833–40.

pubmed: 10534688 doi: 10.1016/S0022-5223(99)70052-8

Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125:23–30.

pubmed: 22082673 doi: 10.1161/CIRCULATIONAHA.111.074047

Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, et al. Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial. Europace. 2019;21:746–53.

pubmed: 30715255 pmcid: 6479508 doi: 10.1093/europace/euy325

Pokushalov E, Romanov A, Elesin D, Bogachev-Prokophiev A, Losik D, Bairamova S, et al. Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol. 2013;24:1338–43.

pubmed: 24016147 doi: 10.1111/jce.12245

Adiyaman A, Buist TJ, Beukema RJ, Smit JJJ, Delnoy P, Hemels MEW, et al. Randomized controlled trial of surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2018;11: e006182.

pubmed: 30354411 doi: 10.1161/CIRCEP.118.006182

Philpott JM, Zemlin CW, Cox JL, Stirling M, Mack M, Hooker RL, et al. The ABLATE trial: safety and efficacy of Cox maze-IV using a bipolar radiofrequency ablation system. Ann Thorac Surg. 2015;100:1541–6; discussion 1547–8.

McGilvray MMO, Barron L, Yates TE, Zemlin CW, Damiano RJ Jr. The Cox-maze procedure: what lesions and why. JTCVS Tech. 2023;17:84–93.

pubmed: 36820335 doi: 10.1016/j.xjtc.2022.11.009

Gillinov AM, Gelijns AC, Parides MK, DeRose JJ Jr, Moskowitz AJ, Voisine P, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372:1399–409.

pubmed: 25853744 pmcid: 4664179 doi: 10.1056/NEJMoa1500528

Hamner CE, Potter DD Jr, Cho KR, Lutterman A, Francischelli D, Sundt TM 3rd, et al. Irrigated radiofrequency ablation with transmurality feedback reliably produces Cox maze lesions in vivo. Ann Thorac Surg. 2005;80:2263–70.

pubmed: 16305886 doi: 10.1016/j.athoracsur.2005.06.017

Schuessler RB, Lee AM, Melby SJ, Voeller RK, Gaynor SL, Sakamoto S-I, et al. Animal studies of epicardial atrial ablation. Heart Rhythm. 2009;6:S41-5.

pubmed: 19959142 pmcid: 2907672 doi: 10.1016/j.hrthm.2009.07.028

Saint LL, Lawrance CP, Okada S, Kazui T, Robertson JO, Schuessler RB, et al. Performance of a novel bipolar/monopolar radiofrequency ablation device on the beating heart in an acute porcine model. Innovations. 2013;8:276–83.

pubmed: 24145972

Bugge E, Nicholson IA, Thomas SP. Comparison of bipolar and unipolar radiofrequency ablation in an in vivo experimental model. Eur J Cardiothorac Surg. 2005;28:76–80; discussion 80–2.

Thomas SP, Guy DJR, Boyd AC, Eipper VE, Ross DL, Chard RB. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg. 2003;75:543–8.

pubmed: 12607670 doi: 10.1016/S0003-4975(02)04314-X

La Meir M. Surgical options for treatment of atrial fibrillation. Ann Cardiothorac Surg. 2014;3:30–7.

pubmed: 24516795 pmcid: 3904328

Khiabani AJ, MacGregor RM, Manghelli JL, Ruaengsri C, Carter DI, Melby SJ, et al. Bipolar radiofrequency ablation on explanted human hearts: how to ensure transmural lesions. Ann Thorac Surg. 2020;110:1933–9.

pubmed: 32522634 pmcid: 7669627 doi: 10.1016/j.athoracsur.2020.04.079

Jaïs P, Haïssaguerre M, Shah DC, Takahashi A, Hocini M, Lavergne T, et al. Successful irrigated-tip catheter ablation of atrial flutter resistant to conventional radiofrequency ablation. Circulation. 1998;98:835–8.

pubmed: 9738636 doi: 10.1161/01.CIR.98.9.835

Haines DE. The biophysics and pathophysiology of lesion formation during radiofrequency catheter ablation. In Zipes DP, Jalife J, Stevenson WG (eds.), Cardiac Electrophysiology: From Cell to Bedside. 4th ed. Philadelphia: WB Saunders Co; 2005;1018–27.

Melby SJ, Zierer A, Voeller RK, Lall SC, Bailey MS, Moon MR, et al. Wide variations in energy delivery using an impedance-controlled algorithm in bipolar radiofrequency ablation: evidence against fixed time ablation. Innovations. 2007;2:67–72.

pubmed: 22436925

Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19:267–94.

pubmed: 12745972 doi: 10.1080/0265673031000119006

Varzaly JA, Chapman D, Lau DH, Edwards S, Louise J, Edwards J, et al. Contact force and ablation assessment of surgical bipolar radiofrequency clamps in the treatment of atrial fibrillation. Interact Cardiovasc Thorac Surg. 2019;28:85–93.

pubmed: 29982423 doi: 10.1093/icvts/ivy191

Schill MR, Melby SJ, Speltz M, Breitbach M, Schuessler RB, Damiano RJ. Evaluation of a novel cryoprobe for atrial ablation in a chronic ovine model. Ann Thorac Surg. 2017;104:1069–73.

pubmed: 28838486 pmcid: 5572802 doi: 10.1016/j.athoracsur.2017.02.041

Weimar T, Lee AM, Ray S, Schuessler RB, Damiano RJ. Evaluation of a novel cryoablation system: in vivo testing in a chronic porcine model. Innovations (Phila). 2012;7:410–6.

pubmed: 23422803 doi: 10.1177/155698451200700607

Cox JL, Malaisrie SC, Churyla A, Mehta C, Kruse J, Kislitsina ON, et al. Cryosurgery for atrial fibrillation: physiologic basis for creating optimal cryolesions. Ann Thorac Surg. 2021;112:354–62.

pubmed: 33279545 doi: 10.1016/j.athoracsur.2020.08.114

Masroor S, Jahnke M-E, Carlisle A, Cartier C, LaLonde J-P, MacNeil T, et al. Endocardial hypothermia and pulmonary vein isolation with epicardial cryoablation in a porcine beating-heart model. J Thorac Cardiovasc Surg. 2008;135:1327-33.e5.

pubmed: 18544381 doi: 10.1016/j.jtcvs.2007.12.038

Aupperle H, Doll N, Walther T, Ullmann C, Schoon HA, Wilhelm Mohr F. Histological findings induced by different energy sources in experimental atrial ablation in sheep. Interact Cardiovasc Thorac Surg. 2005;4:450–5.

Schuessler RB, Lee AM, Melby SJ, Voeller RK, Gaynor SL, Sakamoto S, et al. Animal studies of epicardial atrial ablation. Heart Rhythm. 2009;6:S41-5.

pubmed: 19959142 pmcid: 2907672 doi: 10.1016/j.hrthm.2009.07.028

MacGregor RM, Melby SJ, Schuessler RB, Damiano RJ. Energy sources for the surgical treatment of atrial fibrillation. Innovations (Phila). 2019;14:503–8.

pubmed: 31637938 doi: 10.1177/1556984519878166

Yates TA, McGilvray M, Schill MR, Barron L, Razo N, Roberts HG Jr, et al. Performance of an irrigated bipolar radiofrequency ablation clamp on explanted human hearts. Ann Thorac Surg. 2023;116:307–13.

pubmed: 36935027 doi: 10.1016/j.athoracsur.2023.02.055

Yates T-A, McGilvray M, Razo N, McElligott S, Melby SJ, Zemlin C, et al. Efficacy of a novel bipolar radiofrequency clamp: an acute porcine model. Innovations (Phila). 2022;17:409–15.

pubmed: 36217760 doi: 10.1177/15569845221126524

Watanabe Y, Weimar T, Kazui T, Lee U, Schuessler RB, Damiano RJ Jr. Epicardial ablation performance of a novel radiofrequency device on the beating heart in pigs. Ann Thorac Surg. 2014;97:673–8.

pubmed: 24484804 pmcid: 3912465 doi: 10.1016/j.athoracsur.2013.10.036

Lee AM, Aziz A, Clark KL, Schuessler RB, Damiano RJ Jr. Chronic performance of a novel radiofrequency ablation device on the beating heart: limitations of conduction delay to assess transmurality. J Thorac Cardiovasc Surg. 2012;144:859–65.

pubmed: 22305553 pmcid: 3966079 doi: 10.1016/j.jtcvs.2012.01.001

Bringmans T, Verrijcken A, La Meir M, Rega F. Atrioesophageal fistula after epicardial ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2018;155:e19-21.

pubmed: 28947197 doi: 10.1016/j.jtcvs.2017.08.069

Kiser AC, Nifong LW, Raman J, Kasirajan V, Campbell N, Chitwood WR Jr. Evaluation of a novel epicardial atrial fibrillation treatment system. Ann Thorac Surg. 2008;85:300–3.

pubmed: 18154827 doi: 10.1016/j.athoracsur.2007.05.061

Weimar T, Lee AM, Ray S, Schuessler RB, Damiano RJ Jr. Evaluation of a novel cryoablation system: in vivo testing in a chronic porcine model. Innovations (Phila). 2012;7:410–6.

pubmed: 23422803 doi: 10.1177/155698451200700607

El Arid J-M, Sénage T, Toquet C, Al Habash O, Mugniot A, Baron O, et al. Human comparative experimental study of surgical treatment of atrial fibrillation by epicardial techniques. J Cardiothorac Surg. 2013;8:140.

pubmed: 23725512 pmcid: 3679832 doi: 10.1186/1749-8090-8-140

Schill MR, Melby SJ, Speltz M, Breitbach M, Schuessler RB, Damiano RJ Jr. Evaluation of a novel cryoprobe for atrial ablation in a chronic ovine model. Ann Thorac Surg. 2017;104:1069–73.

pubmed: 28838486 pmcid: 5572802 doi: 10.1016/j.athoracsur.2017.02.041

Milla F, Skubas N, Briggs WM, Girardi LN, Lee LY, Ko W, et al. Epicardial beating heart cryoablation using a novel argon-based cryoclamp and linear probe. J Thorac Cardiovasc Surg. 2006;131:403–11.

pubmed: 16434271 doi: 10.1016/j.jtcvs.2005.10.048

Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S-I, Tanaka S. Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Cardiovasc Surg. 2004;127:770–8.

pubmed: 15001906 doi: 10.1016/j.jtcvs.2003.05.001

Saini A, Hu YL, Kasirajan V, Han FT, Khan MZ, Wolfe L, et al. Long-term outcomes of minimally invasive surgical ablation for atrial fibrillation: a single-center experience. Heart Rhythm. 2017;14:1281–8.

pubmed: 28438723 doi: 10.1016/j.hrthm.2017.04.029

Gillinov AM, Bhavani S, Blackstone EH, Rajeswaran J, Svensson LG, Navia JL, et al. Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg. 2006;82:502–13; discussion 513–4.

Saint LL, Bailey MS, Prasad S, Guthrie TJ, Bell J, Moon MR, et al. Cox-maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease. Ann Thorac Surg. 2012;93:789–94; discussion 794–5.

Enriquez A, Santangeli P, Zado ES, Liang J, Castro S, Garcia FC, et al. Postoperative atrial tachycardias after mitral valve surgery: mechanisms and outcomes of catheter ablation. Heart Rhythm. 2017;14:520–6.

pubmed: 27919764 doi: 10.1016/j.hrthm.2016.12.002

Gwag HB, Jeong DS, Hwang JK, Park S-J, Park K-M, Kim JS, et al. Additional cavotricuspid isthmus ablation may reduce recurrent atrial tachyarrhythmia after total thoracoscopic ablation for persistent atrial fibrillation. Interact Cardiovasc Thorac Surg. 2019;28:177–82.

pubmed: 30060163 doi: 10.1093/icvts/ivy236

Ngaage DL, Schaff HV, Mullany CJ, Sundt TM 3rd, Dearani JA, Barnes S, et al. Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2007;133:182–9.

pubmed: 17198809 doi: 10.1016/j.jtcvs.2006.09.021

McClure GR, Belley-Cote EP, Jaffer IH, Dvirnik N, An KR, Fortin G, et al. Surgical ablation of atrial fibrillation: a systematic review and metaanalysis of randomized controlled trials. Europace. 2018;20:1442–50.

pubmed: 29186407 doi: 10.1093/europace/eux336

Johansson B, Houltz B, Berglin E, Brandrup-Wognsen G, Karlsson T, Edvardsson N. Short-term sinus rhythm predicts long-term sinus rhythm and clinical improvement after intraoperative ablation of atrial fibrillation. Europace. 2008;10:610–7.

pubmed: 18375472 doi: 10.1093/europace/eun066

Grubitzsch H, Dushe S, Beholz S, Dohmen PM, Konertz W. Surgical ablation of atrial fibrillation in patients with congestive heart failure. J Card Fail. 2007;13:509–16.

pubmed: 17826640 doi: 10.1016/j.cardfail.2007.04.011

Saint LL, Damiano RJ Jr, Cuculich PS, Guthrie TJ, Moon MR, Munfakh NA, et al. Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery. J Thorac Cardiovasc Surg. 2013;146:1072–7.

pubmed: 23998785 pmcid: 3804550 doi: 10.1016/j.jtcvs.2013.06.048

Bakir NH, Khiabani AJ, MacGregor RM, Kelly MO, Sinn LA, Schuessler RB, et al. Concomitant surgical ablation for atrial fibrillation is associated with increased risk of acute kidney injury but improved late survival. J Thorac Cardiovasc Surg. 2022;164:1847-57.e3.

pubmed: 33653608 doi: 10.1016/j.jtcvs.2021.01.023

Takahashi K, Miyauchi Y, Hayashi M, Iwasaki YK, Yodogawa K, Tsuboi I, et al. Mechanisms of postoperative atrial tachycardia following biatrial surgical ablation of atrial fibrillation in relation to the surgical lesion sets. Heart Rhythm. 2016;13:1059–65.

pubmed: 26721450 doi: 10.1016/j.hrthm.2015.12.033

Ishii Y, Nitta T, Kambe M, Kurita J, Ochi M, Miyauchi Y, et al. Intraoperative verification of conduction block in atrial fibrillation surgery. J Thorac Cardiovasc Surg. 2008;136:998–1004.

pubmed: 18954642 doi: 10.1016/j.jtcvs.2008.06.022

Phan K, Xie A, Tsai YC, Kumar N, La Meir M, Yan TD. Biatrial ablation vs. left atrial concomitant surgical ablation for treatment of atrial fibrillation: a metaanalysis. Europace. 2015;17:38–47.

pubmed: 25336669 doi: 10.1093/europace/euu220

Bogachev-Prokophiev AV, Afanasyev AV, Pivkin AN, Ovcharov MA, Zheleznev SI, Sharifulin RM, et al. A left atrial versus a biatrial lesion set for persistent atrial fibrillation ablation during open heart surgery. Eur J Cardiothorac Surg. 2018;54:738–44.

pubmed: 29608679 doi: 10.1093/ejcts/ezy126

Kowalewski M, Pasierski M, Finke J, Kołodziejczak M, Staromłyński J, Litwinowicz R, et al. Permanent pacemaker implantation after valve and arrhythmia surgery in patients with preoperative atrial fibrillation. Heart Rhythm. 2022;19:1442–9.

pubmed: 35429649 doi: 10.1016/j.hrthm.2022.04.007

Cox JL, Ad N, Churyla A, Malaisrie SC, Pham DT, Kruse J, et al. The maze procedure and postoperative pacemakers. Ann Thorac Surg. 2018;106:1561–9.

pubmed: 29883654 doi: 10.1016/j.athoracsur.2018.05.013

Badhwar V, Rankin JS, Damiano RJ Jr, Gillinov AM, Bakaeen FG, Edgerton JR, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103:329–41.

pubmed: 28007240 doi: 10.1016/j.athoracsur.2016.10.076

Raanani E, Albage A, David TE, Yau TM, Armstrong S. The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. Eur J Cardiothorac Surg. 2001;19:438–42.

pubmed: 11306309 doi: 10.1016/S1010-7940(01)00576-0

Li H, Lin X, Ma X, Tao J, Zou R, Yang S, Liu H, Hua P. Biatrial versus isolated left atrial ablation in atrial fibrillation: a systematic review and metaanalysis. Biomed Res Int. 2018;2018:3651212.

pubmed: 29854748 pmcid: 5949196

Kainuma S, Mitsuno M, Toda K, Funatsu T, Nakamura T, Miyagawa S, et al. Dilated left atrium as a predictor of late outcome after pulmonary vein isolation concomitant with aortic valve replacement and/or coronary artery bypass grafting†. Eur J Cardiothorac Surg. 2015;48:765–77; discussion 777.

Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a metaanalysis. J Thorac Cardiovasc Surg. 2006;131:1029–35.

pubmed: 16678586 doi: 10.1016/j.jtcvs.2005.10.020

Kim HJ, Kim JB, Kim SO, Cho MS, Kim JK, Kim WK, et al. Long-term outcomes of surgical ablation for atrial fibrillation: impact of ablation lesion sets. JACC Asia. 2021;1:203–14.

pubmed: 36338168 pmcid: 9627916 doi: 10.1016/j.jacasi.2021.06.001

Kainuma S, Mitsuno M, Toda K, Miyagawa S, Yoshikawa Y, Hata H, et al. Surgical ablation concomitant with nonmitral valve surgery for persistent atrial fibrillation. Ann Thorac Surg. 2021;112:1909–20.

pubmed: 33545152 doi: 10.1016/j.athoracsur.2020.11.069

La Meir M, Gelsomino S, Nonneman B. The problem with concomitant atrial fibrillation in non-mitral valve surgery. Ann Cardiothorac Surg. 2014;3:124–9.

pubmed: 24516811 pmcid: 3904341

Civello K, Smith C, Boedefeld W. Combined endocardial and epicardial ablation for symptomatic atrial fibrillation: single center experience in 100+ consecutive patients. J Innov Card Rhythm Manag. 2013;4:1–7.

Gehi AK, Mounsey JP, Pursell I, Landers M, Boyce K, Chung EH, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10:22–8.

pubmed: 23064043 doi: 10.1016/j.hrthm.2012.08.044

Gersak B, Jan M. Long-term success for the convergent atrial fibrillation procedure: 4-year outcomes. Ann Thorac Surg. 2016;102:1550–7.

pubmed: 27345093 doi: 10.1016/j.athoracsur.2016.04.018

Gersak B, Zembala MO, Muller D, Folliguet T, Jan M, Kowalski O, et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients. J Thorac Cardiovasc Surg. 2014;147:1411–6.

pubmed: 23988287 doi: 10.1016/j.jtcvs.2013.06.057

Gilligan D, Joyner C, Bundy G. Multidisciplinary collaboration for the treatment of atrial fibrillation: convergent procedure outcomes from a single center. J Innov Card Rhythm Manag. 2013;4:1396–403.

Tonks R, Lantz G, Mahlow J, Hirsh J, Lee LS. Short and intermediate term outcomes of the convergent procedure: initial experience in a tertiary referral center. Ann Thorac Cardiovasc Surg. 2020;26:13–21.

pubmed: 31495813 doi: 10.5761/atcs.oa.19-00164

Toplisek J, Pernat A, Ruzic N, Robic B, Sinkovec M, Cvijic M, et al. Improvement of atrial and ventricular remodeling with low atrial fibrillation burden after hybrid ablation of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2016;39:216–24.

pubmed: 26643565 doi: 10.1111/pace.12791

Zembala M, Filipiak K, Kowalski O, Buchta P, Niklewski T, Nadziakiewicz P, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci. 2017;13:109–17.

pubmed: 28144262 doi: 10.5114/aoms.2015.53960

Kiser AC, Landers M, Horton R, Hume A, Natale A, Gersak B. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13:E317-21.

pubmed: 20961832 doi: 10.1532/HSF98.20091112

Edgerton Z, Perini AP, Horton R, Trivedi C, Santangeli P, Bai R, et al. Hybrid procedure (endo/epicardial) versus standard manual ablation in patients undergoing ablation of longstanding persistent atrial fibrillation: results from a single center. J Cardiovasc Electrophysiol. 2016;27:524–30.

pubmed: 26766149 doi: 10.1111/jce.12926

Jan M, Zizek D, Gersak ZM, Gersak B. Comparison of treatment outcomes between convergent procedure and catheter ablation for paroxysmal atrial fibrillation evaluated with implantable loop recorder monitoring. J Cardiovasc Electrophysiol. 2018;29:1073–80.

pubmed: 29722468 doi: 10.1111/jce.13625

Gersak B, Pernat A, Robic B, Sinkovec M. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23:1059–66.

pubmed: 22587585 doi: 10.1111/j.1540-8167.2012.02355.x

Zannis K, Alam W, Sebag FA, Folliguet T, Bars C, Fahed M, et al. The convergent procedure: a hybrid approach for long lasting persistent atrial fibrillation ablation, the French experience. J Cardiovasc Surg (Torino). 2020;61:369–75.

pubmed: 31603290

Maclean E, Yap J, Saberwal B, Kolvekar S, Lim W, Wijesuriya N, et al. The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: a single centre, propensity-matched cohort study. Int J Cardiol. 2020;303:49–53.

pubmed: 32063280 doi: 10.1016/j.ijcard.2019.10.053

Kiser AC, Landers MD, Boyce K, Sinkovec M, Pernat A, Gersak B. Simultaneous catheter and epicardial ablations enable a comprehensive atrial fibrillation procedure. Innovations (Phila). 2011;6:243–7.

pubmed: 22437982 doi: 10.1097/imi.0b013e31822ca15c

Lee LS. Subxiphoid minimally invasive epicardial ablation (convergent procedure) with left thoracoscopic closure of the left atrial appendage. Oper Tech Thorac Cardiovasc Surg. 2019;23:152–65.

Thosani AJ, Gerczuk P, Liu E, Belden W, Moraca R. Closed chest convergent epicardial-endocardial ablation of non-paroxysmal atrial fibrillation – a case series and literature review. Arrhythm Electrophysiol Rev. 2013;2:65–8.

pubmed: 26835043 pmcid: 4711551 doi: 10.15420/aer.2013.2.1.65

Makati K, Davoudi R, Giedrimas A, Irwin J, Sherman A, Gerogiannis I, et al. Safety and efficacy of a convergent hybrid procedure using cryo as endocardial energy source for the treatment of persistent and longstanding persistent atrial fibrillation. J Am Coll Cardiol. 2020;75:424.

doi: 10.1016/S0735-1097(20)31051-2

Starck CT, Steffel J, Emmert MY, Plass A, Mahapatra S, Falk V, et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg. 2012;15:416–8.

pubmed: 22647971 pmcid: 3422917 doi: 10.1093/icvts/ivs136

Lee LS. Subxiphoid minimally invasive epicardial ablation (convergent procedure) with left thoracoscopic closure of the left atrial appendage. Oper Tech Thorac Cardiovasc Surg. 2018;23:152–65.

doi: 10.1053/j.optechstcvs.2019.04.002

Gegochkori N, Yang F, Miller A, Kulbak G, Jacobwitz I, Greenberg Y. Comparison of hybrid ablation for persistent atrial fibrillation with and without left atrial appendage closure: report of 1 year follow up. Presented at Venice Arrhythmias, Venice, Italy, 2019. J Interv Card Electrophysiol. 2020;57:164.

Haldar S, Khan HR, Boyalla V, Kralj-Hans I, Jones S, Lord J, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41:4471–80.

pubmed: 32860414 pmcid: 7767634 doi: 10.1093/eurheartj/ehaa658

van der Heijden CAJ, Weberndörfer V, Vroomen M, Luermans JG, Chaldoupi S-M, Bidar E, et al. Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation. JACC Clin Electrophysiol. 2023;9:1013–23.

pubmed: 36752455 doi: 10.1016/j.jacep.2022.12.011

Doll N, Weimar T, Kosior DA, Bulava A, Mokracek A, Mönnig G, et al. Efficacy and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: a randomised, controlled trial. EClinicalMedicine. 2023;61: 102052.

pubmed: 37425372 pmcid: 10329123 doi: 10.1016/j.eclinm.2023.102052

Pearman CM, Poon SS, Bonnett LJ, Haldar S, Wong T, Mediratta N, et al. Minimally invasive epicardial surgical ablation alone versus hybrid ablation for atrial fibrillation: a systematic review and metaanalysis. Arrhythm Electrophysiol Rev. 2017;6:202–9.

pubmed: 29326836 pmcid: 5739900 doi: 10.15420/aer/2017.29.2

Bhatia NK, Shah RL, Deb B, Pong T, Kapoor R, Rogers AJ, et al. Mapping atrial fibrillation after surgical therapy to guide endocardial ablation. Circ Arrhythm Electrophysiol. 2022;15: e010502.

pubmed: 35622437 pmcid: 9839337 doi: 10.1161/CIRCEP.121.010502

de Asmundis C, Chierchia GB, Mugnai G, Van Loo I, Nijs J, Czapla J, et al. Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience. Europace. 2017;19:58–65.

pubmed: 27247011

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.

pubmed: 8572814 doi: 10.1016/0003-4975(95)00887-X

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75:3122–35.

pubmed: 32586585 doi: 10.1016/j.jacc.2020.04.067

Brouwer TF, Whang W, Kuroki K, Halperin JL, Reddy VY. Net clinical benefit of left atrial appendage closure versus warfarin in patients with atrial fibrillation: a pooled analysis of the randomized PROTECT-AF and PREVAIL studies. J Am Heart Assoc. 2019;8: e013525.

pubmed: 31752643 pmcid: 6912972 doi: 10.1161/JAHA.119.013525

Albåge A, Sartipy U, Kennebäck G, Johansson B, Scherstén H, Jidéus L, Swedish Arrhythmia Surgery Group. Long-term risk of ischemic stroke after the Cox-maze III procedure for atrial fibrillation. Ann Thorac Surg. 2017;104:523–9.

pubmed: 28242081 doi: 10.1016/j.athoracsur.2016.11.065

Wang H, Han J, Wang Z, Yin Z, Liu Z, Jin Y, et al. A prospective randomized trial of the cut-and-sew maze procedure in patients undergoing surgery for rheumatic mitral valve disease. J Thorac Cardiovasc Surg. 2018;155:608–17.

pubmed: 28965725 doi: 10.1016/j.jtcvs.2017.07.084

Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM. Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2018;155:983–94.

pubmed: 29246544 doi: 10.1016/j.jtcvs.2017.09.147

Pet M, Robertson JO, Bailey M, Guthrie TJ, Moon MR, Lawton JS, et al. The impact of CHADS2 score on late stroke after the Cox maze procedure. J Thorac Cardiovasc Surg. 2013;146:85–9.

pubmed: 22818126 doi: 10.1016/j.jtcvs.2012.03.087

Alqaqa A, Martin S, Hamdan A, Shamoon F, Asgarian KT. Concomitant left atrial appendage clipping during minimally invasive mitral valve surgery: technically feasible and safe. J Atr Fibrillation. 2016;9:1407.

pubmed: 27909512 pmcid: 5089506

Suwalski P, Witkowska A, Drobiński D, Rozbicka J, Sypuła S, Liszka I, et al. Stand-alone totally thoracoscopic left atrial appendage exclusion using a novel clipping system in patients with high risk of stroke – initial experience and literature review. Kardiochir Torakochirurgia Pol. 2015;12:298–303.

pubmed: 26855643 pmcid: 4735528

Osmancik P, Budera P, Zdarska J, Herman D, Petr R, Fojt R, et al. Residual echocardiographic and computed tomography findings after thoracoscopic occlusion of the left atrial appendage using the AtriClip PRO device. Interact Cardiovasc Thorac Surg. 2018;26:919–25.

pubmed: 29360987 doi: 10.1093/icvts/ivx427

Bedeir K, Warriner S, Kofsky E, Gullett C, Ramlawi B. Left atrial appendage epicardial clip (AtriClip): essentials and post-procedure management. J Atr Fibrillation. 2019;11:2087.

pubmed: 31384360 pmcid: 6652788

Lee R, Vassallo P, Kruse J, Malaisrie SC, Rigolin V, Andrei A-C, et al. A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: internal ligation, stapled excision, and surgical excision. J Thorac Cardiovasc Surg. 2016;152:1075–80.

pubmed: 27422360 doi: 10.1016/j.jtcvs.2016.06.009

Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52:924–9.

pubmed: 18772063 doi: 10.1016/j.jacc.2008.03.067

Vainrib AF, Harb SC, Jaber W, Benenstein RJ, Aizer A, Chinitz LA, et al. Left atrial appendage occlusion/exclusion: procedural image guidance with transesophageal echocardiography. J Am Soc Echocardiogr. 2018;31:454–74.

pubmed: 29158017 doi: 10.1016/j.echo.2017.09.014

van Laar C, Verberkmoes NJ, van Es HW, Lewalter T, Dunnington G, Stark S, et al. Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis. JACC Clin Electrophysiol. 2018;4:893–901.

pubmed: 30025689 doi: 10.1016/j.jacep.2018.03.009

Smith NE, Joseph J, Morgan J, Masroor S. Initial experience with minimally invasive surgical exclusion of the left atrial appendage with an epicardial clip. Innovations. 2017;12:28–32.

pubmed: 28129318

Ad N, Massimiano PS, Shuman DJ, Pritchard G, Holmes SD. New approach to exclude the left atrial appendage during minimally invasive cryothermic surgical ablation. Innovations. 2015;10:323–7.

pubmed: 26523825

Starck CT, Steffel J, Emmert MY, Plass A, Mahapatra S, Falk V, et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg. 2012;15:416–8.

pubmed: 22647971 pmcid: 3422917 doi: 10.1093/icvts/ivs136

Toale C, Fitzmaurice GJ, Eaton D, Lyne J, Redmond KC. Outcomes of left atrial appendage occlusion using the AtriClip device: a systematic review. Interact Cardiovasc Thorac Surg. 2019;29:655–62.

pubmed: 31292605 doi: 10.1093/icvts/ivz156

Ailawadi G, Gerdisch MW, Harvey RL, Hooker RL, Damiano RJ Jr, Salamon T, et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011;142(1002–9):1009.e1.

pubmed: 21906756

Emmert MY, Puippe G, Baumüller S, Alkadhi H, Landmesser U, Plass A, et al. Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg. 2014;45:126–31.

pubmed: 23657550 doi: 10.1093/ejcts/ezt204

Caliskan E, Sahin A, Yilmaz M, Seifert B, Hinzpeter R, Alkadhi H, et al. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery. Europace. 2018;20:e105-14.

pubmed: 29016813 doi: 10.1093/europace/eux211

Zhang S, Cui Y, Li J, Tian H, Yun Y, Zhou X, et al. Concomitant transcatheter occlusion versus thoracoscopic surgical clipping for left atrial appendage in patients undergoing ablation for atrial fibrillation: a metaanalysis. Front Cardiovasc Med. 2022;9: 970847.

pubmed: 36148075 pmcid: 9485627 doi: 10.3389/fcvm.2022.970847

Branzoli S, Guarracini F, Marini M, D’Onghia G, Catanzariti D, Merola E, et al. Heart team for left appendage occlusion without the use of antithrombotic therapy: the epicardial perspective. J Clin Med. 2022;11:6492.

pubmed: 36362719 pmcid: 9656641 doi: 10.3390/jcm11216492

Zipes DP, Calkins H, Daubert JP, Ellenbogen KA, Field ME, Fisher JD, et al. 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (a revision of the ACC/AHA 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion). Circ Arrhythm Electrophysiol. 2015;8:1522–51.

pubmed: 26386016 doi: 10.1161/HAE.0000000000000014

Hoffmann R, Parade U, Bauerle H, Winter KD, Rauschenbach U, Mischke K, et al. Safety and acute efficacy of cryoballoon ablation for atrial fibrillation at community hospitals. Europace. 2021;23:1744–50.

pubmed: 34374746 doi: 10.1093/europace/euab132

Vassilikos VP, Pagourelias ED, Laroche C, Blomström-Lundqvist C, Kautzner J, Maggioni AP, et al. Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) registry. Europace. 2021;23:49–58.

pubmed: 33141150 doi: 10.1093/europace/euaa236

Steinemann S, Berg B, Skinner A, DiTulio A, Anzelon K, Terada K, et al. In situ, multidisciplinary, simulation-based teamwork training improves early trauma care. J Surg Educ. 2011;68:472–7.

pubmed: 22000533 doi: 10.1016/j.jsurg.2011.05.009

Miller D, Crandall C, Washington C 3rd, McLaughlin S. Improving teamwork and communication in trauma care through in situ simulations. Acad Emerg Med. 2012;19:608–12.

pubmed: 22594369 doi: 10.1111/j.1553-2712.2012.01354.x

Friedman DJ, Pokorney SD, Khanna R, Goldstein L, Atwater BD, Bahnson TD, et al. Catheter ablation of atrial fibrillation with and without on-site cardiothoracic surgery. J Am Coll Cardiol. 2019;73:2487–9.

pubmed: 31076234 doi: 10.1016/j.jacc.2019.02.036

Pope MTB, Kuklik P, Briosa EGA, Leo M, Mahmoudi M, Paisey J, et al. Impact of adenosine on wavefront propagation in persistent atrial fibrillation: insights from global noncontact charge density mapping of the left atrium. J Am Heart Assoc. 2022;11: e021166.

pubmed: 35621197 pmcid: 9238707 doi: 10.1161/JAHA.121.021166

Tang S, Razeghi O, Kapoor R, Alhusseini MI, Fazal M, Rogers AJ, et al. Machine learning-enabled multimodal fusion of intra-atrial and body surface signals in prediction of atrial fibrillation ablation outcomes. Circ Arrhythm Electrophysiol. 2022;15: e010850.

pubmed: 35867397 pmcid: 9972736 doi: 10.1161/CIRCEP.122.010850

Saglietto A, Gaita F, Blomstrom-Lundqvist C, Arbelo E, Dagres N, Brugada J, et al. AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation. Europace. 2023;25:92–100.

pubmed: 36006664 doi: 10.1093/europace/euac145

Stojadinovic P, Wichterle D, Peichl P, Nakagawa H, Cihak R, Haskova J, et al. Autonomic changes are more durable after radiofrequency than pulsed electric field pulmonary vein ablation. JACC Clin Electrophysiol. 2022;8:895–904.

pubmed: 35863816 doi: 10.1016/j.jacep.2022.04.017

Boyle PM, Zghaib T, Zahid S, Ali RL, Deng D, Franceschi WH, et al. Computationally guided personalized targeted ablation of persistent atrial fibrillation. Nat Biomed Eng. 2019;3:870–9.

pubmed: 31427780 pmcid: 6842421 doi: 10.1038/s41551-019-0437-9

Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377:2325–36.

pubmed: 29236642 pmcid: 5764179 doi: 10.1056/NEJMoa1613773

Qian PC, Azpiri JR, Assad J, Gonzales Aceves EN, Cardona Ibarra CE, de la Pena C, et al. Noninvasive stereotactic radioablation for the treatment of atrial fibrillation: first-in-man experience. J Arrhythm. 2020;36:67–74.

pubmed: 32071622 doi: 10.1002/joa3.12283

Hohmann S, Deisher AJ, Konishi H, Rettmann ME, Suzuki A, Merrell KW, et al. Catheter-free ablation of infarct scar through proton beam therapy: tissue effects in a porcine model. Heart Rhythm. 2020;17:2190–9.

pubmed: 32673796 doi: 10.1016/j.hrthm.2020.07.011

Avram R, Ramsis M, Cristal AD, Nathan V, Zhu L, Kim J, et al. Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch. Heart Rhythm. 2021;18:1482–90.

pubmed: 33838317 doi: 10.1016/j.hrthm.2021.03.044

Zhu L, Nathan V, Kuang J, Kim J, Avram R, Olgin J, et al. Atrial fibrillation detection and atrial fibrillation burden estimation via wearables. IEEE J Biomed Health Inform. 2022;26:2063–74.

pubmed: 34855603 doi: 10.1109/JBHI.2021.3131984

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Classifications MeSH